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SUMMARY 
This thesis is written as a collection of research papers through which the therapeutic 
effects of imagery and hypnotherapy in rheumatoid arthritis (RA) are investigated using a 
patient-centred approach. The first section of this thesis explores the biomedical model of disease in RA, highlighting the limitations of this model which led to the development of 
a biopsychosocial model. Specifically, the biopsychosocial model of disease in RA identifies factors other than pathology which influence the symptoms associated with the disease, e. g., self-efficacy and social support. With a view that psychosocial variables can have an impact for the outcome in RA, a variety of psychosocial interventions have been 
utilised. Consequently, chapter two reviews the literature on psychosocial interventions 
and provides the rationale for further investigation of imagery and hypnotherapy. The 
second section of this thesis examines the application of these two psychosocial 
interventions using a patient-centred approach in RA patients. Patient-centredness was 
achieved by allowing participants to identify areas for therapeutic intervention using a 
patient generated outcome measure (PGOM). Specifically, chapter three identified that 
both imagery and hypnotherapy significantly increase health related quality of life 
(HRQOL) when measured with a PGOM of HRQOL in the short-term. However, only 
hypnotherapy maintained this significant increase in the long-term. Furthermore, a 
discrepancy between the most commonly used HRQOL measure (the SF-36) and a 
PGOM was identified, indicating that the SF-36 may not be measuring what is perceived 
to be HRQOL in individuals with RA. Using the same participants, chapter four identifies 
that both imagery and hypnotherapy significantly reduce pain in RA in the short-term. 
Additionally, hypnotherapy significantly increased self-efficacy for controlling pain, and 
significantly reduced functional disability. Given these results it was concluded that 
hypnotherapy was statistically superior to imagery. Consequently, as these psychosocial 
interventions provided some benefit to patients with stable RA, chapter five explored 
their use in active RA patients. Specifically, the biopsychosocial model assumes a 
reciprocal relationship between the three systems in the model. Using a case study 
approach several areas of improvement in clinical assessment were identified, with the 
disease activity score (DAS28) of two patients receiving hypnotherapy and four receiving 
imagery, showing a moderate response to the intervention in accordance with the 
European League Against Rheumatism (EULAR) response criteria. Additionally, 
participants reported improvement in psychosocial function with clinically significant 
reductions in pain and fatigue in some cases, and clinically significant reductions in 
functional disability in all ten participants. As the imagery group reported more clinically 
significant change it was concluded that this intervention was clinically more superior to 
hypnotherapy. The final section addresses methodological issues, the strengths and 
weakness of the research programme, future research directions and the clinical 
implications from the results of this thesis. 
General Introduction I 
CHAPTER ONE 
GENERAL INTRODUCTION 
Objectives of the Research Programme 
Throughout the medical literature there is evidence that the predominant disease pattern in 
developed countries is chronic rather than acute disease (Petri & Revenson, 2005). Within- 
disease variation indicates that factors other than underlying pathology and biology may be 
responsible for differences in the way in which chronic disease impacts the life of patients 
(Stanton & Revenson, 2007). Rheumatoid arthritis (RA) is a chronic disease where a disease- 
disability discrepancy is evident (Barlow, Cullen, & Rowe, 2002). Psychosocial interventions 
have been developed for chronic disease for the purposes of helping individuals adjust to the 
disease, to alleviate or treat the symptoms of the disease, and/or as adjunctive care to help 
patients cope with traditional medical care (Nicassio, Meyerowitz, & Kerns, 2004). The 
primary objective of this research programme was to examine the effects of two psychosocial 
interventions, imagery and hypnotherapy, in RA patients, specifically with a focus on 
psychosocial functioning related to the symptoms of the disease and disease activity in active 
RA. A secondary objective of this research programme was to provide training in the 
research process, from inception of the research question to dissemination of research 
findings. 
Rheumatoid Arthritis: The Disease and the Symptoms 
Rheumatoid arthritis is a chronic autoimmune disease (Combe, 2007) involving 
progressive inflammation of the synovial tissue lining of the joints and destruction of 
articular cartilage (Dixon & Symmons, 2005). The disease is normally diagnosed following 
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clinical assessment revealing four or more of the seven criteria provided by American 
College of Rheumatology, which include morning stiffness lasting more than one hour, 
arthritis of three or more joint areas, arthritis of the hand joints, symmetric arthritis, 
rheumatoid nodules, the presence of serum rheumatoid factor in blood, and radiographic 
changes (Arnett et al., 1988). Furthermore, disease activity is often characterised by elevated 
acute phase reactants, namely erythrocyte sedimentation rate and C-reactive protein (Felson 
ct al., 1995). Although more usually associated with the joints, RA can also affect many 
organ systems leading to premature mortality (Simon, Lipman, Allaire, Caudill-Slosberg, & 
Gill, 2002). It is estimated that RA affects 1% of the population where women are almost 
three times more likely than men to be diagnosed with this disease (Gabriel, 2001). 
Symptoms associated with the disease, including swollen and tender joints (Lee & 
Weinblatt, 2001), and pain (Pollard, Choy, & Scott, 2005) result in varying degrees of 
disability (Griffiths, 2006) and diminished quality of life (Gordon, Smith, & Dhillon, 2007). 
RA is also associated with unpredictable acute painful flare-ups (Strahl, Kleinknecht, & 
Dinnel, 2000) which have been shown to cause further progressive joint damage, and 
increased pain anxiety (Zautra, Burleseton, Matt, Roth, & Burrows, 1994). 
Pain. Pain is a primary concern for patients with RA (Pollard et al., 2005). Indeed, 
Sokka, Krishnan, Hdkkinen, and Hannonen (2003) report that patients with RA experience 
higher pain levels than the general population. Moreover, increased pain in RA is predictive 
of higher functional disability (Häkkinen et al., 2005). Pain has also been related to 
psychological health and social factors (Nagyova, Stewart, Macejova, van Dijk, & van den 
Heuvel, 2005). Specifically, individuals with chronic pain may avoid certain activities which 
they believe would aggravate their pain. As a result they engage less in social activities and 
this has a negative impact on their social support networks (Evers, Kraaimaat, Geenen, 
Jacobs, & Bijlsma, 2003). 
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Despite pain being a symptom of the disease, there is evidence to suggest that non- 
disease factors influence the perception and severity of pain in RA (Dixon, Keefe, Scipio, 
Perri, & Abernethy, 2007). For example, Evers, Kraaimaat, van Riel, and Bijlsma (2001) 
reported that physiological and psychological reactions to pain influence future pain 
perceptions and pain behaviours (e. g. avoidance behaviours). Hamilton, Zutra, and Reich 
(2005) report that active coping, specifically, the expression of emotion and feeling in control 
of the pain, results in decreased self-reported pain in RA. More recently, Connelly et al. 
(2007) provide evidence which supports Hamilton et al. (2005), suggesting that 28% of the 
variance in pain can be explained by the regulation of both positive and negative affect. In 
relation to negative affect, Zautra et al. (2007a) have demonstrated that previous episodes of 
depression result in higher perceived pain. 
Fatigue. Fatigue is a common symptom present in RA patients (Wolfe, Hawley, & 
Wilson, 1996). Indeed, patients with RA report fatigue as a major negative influence on their 
quality of life (Rupp, Boshuizen, Jacobi, Dinant, & van den Bos, 2004). It has been suggested 
that fatigue in RA may be due to increased pro-inflammatory cytokines which are known to 
be a contributing factor in increased fatigue in the healthy populations (Kelley et al., 2003). 
However, when investigating possible predictors of fatigue in RA patients, Huyser et al. 
(1998) found no significant correlations between disease activity, or biological indices of 
disease activity, and self-reported fatigue. This indicates that factors other than pathology 
may be responsible for increased fatigue in RA patients. 
More recently, Zautra, Fasman, Parrish, and Davis (2007b) identified a positive 
correlation between lower affect and higher fatigue levels in RA. However the authors did 
not examine the influence of disease activity or inflammation. Furthermore, as the authors 
used a correlation approach in their analysis it is impossible to imply a causal relationship 
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between affect and fatigue. Therefore the results only suggest a relationship between the 
variables. 
Pollard, Choy, Gonzalez, Khoshaba, and Scott (2006) examined the relationship 
between disease activity and fatigue in RA patients. Specifically, they identified three 
variables which could account for 53% of the variation in fatigue scores. These were pain, 
mental health, and the patient's global assessment of disease. Furthermore, they found no 
association between elevated inflammatory markers or disease activity and levels of fatigue. 
In support of these findings Repping-Wuts, Fransen, van Achterberg, Bleijenberg, and van 
Riel (2007) concluded that neither elevated biological markers of inflammation nor increased 
disease activity was significantly related to fatigue levels in RA. 
Functional disability. Functional disability has been identified as the most important 
long-term outcome in RA (Lillegraven & Kvien, 2007). It has been defined as an individual's 
ability to function at many different levels, including person, societal, and environmental 
(Leonardi, Bickenbach, Ustun, Kostanjsek, & Chatterji, 2006). Sokka, Kautiainen, Hannonen, 
and Pincus (2006) identified, from a longitudinal study, that patients with RA are 
significantly more disabled than the general population. However, the authors noted that 
individuals over the age of 70 years were not significantly more disabled than aged-matched 
controls. If functional disability was a consequence of RA then we might expect that 
disability scores would be significantly higher in RA patients irrespective of age. This 
indicates that functional disability in RA is not only a result of disease. 
Early studies investigating the determinants of disability in RA suggested that 
disability was the result of not only disease activity, but also psychological factors such as 
depression and anxiety (McFarlane & Brooks, 1988). However, current evidence indicates 
that disease activity is the most predictive variable of disability in RA (Scott, Smith, & 
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Kingsley, 2003), specifically, disease activity can explain 51% of functional disability (Haze, 
2003). 
Health related quality of life (HRQOL). Currently as there is no cure for RA, greater 
emphasis has been put on evaluating patients HRQOL (Fayers & Machin, 2000). HRQOL is 
defined as that part of overall quality of life affected by health (Moriarty, Zack, & Kobau, 
2003) and includes an individual's perception of life satisfaction in relation to treatment of 
illness or disease (Kushida et al., 2007). Given the severity of the symptoms of RA, it is not 
surprising that studies investigating HRQOL report that patients with RA score lower on 
I IRQOL measures than matched controls (Husted, Gladman, Farewell, & Cook, 2001). 
Uhlig, Loge, Kristiansen, and Kvien (2007) report that RA has a serious impact on physical 
health, but also affects all HRQOL domains, as measured by the Short Form 36 Health 
Survey Questionnaire (SF-36; Ware & Sherbourne, 1992). In a review of HRQOL in RA 
Groessi, Ganiats, and Sarkin (2006) identified several non-disease factors which contributed 
to differences in HRQOL in patients. Specifically, the authors noted that age, gender, 
education, and socio-economic status could account for differences, and were predictors of 
lower HRQOL 
The SF-36 is the most widely used HRQOL measure in RA studies (Kalyoncu, 
Dougados, Daures, & Gossec, 2008), however there is some evidence to suggest that this 
measure may not be an adequate measure of HRQOL in chronic conditions such as RA 
(Bradley et al., 1999). Furthermore, measures of HRQOL such as the SF-36 have been 
criticised because they fail to include the patient's perspective (Patel, Veenstra, & Patrick, 
2003). Issues related to the measurement of HRQOL in RA are addressed within chapter 
three of this research thesis. In particular the use of generic and individualised measures is 
discussed in relation to patient perceived HRQOL. 
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In summary, the symptoms associated with RA are detrimental to the individual. 
Patients experience high levels of pain and fatigue, functional disability, and decreased 
HRQOL. However, the literature indicates that the severity of the symptoms is not the result 
of the disease alone. Several psychological, social and environmental influences can be 
identified which contribute to the consequences of living with RA. Notwithstanding the non- 
disease specific factors associated with the symptoms of RA, the disease and treatment has 
traditionally been conceptualised within a biomedical model (Escalante & del Rincon, 2002). 
A Biomedical Perspective of the Disease and Treatment 
A biomedical perspective of disease in RA assumes that the symptoms and outcomes 
of the disease are determined by the underlying pathology and physiological mechanisms 
related to the disease (Abelson, Rupel, & Pincus, 2008). However, as cited in the previous 
section, there are many non-disease factors which influence the symptoms of this disease. 
More importantly, a challenge for the biomedical model is that the exact cause of RA remains 
unclear (Haas et al., 2006; Smolen, Aletha, Koeller, Weisman, & Emery, 2007). Much is 
known about the immune response and inflammatory processes in RA (Albert & Inman, 
1999; Edwards & Cambridge, 2006; McInnes & Schett, 2007) and possible risk factors 
associated with the aetiology of the disease have also been identified (Stolt et al., 2003). 
However, there is currently no cure for RA (Newman & Milligan, 2004), consequently the 
aim of treatment, from a biomedical perspective, is to control disease progression and 
disability through pharmaceutical intervention using non-steroidal anti-inflammatory drugs 
(NSAIDs) and disease modifying anti-rheumatic drugs (DMARDs). 
Pharmacological intervention using NDAIDs. NSAIDs , 
for example aspirin, 
ibuprofen, diclofenac, and naproxen, are used routinely in RA patients. NSAIDs act almost 
immediately on pain and inflammation in RA patients, however these drugs generally do not 
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alter the course of disease progression (Combe, 2007). They were once considered the first 
course of treatment, often being used conservatively for a number of years before introducing 
DMARDs (Lee et al., 2001). However due to the high risks associated with these drugs, for 
example acute myocardial infarction (Singh, Wu, Langhorne, & Madhok, 2006), 
gastrointestinal ulceration (Moore, Derry, Makinson, & McQuay, 2005), and acute renal 
failure (Griffin, Yared, & Ray, 2000), it is now advised that patients should use NSAID for 
the shortest duration possible (Singh et al., 2003). 
Pharmacological intervention using DMARDs. DMARDs, for example methotrexate, 
sulphasalazine, and cyclosporine, or combinations of DMARDs have shown to effectively 
slow the progression of RA (Landewe et al., 2000; Goekoop-Ruiterman et al., 2002). 
DMARDs are not as fast acting as NSAIDs often taking several months before they have an 
impact on disease progression (Combe, 2007). Evidence further suggests that earlier 
intervention is most effective in order to reduce further joint damage and disability (Nell et 
al., 2004), and that delayed introduction of DMARDs is associated with greater problems in 
controlling the disease (Möttönen et al., 2002). 
The problem of a biomedical approach to the treatment of RA. Identifying early 
disease is extremely difficult for clinicians as there are no diagnostic criteria or tests available 
to define early RA (Visser, 2005). Furthermore, many patients delay seeking medical help 
believing that their symptoms are a result of a preceding activity, for example over-doing 
things with the shopping, or DIY (Sheppard, Kumar, Buckley, Shaw, & Raza, 2008). 
Additionally, not only do patients delay seeking medical attention, but there is a further delay 
between first encounter with a physician and subsequent follow-up with a rheumatology 
specialist (Feldman et al., 2007; Kumar et al., 2007). Indeed Palm and Purinszky (2005) 
noted that many patients face a 16 week delay before being seen by a rheumatology 
specialist. As delayed introduction of DMARD therapy has been associated with greater 
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problems in controlling the disease many patients who experience these delays may have to 
try several DMARDs before the most effective treatment regime is obtained (Choy, Smith, 
Dore, & Scott, 2005). Furthermore, adherence to anti-rheumatic medications is often low. 
Indeed, De Klerk et al. (2003) estimate that RA patient adherence with drug treatment is 
between 30 and 80%, and increases during a flare. 
More recently, biological agents have proven effective at reducing disease activity in 
RA (Emery, 2006). Randomised clinical trials of anti-tumour necrosis factor a (anti-TNF-a) 
have demonstrated effectiveness for reducing functional decline and joint erosion in patients 
who did not respond to traditional DMARD therapy (Breedveld et al., 2006). These new 
developments in the treatment of RA prove promising. However as with established drug 
treatment of RA, anti-TNF-a also carries considerable risks. For example, the risk of serious 
infections such as pneumonia is doubled when compared to traditional DMARD therapy 
(Ianac & Direskeneli, 2006), and increased risk of neurological disease such as multiple 
sclerosis and optic neuritis have also been indicated (Park & Park, 2006). Additionally, 
biological treatments for RA are very expensive (Smolen et al., 2007), and there is 
uncertainty about their cost-effectiveness (Barbieri et al., 2007). 
The biomedical model of disability in RA. Disability is a long-term outcome of RA 
(Cieza & Stucki, 2005). In order to understand the process of disability several conceptual 
models have been developed, for example Disease Handicap Model (WHO, 1980) and the 
Disease Disability Model (Nagi, 1991). Similarly, Verbrugge and Jette (1994) propose a 
model which focuses on the sequence of events from pathology to disability. They propose 
that inflammation from RA causes impairment, for example, swelling, deformity, and pain. 
The impairment caused by the pathology leads to functional limitations, for example loss of 
mobility, loss of strength, and loss of dexterity. Finally, they suggest that functional 
limitation leads to disability, for example being unable to clean the house, or do the shopping. 
General introduction 9 
However, these models of disability have been criticised for the linear fashion they 
portray the progression of disability in RA (Jette & Keysor, 2003). Furthermore, researchers 
using these models have identified variables not directly related to pathology, or impairment, 
which may exacerbate, or reduce disability (Foster et al., 2003; Trilling, 2000). Specifically, 
Escalante and del Rincon (1999) identified that the main disease-disability model proposed 
by Verbrugge et al. (1994) could only account for 33% of the overall disability in RA. More 
recently, Walker, Littlejohn, Jackson, and Dudgeon (2005) demonstrated that the biomedical 
model could only account for 39% of the variance in activities of daily living. These results 
support the findings of Escalante et al. (1999) and provide evidence of the limitations of a 
biomedical model of disease and disability in RA. 
The biomedical model of disease and disability in RA has provided many 
opportunities to understand the pathology and possible underlying mechanisms associated 
with disease progression. A biomedical approach to treatment has also been instrumental in 
the development of new and exciting drug therapies which help to alleviate some of the 
symptoms and the resultant disability associated with the disease. However, given that the 
biomedical model cannot fully account for disability in RA, this indicates limitations of this 
particular theoretical orientation. Specifically, the biomedical model does not consider 
psychological or social factors. Furthermore, clinical evidence of the limitations of a 
biomedical model is provided by the fact that patients of the same age can present with very 
similar clinical measures of disease activity, yet have very different degrees of disability 
(Barlow et al., 2002) in RA. The discrepancy between disease and disability has fuelled 
researchers exploring a biopsychosocial model of disease in RA. 
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A Biopsychosocial Perspective of the Disease and Treatment 
The biopsychosocial model is a general model derived from social cognitive theory 
(Halligan & Aylward, 2006). DiMatteo, Haskard, and Williams (2007) argue that the main 
premise of the biopsychosocial model is that disease and illness are considered within the 
context of three systems, namely biology (e. g., genetics, pathology, immunology), 
psychology (e. g., cognition, emotion, and behaviour), and social (e. g., social and physical 
environments). Furthermore, it is assumed that the three systems in the model have a 
reciprocal relationship, where changes in one system can influence changes in the others 
(Keefe et al., 2002). For example, within RA a biopsychosocial model we might hypothesise 
that increases in the number of swollen joints and elevated inflammatory markers (the 
biology subsystem) would lead to increased pain, anxiety, and decreased self-efficacy (the 
psychology subsystem), which may result in a decrease in the amount of time spent in leisure 
activities (the social subsystem). 
It is clear that the biomedical model of disease and disability in RA concentrates 
almost exclusively on biological, genetic, and pathological influences, and does not 
acknowledge non-disease specific factors such as demographic characteristics and 
psychosocial variables which may contribute towards overall outcome of the disease (Foster 
et al., 2003). These non-disease specific factors are central to the biopsychosocial model of 
disease and disability in RA. Specifically, Escalante et al. (2002) propose that contextual 
factors and psychosocial modifiers can influence the main disease-disability pathway and 
resultant disability. 
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Contextual Factors in the Development of Disability in RA 
Although contextual factors help to inform a biopsychosocial model of disability in 
RA they are generally not amenable to change (Escalante et al., 2002), and include variables 
such as biological sex, and socioeconomic status. 
Biological sex. Studies that investigate the differences in disability between men and 
women often report that women with RA are more disabled than men with RA (Symmons, 
2003). Indeed, Soroosh et al. (2005) identified that pain and disability were consistently rated 
worse in women than men, even though there were no significant differences in joint 
deformity or disease activity. The evidence might seem to indicate that RA affects women 
more than men. However, early studies have shown that men with RA over estimate their 
functional capabilities (Van den Ende, Hazes, Le Cessie, Breedveld, & Dijkmans, 1995). 
Therefore, at present it is unclear whether biological sex plays any significant role in 
disability however, there is evidence that the onset of RA in males is significantly later than 
females (Wilder, 1996). This has prompted novel research investigating the role of sex- 
hormones in the aetiology of RA (Jawaheer, Lum, Gregersen, & Criswell, 2006). 
Socioeconomic status. Early studies linked lower socioeconomic status to increased 
disease severity and morbidity in RA patients from the US (Callahan & Pincus, 1988). It was 
suggested that inadequate access to medical care was a crucial mechanism in explaining this 
finding. However in the UK, where medical care is provided free by the National Health 
Service (NHS), NHS patients with lower socioeconomic status also experience higher 
disability and mortality rates than those NHS patients with higher socioeconomic status 
(Maiden, Capell, Madhok, Hampson & Thomspn, 1999). This is inconsistent with the 
proposed explanations of Callahan et al. (1988). Research has also demonstrated that 
compliance to medication is not a significant factor in explaining socioeconomic differences 
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in RA patients (McEntegart et al., 1997). More recently, Bengtsson, Nordmark, Klareskog, 
Lundberg, and Alfredsson (2005) reported that individuals with lower socioeconomic status 
have a higher risk of developing RA, and conclude that unexplained environmental, or 
lifestyle factors are a risk factor in RA. It is clear from the literature that lower 
socioeconomic status is not only a risk factor of RA, but also has a greater impact on disease 
severity and increased mortality by unknown mechanisms. 
Other contextual factors. Other contextual factors identified by Escalante et al. 
(2002) include age and ethnic background. However, as with biological sex and 
socioeconomic status, the mechanism by which they influence susceptibility and severity of 
disease is not clearly understood. These contextual factors are not considered by the 
biomedical model of disease and disability in RA, but the evidence presented does suggest 
they do account for some of the variance in disability. However, the amount of variance 
contextual factors contribute to disability is relatively low. Using hierarchical regression 
analysis Escalante et al. (2002) calculated that contextual factors could account for 6% of the 
variance in disability in RA. Other variables within the biopsychosocial model which further 
develop our understanding of the variance in disease and disability in RA include 
environmental and lifestyle factors, and psychosocial modifiers (Escalante et al., 2002). 
Psychosocial Modifiers in Rheumatoid Arthritis 
Psychological modifiers are variables which may influence the symptoms of RA, but 
are not directly related to the disease (Escalante et al., 2002). A number of psychological 
modifiers have been identified in RA. For example, Schoenfield-Smith et al. (1996) identified 
pain and feelings of helplessness as psychosocial modifiers in the development of disability 
in RA. Helplessness can occur when individuals perceive no control over the outcome of 
their disease (Smith, Peck, & Ward, 1990), this is particularly salient for individuals with RA 
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where the occurrence of flares is unpredictable and severe (Strahl et al., 2000). Indeed, 
helplessness has been shown to be a significant predictor of pain, disability, and depression in 
chronic pain patients including RA (Samwel, Evers, Crul, & Kraaimaat, 2006). 
Psychological stress has also demonstrated a modifying effect in adjustment to RA 
and consequent health status (Curtis, Groarke, Coughlan, and Gsel, 2005). Zautra and Smith 
(2001) demonstrated that compared to people with osteoarthritis, individuals with RA have 
higher physiological and psychological reactivity to stress. Importantly, increased stress has 
shown to elevate the inflammatory marker C-reactive protein in RA, indicating increased 
disease activity (Zautra, Smith, & Yocum, 2002). 
Psychosocial modifiers, specifically, self-efficacy, and social support have been 
identified as important in the disablement process and health related quality of life in RA 
(Keefe et aL, 2002; Newman & Mulligan, 2004). Pain is also considered a psychosocial 
modifier in the disablement process in RA, however as this was discussed earlier in this 
chapter it will not be repeated here. 
Set(-efficacy. The construct of self-efficacy is a central component of Bandura's 
(1977) social cognitive theory. Briefly, self-efficacy is an individual's belief in their ability to 
successfully organise and carry out a specific course of action to attain the desired result 
(Bandura, 1977). Early studies indicate that higher levels of self-efficacy in RA patients 
resulted in better psychological health (Long, Chastain, Ung, Shoor, & Holman, 1989) and 
lower levels of disability (Shoor & Holman, 1984). Indeed, Riemsma et al. (1998) identified 
that 37% of the variance for fatigue could be explained by self-efficacy and pain. 
Specifically, pain has a direct influence on psychological and functional disability 
(Schoenfield-Smith et al., 1996). 
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In patients with RA where self-efficacy for managing pain is high, then there is a 
possibility that perceived disability will be lower. Indeed, in a large sample of RA patients 
Brekke, Hjortdahl, and Kvien (2001) demonstrated that higher scores in self-efficacy for 
managing pain was significantly correlated with lower scores in pain, fatigue, patients global 
assessment of disease severity and increased mental health over a two year period. More 
recently, Cross, March, Lapsley, Byrne, and Brooks (2006) provided similar evidence, with 
significant correlations between higher scores on self-efficacy measures and better health 
status in RA patients. Although the results from these studies indicate a potential moderating 
role of self-efficacy in RA, it should be remembered that the analyses used in these studies 
was correlational, therefore it is impossible to suggest causation. It may be that self-efficacy 
for controlling pain was higher because perceived pain was lower. Longitudinal prospective 
studies would provide evidence on the direction of causality between self-efficacy and the 
outcome of symptoms associated with RA. 
Social support. Social support has been defined as "the degree to which a persons 
needs are gratified through interaction with others, these needs may be met by either the 
provision of socio-emotional aid or the provision of instrumental aid" (Thoits, 1982, p. 147). 
Early studies investigating the role of social support in RA patients have provided some 
evidence that social support influences not only the outcomes of the disease but also disease 
activity. For example, Guccione, Anderson, Anthony, and Meenan (1995) reported that 
patients who were married had slower disease progression rates than those who were single. 
Newman, Fitzpatrick, Lamb, and Shipley (1989) identified that patients with a greater 
number of social contacts had better psychological health. 
These two early studies raise important questions regarding the nature of social 
support. There are assumptions that social support is a positive factor, and that quantity may 
be better than quality and satisfaction of support transactions. In relation to the quality of 
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social support, research investigating married couples has identified that where the spouse of 
the patient is critical then this has a negative effect on psychological health (Kraaimaat, van 
Dam-Baggen, & Bijlsma, 1995). 
The results of more recent studies investigating social support as a psychosocial 
modifier in RA confirm the findings of earlier studies. Evers et al. (2003) reported that 
greater social support predicted lower functional disability and pain at three years follow-up 
and still remained a significant predictor after five years. However, a limitation of this study 
was participants low disease duration, less than one year. Given the improvement in 
aggressive treatment of early RA it is possible that the beneficial changes may not be due to 
social support, but may be due to the medication. Indeed, Strating, Suurmeijer, and Van 
Schuur (2006) found that although social support seems to buffer the impact of early RA, 
there was no effect for patients with long-standing RA. Suggesting that possibly there are 
other variables not measured in these studies which contribute to improve functional abilities, 
for example anti-rheumatic medication. However, in a study examining RA patients with a 
mean disease duration of 13years (ranged between less than one year and 43years), Zyrianova 
et al. (2006) investigated the possible buffering effects of social support on depression and 
anxiety in RA patients. The authors reported that scores on measures of depression and 
anxiety were highly correlated with pain and functional disability. More importantly, 
perceived social support was found to be a significant predictor of both depression and 
anxiety. This study suggests that social support may have a beneficial buffering effect in RA 
irrespective of disease duration. 
In summary, the symptoms of RA cannot be fully explained by the biomedical model. 
Factors specific to the individual person such as contextual and psychosocial variables 
contribute to the symptoms of RA including resultant disability. Contextual variables are 
generally not possible to change, however many of the symptoms of the disease can modified 
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by psychosocial factors such as self-efficacy, psychological health, and social support. Given 
that the symptoms of RA can be modified by psychosocial variables, research within a 
biopsychosocial perspective has focussed on psychosocial interventions to help alleviate the 
symptoms of the disease. Consequently, an objective of the present research programme was 
to examine the effect specific psychosocial interventions in patients with RA in order to 
examine changes in the symptoms associated with the disease. 
A Patient-Centred Approach as an Outcome of a Biopsychosocial Perspective 
The transition from a biomedical to a biopsychosocial perspective of disease raises a 
number of important issues regarding the management and delivery of treatment for chronic 
diseases such as RA. Indeed, within the UK, the NHS has adopted a new strategy in creating 
a patient-led NHS, giving patients greater choice and control of treatment (Department of 
Health, 2005). This strategy reflects the growing awareness of the changing roles of patients 
as service users and physicians as service providers, the need for increased satisfaction in 
service provision, and a change in focus from disease to understanding the patient's 
perspective (Epstein et al., 2005). It has been acknowledged that the focus from the disease to 
the person integrates a patient-centred focus, rather than a physician-centred, or disease- 
centred focus (Silverman, 1987; Stewart, 2001). 
Several models of patient-centredness have been proposed (Brown, Stewart, & Ryan, 
2001; Stewart et al., 1995; Epstein et al., 2005). These models differ on what constitutes a 
patient-centred approach, largely due to different definitions, for example Epstein et al., 
(2005) argue that communication between the patient and the physician is a key determinant 
in developing a patient-centred approach, while Brown et at. (2001) propose that sharing 
power and responsibility are important elements of patient-centredness. However, the 
essential focus of all models of patient-centredness is the role of psychological and social 
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factors which interact with the biological factors, i. e. the biopsychosocial model of disease 
(Del Piccolo, Mazzi, Scardoni, Gobbi, & Zimmermann, 2008). 
Within research and clinical practice, patient-centredness is further enhanced through 
the use of patient reported outcome measures (PROMs; Carr & Higginson, 2001) and patient 
generated outcome measures (PGOMs; Patel et al., 2003). PROMs are instruments that 
measure any aspect of a person's health that come directly from the patient (Marshall, 
Ilaywood, & Fitzpatrick, 2006). Examples of PROMs used routinely in research and clinical 
practice include visual analogue scale for pain and fatigue, and fixed-item measures such as 
the hospital anxiety and depression scale (Zigmond & Snaith, 1983) and the Short Form 36 
Health Survey Questionnaire (SF-36; Ware et al., 1992). PGOMs are different from PROMs 
in that patients identify specific areas of their life which are important to them, rather than 
pre-selected items thought to be important by clinicians (Carr et al., 2001). Examples of 
PGOMs include the Patient Generated Index (PGI; Ruta, Garratt, Leng, Russell, & 
MacDonald, 1994) and the Schedule for the Evaluation of Individual Quality of Life 
(SEIQoL; O'Boyle, Browne, Hickey, McGee, & Joyce, 1995). 
The use of such measures as outcomes in research and clinical practice facilitate 
improved patient-clinician communication (Gilbody, Whitty, Grimshaw, & Thomas, 2003). 
Furthermore, PROMs and PGOMs can be used to identify patient preferences enabling 
shared power and responsibility for goals of treatment (Lindblad, Ring, Glimelius, & 
Hansson, 2002). Furthermore, the use of PROMs and PGOMs to facilitate a patient-centred 
approach to treatment may result in greater satisfaction with healthcare (Hirsh et al., 2005) 
and increases compliance to treatment (Fuertes et al., 2007). 
In summary, the primary aim of a biomedical perspective in chronic disease, the 
diagnosis and subsequent treatment, is dictated by pharmacological intervention to restore the 
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underlying biological mechanism to a state of normality (Mead & Bower, 2000). This 
emphasises a disease-centred approach. The biopsychosocial perspective of disease focuses 
more on the individual and reflects a patient-centred approach (Stewart, 2001). Furthermore, 
the use of PROMs and PGOMs in research and clinical practice help to reinforce a patient- 
centred approach in the treatment of chronic disease. Consequently, within the current 
research programme both PROMs and PGOMs were utilised to ensure a patient-centred 
approach was possible. 
Overview of the Research Programme 
This research programme aims to investigate psychosocial interventions in RA. A 
patient-centred approach will be utilised by employing PROMs and, more specifically the 
PGI, a PGOM. However, in determining which psychosocial interventions will be employed 
it is necessary to conduct a review of the literature of psychosocial interventions in RA. This 
review will identify which psychosocial interventions warrant further investigation. 
Consequently, chapter two of this research thesis will provide a literature review of 
psychosocial interventions in RA. 
An important outcome of any intervention in chronic disease is HRQOL as this will 
help direct the management of the disease (Fayers & Machin, 2000). Consequently, chapter 
three of this thesis will focus on the measurement of HRQOL in RA, following a 
psychosocial intervention identified in chapter two. Specifically, a HRQOL PGOM will be 
compared to a HRQOL PROM. 
Chapter four of this thesis will examine the efficacy of the chosen psychosocial 
intervention with regard to the symptoms of RA (e. g. pain, fatigue, pain anxiety, self- 
efficacy, and functional disability). Chapter five will focus on the assumptions of a 
biopsychosocial model of RA and examine whether changes in the psychology subsystem of 
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this model results in any beneficial change to the biology of the disease following 
psychosocial intervention. 
The final chapter of this thesis will provide overall conclusions concerning the 
efficacy of the psychosocial interventions employed in the research programme. The 
strengths and limitations of the current research will be identified, through which areas for 
future research and the clinical implications of this research programme will also be 
addressed. In concluding this research thesis the mnemonic FINER, suggested by Hartrick 
(2008) for aiding systematic reflection of the research process will be employed. Specifically, 
Hartrick (2008) argues that high quality studies should be feasible, interesting, novel, ethical, 
and relevant. 
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CHAPTER TWO 
PSYCHOSOCIAL INTERVENTIONS FOR RHEUMATOID ARTHRITIS: A 
REVIEW OF THE LITERATURE. 
The objective of this chapter is to identify the psychosocial interventions which will be 
employed throughout the research programme. The term `psychosocial intervention' is an 
umbrella term which covers a broad spectrum of psychological interventions (Astin, Shapiro, 
Eisenberg, & Forys, 2003). Indeed, Astin et al. (2003) note that interrelated terms include 
`behavioural', `psycho-educational', and `mind-body therapy' and simply reflect the 
theoretical orientations of the investigators. For simplicity, unless stated otherwise the term 
`psychosocial intervention' will be used throughout this chapter. Psychosocial interventions 
commonly employed in RA studies include relaxation techniques, meditation, biofeedback, 
cognitive behavioural therapy, educational programmes, imagery, and hypnotherapy, (Astin 
et al., 2003; Wolsko, Eisenberg, Davis, & Phillips, 2004). 
Although meta-analyses are considered the optimum statistical procedure for testing 
assumptions about the efficacy of treatments in medicine (Glass, 1976) visual inspection of 
the available data highlighted some limitations in conducting a meta-analysis. The 
interventions employed in the studies that were identified were heterogeneous in the design 
and administration and were multimodal. For example one study employed education and 
information about exercise with a relaxation intervention (Lord, Victor, Littlejohns, Ross, & 
Axford, 1999), yet in other study coping skills training and imagery techniques were 
combined with relaxation (Radojevic, Nicassio, & Weisman, 1992). It is the opinion of the 
present author that conducting a meta-analysis on studies where the interventions are so 
different would render the effect size meaningless. Therefore a review of the literature is 
presented. 
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In order to review published studies of psychosocial interventions utilised in 
rheumatoid arthritis (RA) a search was performed in the electronic databases, MedLine, 
PsychArticles, and ScienceDirect. An advanced Boolean search option was chosen using the 
terms "rheumatoid arthritis" AND "psychosocial intervention", or "relaxation", or 
"meditation", or "biofeedback", or "cognitive behavioural therapy", or "CBT", or 
"psychoeducation", or "patient education", or "imagery", or "guided imagery", or 
hypnotherapy", or "hypnosis" between 1980 and 2008. Only studies which used RA patients 
who were classed as adults, and were written in English were included. 
In total 14 studies employing relaxation techniques (see table 1), two studies 
employing meditation, three studies employing biofeedback (see table 2), 18 studies 
employing cognitive behavioural-therapy (see table 3), 14 studies employing educational 
approaches (see table 4), seven studies employing imagery (see table 5), and two studies 
employing hypnotherapy, were identified and included in the present review. Tables are 
presented in each of the sections below identifying (a) the first author and year of publication, 
(b) the design of the study, (c) whether any other therapeutic modality was included in the 
design, (d) the sample size in the study, (e) the type of control group used in the study, (f) the 
duration of the intervention, (g) whether the intervention was administered in a group or 
individual setting, (h) the outcomes measured in the study, and (i) the results reported for the 
study. 
Relaxation techniques. The goal of relaxation techniques is to achieve a state of 
reduced sympathetic arousal and /or reduced muscle tension (Hellman, Budd, Borysenko, 
McClelland, & Benson, 1990; McCaffery & Pasero, 1999). Several models have been 
proposed regarding the effects of relaxation. For example, Davidson and Schwartz (1976) 
propose that the beneficial effects of relaxation are due to specific effects. That is, relaxation 
aimed at reducing muscular stress will have that specific effect and no other effects. 
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I Iowever, Benson (1983) argues that there is a single relaxation response which may have a 
number of beneficial effects, rather than one specific effect. Studies employing relaxation as 
a therapeutic intervention have shown significant positive effects in chronic conditions such 
as anxiety (Rasid & Parish, 1998), panic disorders (Oest & Westling, 1995), and headaches 
(Primavera & Kaiser, 1992). 
More specifically, the use of relaxation as a psychosocial intervention in the adjunct 
treatment of RA (see table 1) has shown significant decreases in anxiety (Bagheri-Nesami, 
Mohseni-Bandpei, & Shayesteh-Azar, 2006; Leibling, Pfingsten, Bartmann, Rueger, & 
Schuessler, 1999), depression (Bagheri-Nesami et at., 2006; Radojevic, Nicassio, & 
Weisman, 1992; Sharpe et al., 2001), pain (Achterberg, McGraw, & Lawlis, 1981; Fries, 
Carey, & McShane, 1997; Keefe et al., 1999; Leibling et al., 1999; Radojevic et al., 1992), 
and functional disability (Fries et al., 1997; Keefe et al., 1999; Lundgren & Stenstrom, 1999; 
Taal, Riemsma, Brus, & Seydel, 1993). Only one study found significant effects for 
relaxation with regard to decreased morning stiffness (Bagheri-Nesami et al., 2006), one 
study reported significantly reduced tender joints (Fries et al., 1997), and one other study 
reported significantly increased self-efficacy to control pain (Taal et al., 1993). 
Nine studies included a follow-up period in their design. Significant decreases in 
depression at six months follow-up was reported by one study (Sharpe et at., 2001), self- 
efficacy for controlling pain at 14 months follow-up was reported in one other (Taal et at., 
1993). Five other studies where relaxation had previously demonstrated a significant effect at 
post-intervention were not significant at follow-up. Furthermore, five of the 14 studies 
reviewed reported no significant effects for relaxation at post-intervention or follow-up 
(Germond, Schomer, Meyers, & Weight, 1993; Kraaimaat, Brons, Geenen, & Bijlsma, 1995; 
Lord et al., 1999; Mutton et aL, 2001; Schotten et al., 1999). 
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Thirteen of the 14 studies identified which utilised relaxation as a psychosocial 
intervention reported combining this with at least one other modality. Specifically, eight 
studies combined relaxation with cognitive behavioural therapy, five included imagery, three 
included education, two included exercise, and one included biofeedback with relaxation. 
Therefore, the evidence for the effectiveness of relaxation as a psychosocial intervention in 
isolation from other modalities is extremely limited. Only one study employed relaxation as a 
singular therapeutic modality. The results of this study identified significant decreases in 
anxiety, depression, and duration of morning stiffness at post-intervention (Bagheri-Nesami 
et al., 2006). However, as there was no follow-up in the design of this study it is impossible 
to state any long-term benefits of relaxation as a singular mode of psychosocial intervention 
in RA. 
In summary, relaxation interventions shown some evidence of improving the 
symptoms associated with RA in the short-term. The long-term benefit is inconclusive. A 
criticism of relaxation interventions is the multimodal nature of such interventions. Indeed, in 
a recent review specifically with regard to pain management in different musculoskeletal 
conditions, which included RA, Nicholas (2008) identified that relaxation techniques are 
rarely used in isolation. The evidence presented in the current review, specifically related to 
RA and the symptoms of the disease, indicates that relaxation as a multimodal adjunct may 
be effective. However there is no long-term evidence that this psychosocial intervention 
would be effective in isolation. 
Meditation. The practice of meditation predates traditional medicine (Kabat-Zinn, 
1982). Recently two specific forms of meditation have been employed as psychosocial 
interventions for chronic conditions, namely transcendental and mindfulness meditation 
(Morone & Greco, 2007). Transcendental meditation involves focussed attention, often 
achieved by repeating a word or phrase in a chant-like fashion (Goleman & Schwartz, 1976) 
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with the purpose of gaining conscious control over autonomic nervous system responses. 
Indeed, early studies have indicated that transcendental meditation can bring about a 
profound state of relaxation, specifically with reduced heart rate, respiration rate, and 
increased EEG alpha rhythms (Shapiro, 1995). Mindfulness meditation involves a moment to 
moment awareness of emotions, thoughts, and sensations (Kabat-Zinn, 1982). Mindfulness 
meditation has been utilised as a therapeutic modality in many trials of chronic pain, with the 
results of these studies indicating this to be effective with long term beneficial outcome 
(Kabat-Zinn, Lipworth, Burney, & Sellers, 1986). More recently, Sephton et al. (2007) 
reported significant reductions in depression in fibromyalgia patients following an eight week 
course of mindfulness meditation. Additionally, in a community based sample of patients 
with an eating disorder, Smith, et al. (2008) concluded that mindfulness meditation was more 
effective than cognitive behavioural therapy for reducing incidences of binge eating episodes. 
Specifically, studies employing meditation as a psychosocial intervention with RA 
patients are very limited. Indeed, to the best of the present author's knowledge, only two 
studies exist in the literature investigating the possible therapeutic effects of this modality. 
Pradhan et al. (2007) assessed the benefits of mindfulness meditation on depressive 
symptoms, psychological well-being, and disease activity in a sample of 63 patients with RA. 
Following an eight week course with one 2.5 hours session of meditation a week, the authors 
reported that there were no significant differences between the groups in any of the outcomes 
measured. However, at six months follow-up there was a significant improvement in 
depressive symptoms and psychological distress observed in the intervention group and not in 
the controls. The authors also reported that the intervention had no impact on disease activity 
levels in their sample of RA patients. Although this initial study provides some evidence for 
mindfulness meditation as an effective psychosocial intervention for reducing depression and 
psychological distress in RA patients, there are some limitations to note. Although a care-as- 
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usual control group was included in the design of this study, the authors did not take into 
account possible experimenter effects which may confound their results. Specifically, 
changes in depression and psychological distress have shown to be associated with changes 
in levels of social support (Zyrianova et al., 2006). 
Zautra et al. (2008) conducted a trial comparing the effectiveness of mindfulness 
based meditation to cognitive behavioural therapy. Forty seven patients completed an 8 week 
course of group sessions in mindfulness meditation, 44 completed a tailored cognitive 
therapy course lasting for the same duration as the mindfulness meditation group, and 40 
participants who were randomised to an attention control group received an 8 week education 
course. The outcomes measured in this study included pain, affect, depression, self-efficacy 
for coping with pain, and pain catastrophising. Laboratory measures of disease activity were 
also included, specifically, interleukin-6 (IL-6), a proinflammatory cytokine related to disease 
activity. Following the interventions participants in the CBT group reported the greatest 
decrease in pain and reductions in IL-6. Both the CBT and the mindfulness meditation groups 
reported similar significant increases in self-efficacy for controlling pain when compared to 
the attention control group. In a further analysis, taking into account previous history of 
depression, the authors reported that participants with recurrent depression benefited most 
from mindfulness meditation more than those participants in the CBT group, specifically in 
affect and physician ratings of tender joints. The additional analyses of this study suggest that 
individuals with RA and a history of recurrent depression may benefit more from 
mindfulness meditation than CBT. 
In summary, meditation has shown to be a promising psychosocial intervention in 
other chronic conditions such as fibromyalgia, specifically reducing depression. Studies 
conducted with RA patients provide some evidence for the usefulness of mediation, 
particularly mindfulness mediation for patients with relatively stable RA and a history of 
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recurrent depression. However as there are limited studies investigating the effects of 
meditation in RA patients, the evidence to support this psychosocial intervention is 
inconclusive. Furthermore, it requires a lengthy amount of time for participants to practice, 
for example, two and a half hour sessions were reported by Pradhan et al. (2007) and this 
may be a complication for patients who may perceive this to be very time consuming. 
Biofeedback Biofeedback techniques are designed to enable participants to gain 
control over physiological processes, for example muscle tension (Dixon et al., 2007). 
Specifically, it is assumed that by gaining control over muscle tension will result in decreased 
pain (Nicholson & Blanchard, 1993). This psychosocial intervention usually involves the use 
of electrical equipment which records and amplifies physiological signals which then 
provides visual or auditory feedback to the participant (Arena & Blanchard, 2002). With 
practice individuals learn to regulate physiological processes such as heart rate and breathing 
rate by controlling the feedback signal (Morone et al., 2007). Traditionally, biofeedback 
usually forms part of multimodal therapy involving other interventions such as cognitive 
behavioural therapy, imagery, and relaxation (Andrasik, 2004). There is some evidence for 
the use of this psychosocial intervention in chronic pain conditions such as tension headaches 
and chronic joint pain (Arena, Hannah, Bruno, & Meador, 1991; Kabela, Blanchard, 
Applebaum, & Nicholson, 1989). 
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In a novel study with the use of biofeedback and mock biofeedback as a control in 
patients with chronic rheumatic back pain, Flor, Haag, Turk, and Koehler (1983) reported 
that participants with the real biofeedback reported significantly lower levels of pain 
intensity, and pain duration compared to those who received the mock biofeedback. The 
results of this study indicate positive benefits for this type of psychosocial intervention in 
patients with chronic pain. 
The use of biofeedback in RA populations is limited. Only three studies were 
identified which utilised this form of intervention (see table 2). Furthermore, these studies 
were multimodal, involving relaxation and cognitive behavioural therapy for pain reduction. 
Therefore, it is impossible to state the efficacy of biofeedback in RA. However, in an early 
study, Applebaum, Blanchard, Hickling, and Alfonso (1988) reported significant reductions 
in pain and disability when biofeedback was employed in conjunction with cognitive pain 
management techniques. However, the authors further reported that at 18 months follow-up 
there were no significant differences between the intervention and control group. Similarly, 
Bradley et al. (1987) reported significant decreased pain and disease activity following five 
two hour sessions of biofeedback combined with cognitive behavioural therapy. However, at 
six months follow-up there were no significant differences between the intervention and 
control group. Interestingly, in a long term follow-up of the participants reported by Bradley 
et al. (1987) it was noted that those participants who received the multimodal biofeedback 
intervention had significantly fewer RA related clinical and hospital admissions (Young, 
Bradley, & Turner, 1995). 
In summary, studies using biofeedback as an adjunct treatment in RA vary in the 
administration and duration of the intervention, for example one study reported participants 
received eight one-hour sessions (Achterberg et al., 1981), in another study participants 
received ten one-hour sessions. The lack of standardisation in the content and the number of 
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sessions causes difficulty in determining the efficacy of this particular psychosocial 
intervention. In order to assess the effectiveness of biofeedback in RA, future studies should 
standardise the number of sessions and use this modality in isolation. As the literature 
currently stands, there is limited evidence for the use of biofeedback in reducing the short- 
term symptoms associated with RA, and no long-term efficacy. Additionally, the equipment 
used for this modality can be expensive and thus its use is further limited. 
Cognitive Behavioural Therapy (C37). CBT is a psychosocial intervention where the 
focus of treatment is to modify an individuals thought processes in order to change their 
behaviour (Beck, 1970). The definition of CBT poses a problem for both researchers and 
clinicians due to the fact that this type of intervention often includes a variety of approaches 
(e. g., education, skills training, problem solving), and different theoretical frameworks (e. g., 
cognitive therapy, behaviour therapy, and rational emotive therapy; Dobson & Dozois, 2001). 
Irrespective of a definition, a central theme of CBT is the systematic application of 
psychological principles for beneficial therapeutic outcome (Luskin et al., 2000). 
The application of CBT as a psychosocial intervention has prominence in the mental 
health field, particularly in personality disorders and behavioural problems (Cooper, 2008). 
However there is a growing use of CBT in targeting specific symptoms of chronic disease 
(Butler, Chapman, Forman, & Beck, 2006), such as pain (Morley, Eccleston, & Williams, 
1999), and depression associated with adapting to chronic conditions (Gloaguen, Cottraux, 
Cucherat, & Blackburn, 1998). 
Specifically related to RA, out of 18 studies identified in this review using CBT as a 
psychosocial intervention, 14 measured pain as an outcome and nine of these reported a 
significant decrease in pain at post-intervention (see table 3). However, 13 studies provided 
follow-up data which identified that pain was not significantly lower at follow-up. 
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Six studies reported CBT interventions significantly reducing depression in RA 
patients, and in two studies this reduction in depression remained significant at six months 
follow-up (Evers, Kraaimaat, van Riel, & de Jong, 2002; Sharpe et at., 2001). However, no 
significant decreases in depression was reported in six other studies (O'Leary, Shoor, Korig, 
& Holman, 1988; Parker et al., 1995; Parker et al., 2003; Scholten et al., 1999; Zautra et al., 
2008). Five studies measured anxiety as an outcome and only one reported a significant 
decrease when compared to the control group following the CBT intervention (Leibing et al., 
1999). Five studies measured self-efficacy for controlling pain. Of these, four studies 
reported significant improvement following the intervention which was maintained at follow- 
up (O'Leary et al., 1988; Parker et at., 1995; Rhee et al., 2000; Zautra et al., 2008). 
Disability was measured in nine of the studies, however only one study reported a 
significant decrease in disability following a CBT intervention, which remained significantly 
lower 12 months follow-up (Keefe et al., 1999). In terms of disease activity, 13 studies 
included laboratory measures of disease activity and/or swollen and tender joints. Ten studies 
reported that the CBT intervention had no impact on disease activity. However, Bradley et al. 
(1987) reported a significant decrease in the number of swollen joints at post-intervention in 
their CBT group when compared to the control group. Additionally, Freeman, Hammond, and 
Lincoln (2002) reported a significant reduction in the number of swollen and tender joints in 
their CBT group when compared to the control group, Finally, Zautra et al. (2008) reported a 
significant decrease in the proinflammatory cytokine IL-6 post-intervention. However, in all 
three of these studies the authors report that there were no significant differences in measures 
of disease activity at six months follow-up. 
In determining the efficacy of this approach it is clear that the multimodal nature of 
this intervention poses some difficulties. For example, eight of the eighteen studies identified 
used relaxation with their CBT intervention, four added imagery, biofeedback was included 
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as part of the intervention package in another study. Thus, it is impossible to know which 
component of these CBT interventions was responsible for the outcome, or indeed whether a 
combination of modalities is necessary for the most beneficial outcome. Furthermore, half of 
the studies identified in this review administered CBT as a group intervention, thus the 
effects of social support may confound the results. Indeed, three of the studies which 
administered the intervention in an individual setting reported no significant outcomes, 
whereas when applied in a group setting only one study which reported no significant change 
in any of the outcomes. 
In summary, this review indicates that utilising CBT as a psychosocial intervention in 
RA has a significant beneficial impact in relation to pain and self-efficacy for controlling pain 
in RA patients. Additionally, this type of psychosocial intervention is more beneficial when 
administered in a group rather than an individual setting. This raises the question of increased 
social support influencing outcome. Furthermore, given the nature of CBT it could be argued 
that the investigation of this intervention as a singular mode of psychosocial intervention is 
not possible. 
Education. Education or patient information interventions are designed to enable 
patients with chronic diseases to adapt to, and cope with the consequences of their disease 
(Nicholas, 2008). In relation to RA, Lorig and Holman (1993) state that the purpose of this 
type of psychosocial intervention is to maintain or improve the health status of the individual. 
Within the UK a standardised approach has been developed towards patient education for 
arthritis. The Arthritis Self-Management Programme (ASMP; Lorig et al., 1993) was 
designed as a community based patient information programme, embedded within the 
principles of Bandura's (1991) self-efficacy theory. Although primarily education based, the 
ASMP is a multimodal intervention which may include exercise, cognitive symptom 
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management (e. g. imagery and relaxation techniques), and communicating effectively with 
family and medical professionals. 
A recent study using this programme in osteoarthritis patients reported increased self- 
efficacy for controlling pain, increased performance of adaptive health behaviours, improved 
functioning, and less depression, when compared to a control group, 4 months follow-up 
(Barlow, Turner, & Wright, 2000). Barlow et al. (2000) also reported significant decreases in 
pain and depression, and increased self-efficacy for controlling pain, which was maintained at 
12 months follow-up. 
Fourteen studies were identified in this review examining the efficacy of education 
interventions for RA patients (see table 4). Similar to the ASMP intervention, education 
interventions identified in this review were multimodal. Indeed, nine of the studies identified 
included a combination of CBT (e. g. coping with pain, goal setting, and problem solving 
skills), relaxation techniques, physical therapy, and exercise. Four studies identified had no 
follow-up period, four had a follow-up of less than six months, and the remaining six had a 
follow-up period of more than six months but no more than 12 months. The intervention 
varied across studies, for example a leaflet about RA and its symptoms, and group discussion 
with health professional. 
Five of these studies reported no significant differences in any outcomes measured at 
post-intervention, between the education group and a control group. Given the type of 
intervention employed in these studies it was surprising that only three studies measured 
knowledge as an outcome. Two of these studies reported a significant increase in knowledge 
at post-intervention (Barlow, Pennington, & Bishop, 1997) and 6 months follow-up (Barlow 
& Wright, 1998) when compared to a control group. The other study reported no significant 
differences in knowledge of RA between their intervention and control group (Maggs, Jubb, 
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& Kemm, 1996). Pain was measured as an outcome in nine studies, however only four of 
these reported significant decreases post-intervention (Barlow et al., 1997; Fries et al., 1997; 
1lammond & Freeman, 2001; Lindroth et al., 1997), and two reported maintained 
significance, one at six months follow-up (Fries et al., 1997), and the other at 12 months 
follow-up (Hammond et al., 2001). Of the seven studies that measured disability none 
reported that an education intervention had any significant impact. However, of five studies 
measured physical functioning, two studies reported significant increase at post-intervention 
(Savelkoul, de Witte, Candel, van der Tempel, & van den Bome, 2001), with one reporting 
significant improvement at six months follow-up (Fries et al., 1997). 
Only one study reported a significant improvement in depression following 
intervention (Barlow et al., 1997). No study reported a significant decrease in anxiety 
following the education intervention. Although education interventions have a theoretical 
underpinning in self-efficacy theory, only two studies measured self-efficacy, and none of 
these reported any significant change (Barlow et al., 1997; Barlow et at., 1998). 
In relation to clinical assessment of RA following an education intervention, five 
studies reported the number of tender joints as an outcome. However, only one of these 
reported a significant decrease when compared to the control group, which remained 
significant at six months follow-up (Fries et al., 1997). Four studies reported no significant 
change in the number of swollen joints following an education intervention (Brus, van de 
Laar, Taal, Rasker, & Wiegman, 1998; Fries et al., 1997; Hammond, Lincoln & Sutcliffe, 
1999; Hammond et al., 2001). Two studies measured laboratory indicators of inflammation 
(e. g. ESR and CRP) and reported no significant change or difference between the control 
groups (Brus et al., 1998; Kraaimaat et al., 1995). 
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In summary, given the lack of standardisation in the mode of administration and the 
content of the intervention between these studies the evidence to support the efficacy of 
education interventions is inconclusive. Moreover, Jones (2002) argues that educational 
interventions are not a treatment modality, but an ethical requirement. This may explain the 
lack of education intervention studies post-2002. 
Imagery. Imagery has been defined as the generation of images from at least one 
sensory modality for the purpose of evoking a psycho-physiological state (Astin et al., 2003). 
Although normally associated with relaxation, Post-White (2002) argues that imagery and 
relaxation are separate modalities and need not be combined to have therapeutic effects. 
However throughout the literature, imagery forms part of a therapeutic package including 
other modalities such as relaxation, CBT, and music (Astin et al., 2003). Imagery combined 
with other modalities has shown to be effective for reducing stress, anxiety, and depression in 
patients with breast cancer undergoing radiotherapy (Nunes et al., 2007), reducing pain and 
improving health related quality of life in patients with chronic tension headache (Mannix, 
Chandurkar, Rybicki, Tuesk, & Solomon, 1998), and reducing pain and mobility difficulties 
in patients with osteoarthritis (Baird & Sands, 2004). 
Specifically for RA, seven studies were identified which included imagery (see table 
5). No study utilised imagery as a treatment modality on its own. Only one study included an 
attention control group within the design, two studies did not include any control group, and 
four studies included a care as usual control group. Follow-up was not included in the design 
of two studies, three studies had a follow-up period of less than six months, and two studies 
had a follow-up of more than six months. The number and duration of intervention session 
varied between the studies, specifically the number of sessions varied between five and 12, 
and the duration varied between 30 minutes and two hours. 
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Six studies measured pain as an outcome following the imagery intervention. Of 
these, four studies reported a significant reduction in pain when compared to a control group 
post-intervention (Leibing et al., 1999; O'Leary et al., 1988; Radojevic et al., 1992; Taal et 
al., 1993). However, none of these studies reported any significant reduction in pain at 
follow-up. One study did report a significant reduction in pain at post-intervention, which 
was maintained at 18 weeks follow-up (Jacobi & Eisenberg, 2001-2002), whereas another 
study reported no significant change in pain post-intervention (Lundgren & Senstrom, 1999). 
However, neither these two last studies had a control group in their design. 
Self-efficacy for controlling pain was measured in two studies (O'Leary et al., 1988; 
Radojevic et al., 1992). Both studies reported significant increases in self-efficacy when 
compared to a control group. Furthermore, in both studies self-efficacy for controlling pain 
remained significantly higher than the control group at two months follow-up (Radojevic et 
al., 1992) and four months follow-up (O'Leary et al., 1988). 
Five studies measured functional disability as an outcome. Two studies reported a 
significant decrease post-intervention (Lundgren et al., 1999; Radojevic et al., 1992). 
Furthermore, Lundgren et al. (1999) reported significant reduction in disability at six months 
follow-up. Of the five studies that examined depression, three studies reported a significant 
reduction (Leibing et al., 1999; Radojevic et al., 1992; Taal et at., 1993), however these 
reductions in depression were not significant at follow-up. Jacobi et al. (2001-2002) reported 
a significant reduction in depression post-intervention and 18 weeks follow-up, however with 
no control group the results from this study are inconclusive. 
Anxiety was measured as an outcome in three of the studies identified with an 
imagery intervention. Leibing et al. (1999) reported a significant decrease post-intervention 
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which was not maintained at follow-up. However, Jacobi et al. (2001-2002) reported a 
significant decrease at post-intervention which was maintained at 18 week follow-up. 
In relation to clinical outcomes in RA following an imagery intervention, four studies 
included the number of swollen joints as an outcome (Jacobi et al., 2001-2002; Leibing et al., 
1999; Radojevic et al., 1992; Taal et al., 1993), however none of these studies reported any 
significant decreases. Only one study included the number of tender joints and they reported 
no significant change at post-intervention (O'Leary et al., 1988). Two studies examined 
changes in ESR and reported no significant change (Jacobi et al., 2001-2002; O'Leary et al., 
1988). One study included CPR and rheumatoid factor and reported no significant change 
post-intervention (Jacobi et al., 2001-2002). 
In summary, studies employing imagery as a psychosocial intervention in patients 
with RA provide some evidence of the therapeutic benefits in relation to decreased pain and 
increased self-efficacy for controlling pain. However, imagery was combined with other 
therapeutic modalities. Therefore it is unknown whether imagery as an intervention in 
isolation has any impact of the symptoms of RA. Indeed, repeatedly in the literature it is 
suggested that imagery should be examined as an intervention without any other combined 
therapies in order to investigate the mechanisms and the extent to which imagery influences 
chronic conditions such as RA (Astin, Beckner, Soeken, Hochberg, & Berman, 2002; Luskin 
et al., 2000; Morone et al., 2007). Consequently, a general objective of the present research 
programme was to investigate the effects imagery as a psychosocial intervention without 
combining it with any other therapeutic modality. 
Hypnotherapy. Hypnotherapy is defined as `a state of inwardly focussed attention in 
which the mind is focussed on ideas of therapeutic value that can potentiate 
psychophysiologic change' (Anbar, 2006, p. 438). During a hypnotic state it is assumed that 
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the conscious mind is guided to become dormant while the unconscious mind becomes more 
ready and open to suggestion (Spiegel, Greenleaf, & Spiegel, 2000). The therapeutic value of 
this psychosocial intervention has been recognised in acute and chronic pain. For example in 
an early review of hypnotherapy in pain conditions, Holroyd (1996) concluded that 
hypnotherapy was equally, if not more effective, than other psychosocial interventions for 
reducing pain. In another review of randomised controlled trials involving hypnotherapy, 
Patterson and Jensen (2003) reported significant decreases in self-reported pain in both acute 
and chronic pain patients. More recently, Jensen and Patterson (2006) reviewed the evidence 
for hypnotherapy for pain in patients with a variety of chronic conditions, including cancer- 
related pain, fibromyalgia, and osteoarthritis. The authors reported significant decreases in 
pain for each of these conditions. Importantly, significant reductions in pain were observed at 
12 months follow-up. 
Hypnotherapy has proven an effective psychosocial intervention in areas other than 
pain. For example, post-operative wound healing (Ginandes, Brooks, Sando, Jones, & Aker, 
2003), dermatological conditions such as warts (Shenefelt, 2000), irritable bowel syndrome 
(Gonsalkorale, Houghton, & Whorwell, 2002), and reduced feelings of nausea and vomiting 
following chemotherapy (Zeltzer, Dolgin, LeBaron, & LeBaron, 1991; Jacknow, Tschann, 
Link, & Boyce, 1994). 
Despite the evidence for hypnotherapy as an effective adjunct treatment for many 
chronic conditions, there is little research examining its effectiveness in RA. Indeed, this 
review of the literature identified only two published research papers. In an early clinical trial 
of hypnotherapy with no control group Domangue, Margolis, Lieberman and Kaji (1985) 
demonstrated significant decreases in pain, anxiety, and depression post-intervention. The 
authors also reported significant increased plasma levels of ß-endorphin. They concluded that 
hypnotherapy not only reduces self-report levels of pain, but also a biochemical correlate of 
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pain intensity. Although this study indicates some evidence for hypnotherapy reducing the 
symptoms of RA, including biochemical indices, there are several limitations. As there was 
no control group in the study there is a possibility that the changes observed were not the 
result of the intervention. Furthermore, the authors did not report disease activity, as the 
natural progression of the disease is characterised with unpredictable flares, participants may 
have been recovering from such flares. This may have had a greater impact on the outcomes 
measured, rather than the hypnotherapy intervention. 
More recently, Horton-hausknecht, Mitzdorf, and Melchart (2000) conducted a 
randomised controlled trial investigating the effects of hypnotherapy. Within the design of 
the study the authors included a wait list control group and a relaxation group. Participants in 
the hypnotherapy and relaxation groups each received ten group intervention sessions, where 
each, session lasted no more than one and a half hours. The outcomes measured included joint 
pain, morning stiffness, joint swelling, and a German translation of the Arthritis Impact 
Measurement Scale (Meenan, Gertman, & Mason, 1980). Measures of disease activity (ESR 
and CRP) were also included. Following the intervention sessions the authors reported 
significant decreases in joint pain, joint swelling, significantly improved activities of 
daily 
living and body activity, and a significant reduction in ESR. The authors concluded that 
hypnotherapy produced clinically significant decreases in disease activity and self-reported 
pain. 
However methodological flaws in this study require the results to be interpreted with 
caution. For example, some participants chose which arm of the study they wanted to 
participate in, and the intervention was conducted in small groups. The results of this study 
may therefore be contaminated by confounding variables such as expectancy and social 
support. Furthermore, although the authors conducted analyses for within-group changes, 
they do not report any between-group differences. For example, both intervention groups 
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demonstrated significantly reduced ESR, however it may be that there were no significant 
differences between the groups, therefore the results do not inform us whether hypnotherapy 
was more effective than relaxation in RA. 
In summary, only two studies exist examining the use of hypnotherapy as a 
psychosocial intervention in RA. Both these studies indicate that hypnotherapy may provide 
some therapeutic benefits for the symptoms related to RA (e. g. reducing pain and biological 
markers associated with disease activity). However, due to methodological issues the results 
of these studies do not provide conclusive evidence of the effectiveness of this type of 
intervention for patients with RA. Given the efficacy of this psychosocial intervention in 
other chronic conditions and the lack of studies within the RA literature, a general objective 
of the present research programme is to investigate the effects of hypnotherapy in patients 
with RA. 
Conclusions from the Literature Review 
This review of psychosocial interventions for the management of symptoms related to 
RA provides some evidence of their effectiveness in the short-term, however as the majority 
of studies fail to report any significant differences at follow-up, their use in the long-term is 
inconclusive. A general limitation of the majority of these psychosocial interventions is the 
multimodal nature of the intervention. As a consequence of this, it is extremely difficult to 
conclude whether one approach is more or less effective than another. Furthermore, very few 
studies report the effect sizes of these interventions. Where effect sizes are reported they are 
generally low to moderate post-intervention, and become non-significant at follow-up. A 
further limitation is the lack of studies measuring disease activity following a psychosocial 
intervention. The biopsychosocial model of disease in RA provides a systems perspective of 
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Rik, in that, changes in one part of the system can produce changes in the other parts of that 
system (Keefe et at, 2002). However, many studies fail to test this assumption of the model. 
Psychosocial Interventions in the Present Research Programme 
Imagery and hypnotherapy were chosen as the psychosocial interventions for a 
number of reasons. First, in relation to relaxation, Nicholas (2008) argues that relaxation is a 
useful adjunct, but there is no evidence that it would be beneficial as a stand-alone therapy. 
Second, although the use of meditation provides some promising results from the few studies 
published using this intervention, it requires a lengthy amount of time for participants to 
practice, for example, two and a half hour sessions were reported by Pradhan et al. (2007). 
Third, the results from studies involving biofeedback show no long term efficacy and the 
apparatus involved in this technique can be expensive and therefore its use is limited. Fourth, 
numerous studies already exist on the efficacy of CBT and reduction of RA symptoms and 
due to the nature of this multimodal intervention it is difficult to conclude which parts are 
effective. Fifth, as with CBT interventions there are numerous studies investigating the effect 
of education interventions, the majority report no long term efficacy. Additionally, given the 
criticisms of Jones (2002), restricting an education intervention to one particular group of a 
study would be unethical. Imagery and hypnotherapy are simple inexpensive techniques 
which if proven beneficial for symptom reduction in RA could easily be utilised as self- 
management techniques. 
Specifically, within this research programme the effects of imagery and hypnotherapy 
as psychosocial interventions without the addition of any other modality will be addressed 
throughout the proceeding chapters. Additionally it will be explored whether these 
psychosocial interventions have any beneficial impact on disease activity in patients with 
active RA. 
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CHAPTER THREE 
HEALTH-RELATED QUALITY OF LIFE IN RHEUMATOID ARTHRITIS: 
COMPARING A PATIENT REPORTED OUTCOME MEASURE AND A PATIENT 
GENERATED OUTCOME MEASURE FOLLOWING A PSYCHOSOCIAL 
INTERVENTION' 
1 This research was presented as an oral presentation at the Annual European Congress of Rheumatology, 
EULAR, in June 2008, the abstract was accepted for publication: Bennett, B. M., Callow, N. & Jones, J. (2008). 
Individualised quality of life in rheumatoid arthritis following a psychosocial intervention. Annals of Rheumatic 
Diseases, 67 (suppl 2), 82 & 655. 
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Abstract 
Objective. The present study had three objectives. Firstly, to examine whether a health- 
related quality of life (HRQOL) patient reported outcome measure (PROM) would capture 
items identified as being important by participants with rheumatoid arthritis (RA) in a 
IIRQOL patient generated outcome measure (PGOM). Secondly, to examine the relationship 
in HRQOL between a PROM and a PGOM, following a patient-centred psychosocial 
intervention. The third objective of the study was to examine possible differences in HRQOL 
in RA following an imagery or hypnotherapy intervention. 
Afethod. Forty two participants with stable RA were randomised to an imagery intervention, 
hypnotherapy intervention, or `care-as-usual' control group. Participants completed the 
Patient Generated Index (PGI) a HRQOL PGOM and the SF-36 a HRQOL PROM, at pre- 
intervention, six weeks post-intervention, and six months follow up. 
Results. The SF-36 failed to capture 27% of the items identified on the PGI. Participants 
reported a significant increase in HRQOL when measured with the PGI, however no change 
was reported when using the SF-36. Participants in the imagery and hypnotherapy group 
reported significantly higher HRQOL when compared to the control group post-intervention. 
At follow-up, only the hypnotherapy group remained significantly higher than the control 
group. 
Conclusions. The use of PROMs such as the SF-36 may not be measuring what is perceived 
to be HRQOL in individuals with RA. PGOMs, such as the PGI are appropriate for 
enhancing a patient-centres approach and for measuring HRQOL following tailored 
interventions. 
14RQOL in RA 61 
Patient reported outcome measurements (PROMs) are instruments that measure any aspect of 
a person's health reported directly by the patient (Marshall, Haywood, & Fitzpatrick, 2005). 
Examples of PROMs used routinely in research and clinical practice include visual analogue 
scales for pain and fatigue, and fixed-item measures such as the hospital anxiety and 
depression scale (Zigmond & Snaith, 1983), and the Short Form 36 Health Survey 
Questionnaire (SF-36; Ware & Sherbourne, 1992). 
In clinical practice, several roles for these measures have been proposed. For 
example, Gilbody, Whitty, Grimshaw, and Thomas (2003) state that PROMs can be used to 
improve patient-provider communication by allowing patients to report the severity of their 
own symptoms. They can also be used to identify patient preferences to enable clinicians to 
make informed decisions (McHomey, 2002). Lindblad, Ring, Glimelius, and Hansson (2002) 
further state that the use of PROMs facilitates shared decision making and goal setting 
between the patient and provider within the health care process. These roles help build upon 
a patient-centred model of treatment and may promote greater patient satisfaction with 
healthcare (Hirsh et al., 2005) and increased compliance to treatment (Fuertes et al., 2007). 
The area of health related quality of life (HRQOL) has witnessed a growth in the 
number of PROMs used in research and clinical practice (Emery, Perrier, & Acquadro, 
2005). This reflects the increased importance of HRQOL as an outcome in health research 
(Patrick & Chiang, 2000) and in patient perceptions in the health care process (Carr & 
Higginson, 2001). HRQOL is that part of overall quality of life affected by health (Moriarty, 
Zack, & Kobau, 2003) and includes an individual's perception of life satisfaction in relation 
to treatment of illness or disease (Kushida et al., 2007). Indeed, in populations with a chronic 
condition, such as rheumatoid arthritis (RA), where there is no cure (Leibing, Pfingsten, 
Bartmann, Rueger, & Schuessler, 1999) and psychosocial factors have an influence on the 
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outcome of disease, the measurement of HRQOL has become a priority to help direct 
management of the condition (Fayers & Machin, 2000). 
At a specific level, HRQOL is the sum of a number of life domains, for example 
physical function, psychological, emotional, and social well-being, which guide its 
measurement (Cummins, 1997). Central to the measurement of HRQOL, is the debate as to 
which type of measure should be employed (Arnold et at., 2004; Garratt, Schmidt, 
Mackintosh, & Fitzpatrick, 2002; Joyce, O'Boyle, & McGee, 1999). HRQOL measurement 
tools can be divided into two categories, fixed-item PROMs, and individualised, or patient 
generated outcome measurements (PGOMs). Further, within these categories, measures can 
be sub-divided into generic or disease-specific measures (Chorus, Miedema, Boonen, & van 
der Linden, 2003; Greenwood, Hakim, & Doyle, 2006). 
The most widely used generic fixed-item HRQOL PROMs include the SF-36 (Ware 
& Sherbourne, 1992), the EuroQOL EQ-5D (Brooks, 1996); and the Nottingham Health 
Profile (NHP; Hunt, McEwan, & McKenna, 1986). Advantages of these fixed-item PROMs 
are their ease of administration (Fayers et at., 2000) and established psychometric properties 
(e. g., Stofineel, Post, Kelder, Grobbee, & van Hemel, 2001; Luo et at., 2003; Sharples, Todd, 
Caine, & Tait, 2000). Furthermore, given the generic nature of these HRQOL PROMS, the 
results can be compared across disease specific groups and across different populations (Carr, 
Higginson, 2001). 
Despite these advantages, fixed-item PROMs fail to acknowledge the unique nature of 
individuals (Patel, Veenstra, & Patrick, 2003) and this can create a number of limitations. 
First, many fixed-item HRQOL PROMs exclude the patient's perception of what is important 
(Day & Jankey, 1996). For example, in an early study Coates et al. (1983) identified that 
within a sample of cancer patients locating a parking space for their clinic appointment was 
one of the most important factors influencing HRQOL, rather than the items specified on the 
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fixed-item HRQOL PROM used in their study. Given the shift towards a patient-centred 
approach to treatment, it is surprising that many of these PROMs have been developed 
without public or patient involvement (Bowling, 1995). 
Second, there is a degree of disparity in the HRQOL domains measured in these 
fixed-item measures. Specifically, the SF-36, reported as the `gold standard' by some 
researchers (Jordon-March, 2002), does not include the domains of sleep, 
dependence/independence, sexual functioning, self-perception or body image, or perceptions 
of the future as HRQOL domains (Carr & Higginson, 2003). This raises concerns over the 
content validity of such measures. The omission of certain HRQOL domains in generic fixed- 
item PROMs can lead to problems because for people with chronic conditions some domains 
are more relevant than others. For example, in RA pain and fear of deformity are more 
important than body weakness, which is an important feature reported by patients with 
multiple sclerosis. Indeed, Arnold et al. (2004) provide evidence that psychological 
functioning contributes more to overall HRQOL in many chronic conditions than physical or 
social functioning. Therefore fixed-item HRQOL PROMs which have a greater emphasis on 
physical and social functioning may not adequately reflect the HRQOL of individuals with 
chronic conditions. 
Third, generic fixed-item HRQOL PROMs may capture irrelevant information, for 
example, in a study of elderly hospitalised patients employing an individualised HRQOL 
measure, Dempster and Donnelly (2000) stated that many of the items in HRQOL PROMs 
would have been redundant. More specifically, items in the SF-36 asks about an individual's 
ability to climb one flight or several flights of stairs, if the individual lives in a bungalow 
there will be no stairs to climb and these items may not be as relevant. Indeed, a person who 
is home-bound because of a chronic condition such as RA may well not be able to answer 
these questions. 
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Given these limitations it could be argued that generic HRQOL PROMs fall short in 
their proposed roles in relation to improving patient-provider communication, identifying 
patient preferences, or facilitating shared decision making in a healthcare process. It can also 
be argued that as these roles are not fulfilled then many HRQOL PROMs do not build upon a 
patient-centred model of health-care. 
In an attempt to overcome these limitations researchers have used HRQOL PGOMs, 
for example Patient Generated Index (PGI; Ruta, Garratt, Leng, Russell, & MacDonald, 
1994) and the Schedule for the Evaluation of Individual Quality of Life (SEIQoL; O'Boyle, 
Browne, Hickey, McGee, & Joyce, 1995). Typically, these PGOMs allow the individual, 
rather than the clinician, to identify areas of their life which they perceive as important. 
Advocates of this approach argue that content validity is enhanced (Greenhaugh, Long, & 
Flynn, 2005) and relevance is increased as PGOMs capture the individual's perception of 
what is important (Higginson & Carr, 2001). Furthermore, as they can be used to negotiate 
the goals of treatment and intervention they may promote patient-centred practice (Higginson 
et at., 2001). 
Despite claims that fixed item HRQOL PROMs (e. g. SF-36) do not capture HRQOL 
as perceived by the individual (Dempster & Donnelly, 2000; Morris et al., 2006) research has 
yet to explore the relationship between HRQOL PROMs and PGOMs in RA patients. 
Consequently, one of the objectives of the present study was to allow individuals with a 
longstanding RA to identify HRQOL items using a HRQOL PGOM, and to examine whether 
these items would be captured by a generic fixed-item HRQOL PROM, the SF-36. 
The HRQOL PGOM used in this study was the PGI (Ruta, et al., 1994). The PGI is 
based on Calman's (1984) theoretical conceptualisation of HRQOL as "the extent to which 
our hopes and ambitions are matched by experience" (p. 125). Individuals identify up to 
five 
areas of their life that they perceive to be the most important (e. g., playing with 
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grandchildren, or having a leisurely walk with friends). Often, participants are given a 
`prompt' list to help them identify areas. There is also a sixth item which represents all other 
aspects of the individual's life not captured in the identified five areas. Participants are then 
asked to score each area to reflect how seriously it is affected by their disease. Finally, they 
are asked to give their own weighting to each of these areas. The resultant index score is an 
overall reflection of the individuals perceived HRQOL. 
The PGI has been used as an outcome measure to assess HRQOL across a wide range 
of chronic conditions, for example, severely disabled multiple sclerosis patients (Lintern, 
Beaumont, Kenealy, & Murrell, 2001), rectal cancer (Camilleri-Brennan, Ruta, & Steele, 
2002), and head and neck cancer, (Llewellyn, McGurk, & Weinman, 2005). The use of 
HRQOL PGOMs is particularly relevant for patients with RA because it is a chronic 
musculoskeletal condition where the physical and psychosocial impacts of the disease vary 
from individual to individual (Hammond & Freeman, 2004). The symptoms of this disease 
(i. e. joint pain, swelling, stiffness and fatigue) have a variable impact on function and 
HRQOL (Gordon, Smith, & Dhillon, 2007). Employing the PGI as a HRQOL PGOM will 
enable patients with RA to generate their unique HRQOL. Consequently, the second 
objective of this study was examining the relationship in HRQOL when measured by SF-36, 
the most commonly used HRQOL PROM in RA trials (Kalyoncu, Dougados, Daures, & 
Gossec, 2008) and the PGI. Furthermore the items identified by the PGI can be used to 
negotiate the goals of treatment and in tailoring individual interventions, thus facilitating a 
patient-centred approach to intervention. 
The interventions employed in this study were imagery and hypnotherapy. Both these 
interventions are cognitive therapeutic tools which involve the generation of images from at 
least one sensory modality (Suinn, 1984). However, within the literature there is a degree of 
confusion between these two interventions. The terms hypnosis, hypnotherapy, guided 
HRQOL in RA 66 
imagery, and imagery are often used interchangeably and applied to both imagery and 
hypnotherapy (Zelter et al., 2002). For the purpose of this study imagery is defined as the 
generation of images from at least one sensory modality for the purpose of evoking a psycho- 
physiological state (Astin, Shapiro, Eisenberg, & Forys, 2003) and hypnotherapy is defined 
as `a state of inwardly focussed attention in which the mind is focussed on ideas of 
therapeutic value that can potentiate psychophysiologic change' (Anbar, 2006, p. 438). 
Although imagery and hypnotherapy are similar cognitive therapeutic tools (Luskin et 
at., 2000) there is a procedural difference between them. In hypnotherapy there is an 
induction procedure involving relaxation and focussed attention (British Psychological 
Society, 2001), which is not involved in imagery. Within the health and medical literature, 
research has not explored any therapeutic difference between these two psychosocial 
interventions. Consequently, a third objective of this study was to examine differences in 
HRQOL in RA patients, following an imagery or hypnotherapy intervention. 
In summary, the present study had three research objectives. The first of these was to 
compare how the items identified as important by RA patients in the PGI was related to the 
fixed items of the SF-36. It was hypothesised that because of the generic nature of the SF-36 
and the individualised nature of the PGI, the SF-36 would not capture all items identified as 
important by the patient in the PGI. The second objective of the study was to examine the 
relationship in HRQOL, following a psychosocial intervention, when measured by a generic 
HRQOL PROM, the SF-36, and a PGOM, the PGI. In relation to this objective it was 
hypothesised that there would be no significant relationships in HRQOL between the SF-36 
and the PGI because the intervention was tailored based on items identified in the PGOM. 
The final objective was to investigate possible differences in HRQOL between the SF-36 and 
the PGI, following an imagery or hypnotherapy intervention. It was hypothesised that there 
would be a significant increase in HRQOL, measured by the PGI, in both intervention groups 
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when compared to a control group. Furthermore, due to the additional induction procedure 
involved in hypnotherapy, we further hypothesised there would be significantly higher 
IIRQOL reported by those participants in the hypnotherapy group when compared to those in 
the imagery group. 
Method 
Participants 
Forty two patients were recruited from the North West Wales NHS Trust 
rheumatology clinics, by written invitations sent to RA patients from a database made 
available from the rheumatology department, and through advertisements placed in the local 
press (see figure 1 for recruitment and randomisation flow chart). Inclusion criteria included a 
diagnosis of RA according to the American Rheumatism Association criteria (Arnett et al., 
1987) for more than three years. To minimise the effect of flares of RA activity the 
participants must have had no change in prescribed medication within the last six months and 
no expected change in prescribed medication for the duration of the study. Participants were 
not paid to take part in the study however they could claim their travelling expenses. 
Study Design 
A randomised controlled intervention trial, three by three (group x time) factorial 
design with repeated measures on time was employed. The groups were imagery intervention, 
hypnotherapy intervention, and `care-as-usual' control group. Data collection time points 
were pre-intervention, six week post intervention, and six months follow-up. The study was 
approved by the Local Ethics Committee of North West Wales NHS Trust. Written informed 
consent was obtained from all participants. 
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Figure 1. Recruitment and Randomisation Flow Chart 
Rheumatology Clinic 
(n = 60) 
Written invitations 
(n = 42) 
Advertising in local 
press 
(n = 34) 
Agreed Declined 
(n - 12) (n = 48) 
Did not 
give 
consent 
(n = 4) 
Gave 
consent 
(n=8) 
Agreed Declined 
(n = 10) (n = 32) 
Did not 
give 
consent 
(n = 2) 
Gave 
consent 
(n = 8) 
Met Excluded 
criteria 
(n = 26) (n = 8) 
Gave 
consent 
(n = 26) 
Sample size 
(n = 42) 
Imagery Group Hypnotherapy Group Control Group 
(n 14) (n = 14) (n = 14) 
Six intervention Six intervention Treatment as usual - 
sessions over a six sessions over a six no intervention over 
week period week period six week period 
(n = 14) (n =14) (n =14) 
Follow up sessions Follow up sessions Treatment as usual 
every two months every two months no intervention 
for six months for six months over six week 
(n = 14) (n = 14) period 
(n = 14) 
Baseline measures 
collected 
Six weeks 
post intervention 
measures collected 
Six months follow 
up, post 
experimental and 
perceived social 
support measures 
collected 
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Sample Size Calculation 
A sample size of 57 was calculated through the following assumptions and methods. 
There were no studies in the literature that have used the PGI as a primary outcome measure 
following a psychosocial intervention. However Astin et al. (2002) conducted a meta-analysis 
of psychosocial interventions in RA are reported moderate to large effect sizes for 
psychosocial functioning following this type of intervention. Furthermore, Jenkinson, 
Stradling, & Peterson (1997) reported an effect size of 1.33 in a study using the PGI 
ibllowing a medical intervention for obstructive sleep apnoea. Therefore it was assumed that 
psychosocial interventions can produce large effect sizes in RA and that the PGI is sensitive 
to large effect sizes with an intervention. 
As the design of the study is repeated measures Stevens (1996) method for calculating 
sample size was followed. Stevens (1996) uses Cohen's (1992) effect size value of 0.1,0.25, 
and 0.4 for small, moderate, and large effect sizes respectively, with one way ANOVAs. 
Assuming an average correlation of 0.5 between the repeated measures variables, the Cohen 
effect size is divided by the square root of 1 minus 0.5 (i. e. the average correlation), with the 
product of a (large) effect size of 0.57. With repeated measures of 3 (pre, post, and follow- 
up), an alpha level of 0.01, a large effect size of 0.57, and a power of 0.8, according to 
Stevens (1996) a sample size of 19 in each group is required. 
Randomisation 
Participants were randomised to either an imagery group, a hypnotherapy group, or a 
`care-as-usual' control group using an internet based package (www. randomizer. org), with an 
equal number of males and females in each group. Participants randomised to the control 
group were offered sessions in either imagery or hypnotherapy after the duration of the study. 
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Measurements 
HRQOL using a PGOM The primary outcome measure was the Patient Generated 
Index (PGI: Ruta et al., 1994). The PGI is a HRQOL PGOM. When completing the PGI, 
participants are asked to identify up to five areas of their life that they perceive as being 
important (e. g. playing with grandchildren, leisure walking etc, ). A score between 0 (the 
worst you could imagine) and 10 (exactly as you would like it to be) is allocated by 
participants to reflect how seriously each of these areas is affected by their disease. 
Participants are then asked to give their own weighting to each of these areas. This is 
conducted by dividing 12 points on each of the areas identified. The more points spent on a 
particular area indicates greater importance. The resultant index score is an overall reflection 
of that individuals perceived HRQOL. Higher index scores indicate higher perceived 
HRQOL. The PGI has good reliability, validity, and responsiveness (Martin, Camfield, 
Rodham, Kleimpt, & Ruta, 2007). 
HRQOL using a PROM. The SF-36 questionnaire is a generic HRQOL PROM which 
contains 36 items. These items are grouped into eight subscales measuring physical 
functioning, role limitations due to physical health, bodily pain, general health, vitality, social 
functioning, role limitations due to emotional problems, and mental health. Scores on each 
subscale are expressed as values between 0 and 100 where a high score indicates good health. 
The SF-36 has been shown to have good psychometric properties (McHorney, Ware, & 
Raczek, 1993) and is the most frequently used measure of HRQOL in RA (Kalyoncu et al., 
2008). 
The questionnaire pack given to participants also contained measures relating to pain, 
fatigue, pain anxiety, arthritis self-efficacy, and functional disability (see Appendix A). The 
outcome of these measures is reported in chapter four of this research thesis. 
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A post experimental questionnaire (see Appendix B) was administered after the six 
month follow-up to gain information about what participants expected and hoped would 
happen to the symptoms of their disease by taking part in the study, and their reaction to 
which group they were randomised into. Hope and expectation were measured with a I00mm 
visual analogue scale, which was anchored with the statements 'no change' and 'a lot of 
change' at opposite ends. Initial reaction to randomisation was measured using a 100mm 
visual analogue scale with the anchors 'very dissatisfied' and `very satisfied'. Participants 
were asked about the frequency of using an audio recording of the intervention, and how easy 
it was to schedule the intervention into their daily life routine. These variables were analysed 
to identify possible confounding effects in the results. 
As social support has been shown to have a beneficial effect on HRQOL for patients 
with RA (Minnock, Fitzgerald, & Bresnihan, 2003), a modified version of the perceived 
social support scale (PSS; Procidano & Heller, 1983) to include social support from the 
experimenter was used to examine possible experimenter effects (see Appendix Q. Scores on 
the perceived social support scale range from +20 to -20 where higher scores indicate greater 
perceived social support. 
Procedure 
Patients meeting the inclusion criteria were given an information sheet detailing the 
objectives of the study, a brief description of imagery and hypnotherapy, and what would be 
involved if they decided to participate. If patients decided to participate they were given a 
consent form and a questionnaire pack which contained a copy of the PGI and the SF-36- 
Returned consent forms and questionnaire packs were allocated a study number. This was 
entered into the on-line randomisation software package to allocate patients to each group. 
After randomisation, participants in the intervention groups choose whether to attend the six 
weekly intervention sessions at a private room in the School of Sport, Health, and Exercise 
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Sciences, Bangor University or in their own home. All intervention sessions were conducted 
by the same researcher throughout the duration of the study. 
After participants had completed the six weekly intervention sessions they completed 
the same questionnaire pack and three follow-up sessions were timetabled over a six month 
period. Participants in the control group continued with `care-as-usual' and completed the 
same questionnaire pack six weeks after consent was taken. 
For post-intervention and follow-up, the original items that participants had identified 
as being important in the PGI were written in the PGI questionnaire however, participants 
were informed that they could change these items if they felt they were no longer important, 
or if something more important was relevant to them. At six months follow-up all participants 
completed the questionnaire pack, the post experimental questionnaire, and the modified 
perceived social support questionnaire. 
Intervention 
The first session in both intervention groups was standardised and the content of the 
five remaining sessions were based on the items identified in the PGI (see Appendix D and E 
for examples of imagery and hypnotherapy sessions). If a participant identified less than 
five 
items, the remaining sessions consisted of repetition of the previous sessions. The 
intervention sessions lasted approximately one hour, and all sessions were recorded. 
Participants were given an audio CD recording of the first standardised session, and the 
subsequent intervention sessions, and asked to practice the intervention on a daily basis. The 
three follow-up sessions were based on the previous six sessions and participants were also 
encouraged to continue using the audio CD's on a daily basis. 
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Data Analyses 
Patient characteristics. Univariate statistics (means and standard deviations) were 
used to examine participant characteristics. One-way ANOVA were conducted to examine 
any differences in patient characteristics between the groups. The assumptions of normality 
and homogeneity of variance were not violated. 
Reliability and responsiveness of the PGI and the SF-36. Reliability of the PGI in this 
sample was assessed using the index of change (IOC) method (Ruta et al., 1994), and 
responsiveness was assessed using effect size. Responsiveness of the SF-36 was assessed 
using effect sizes, using the guidance provided by Cohen (1988). 
HRQOL: Relationship between a PROM and a PGOM. To test the hypothesis that the 
SF-36 would not capture all of the important items identified by participants in the PGI, four 
researchers independently categorised the items into the domains of the SF-36. Fleiss' kappa 
value was used to calculate the level of inter-rater reliability as there were more than 2 
independent raters (Fleiss, 1971). The items not captured by the SF-36 were also recorded. 
In order to test the hypothesis that there would be no significant relationship in 
HRQOL between the SF-36 and the PGI a series of correlations were performed between the 
scores of these two measures at baseline, post-intervention, and follow-up. Scores for the 
intervention groups were combined, and control group data were excluded from this analysis. 
The assumptions of normality, linearity, and homoscedaticity were not violated. 
Interpretation of Pearsons correlation was defined by Cohen (1988) where values less than 
0.29 are small, values between 0.30 and 0.49 were accepted as medium, and any value greater 
than 0.50 was accepted as large. Additionally, if these two measures were measuring the 
same construct, namely HRQOL, then similar trends would be expected across time between 
the two measures. Therefore repeated measures ANOVAs were conducted, using data from 
combining the intervention groups only, to examine the trend over time in 1IRQOL as 
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measured by the SF36 summary scales and the PGI. The assumptions of normality, 
homogeneity of variance, and homogeneity of inter-correlations were not violated. 
Significance was accepted as p<0.05. 
HRQOL: Following an Imagery or Hypnotherapy Intervention. In order to test the 
hypothesis that the intervention groups would report a significant increase in HRQOL when 
compared to the control group, and that the hypnotherapy group would report greater 
IIRQOL than the imagery group a two-way repeated measures ANOVA was conducted to 
assess intervention effects from baseline, six weeks post-intervention and six months follow- 
up for PGI scores. Additionally, a series of two-way repeated measures ANOVA were 
conducted to assess intervention effects from baseline, six weeks post-intervention and six 
months follow-up for all the subscales of the SF-36. The assumptions of normality, 
homogeneity of variance, and homogeneity of inter-correlations were not violated. 
Significance was accepted as p<0.05 (one-tailed tests). Tukeys test was employed as a post 
hoc procedure. 
Post experimental data and manipulation check A series of one-way ANOVAs were 
conducted on expectation, hope, initial reaction to randomisation, and independent samples t- 
test on frequency of use of CD to assess whether there were any differences between the 
groups. Where any difference was identified, follow-up correlation analyses were conducted 
to assess the relationship between these variables and changes in HRQOL at post-intervention 
and follow-up. 
Perceived social support from the experimenter was used as a manipulation check. 
This was thought essential as the literature indicates that additional social support may 
confound the results of outcome measurement in intervention studies (Stone, Kerr, Jacobson, 
Conboy, & Kaptchuk, 2005; Spiro, 1998). Mann-Whitney tests were conducted to investigate 
the differences in perceived social support received from the experimenter between the 
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groups. Spearman's rho correlations were conducted to investigate the relationship between 
the perceived social support received from the experimenter and the SF-36 subscales and PGI 
scores. 
Results 
Patient Characteristics 
A total of 136 patients with RA were invited to participate in this study. Due to the 
time constraints and the difficulty in recruiting patients to participate in this study the 
required sample size was not achieved. Forty two patients who met the criteria agreed to 
participate and completed all stages of the study. Thirty of the participants were female. The 
mean age of participants was 59 years (sd=9.1) and there were no significant differences in 
age within the three groups. The majority of participants (83%) were either married or living 
as married. Three participants were widowed, three were divorced and one participant was 
single. The mean disease duration was 160 months (sß=104) and there were no significant 
differences in disease duration between the three groups. 
Reliability and Responsiveness of PGI and SF-36 
The IOC value of the PGI in this study was 0.976. This high value indicates that at 
post-intervention and follow-up, participants changed very few of the original items they 
identified as being important at baseline. The responsiveness of the PGI was assessed by the 
effect size. The effect size following the intervention was large (rye =0.368) indicating the PGI 
to be responsive to changes in HRQOL. The consistency and responsiveness shown in these 
results indicate that the PGI is a reliable measure of HRQOL in our sample of RA patients. 
Effect sizes for the SF-36 subscales were very low (rye =0.02 to 0.04). These low effect sizes 
observed in the SF-36 subscales and summary scales indicate that this was not a responsive 
measure in our study. 
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IIRQOL: Relationship between a PROM and a PGOM 
A total of 165 items were identified by participants in this study. Table 6 provides a 
summary of the number of items identified under each of the SF-36 subscales. 
Table 6. Number of items identified in the PGI, and SF-36 subscales with Fleiss' kappa. 
SF-36 subscales* 
PF RP BP GH VT SF RE MH Not in 
SF-36 
PGI Na 48 42 28 5 13 37 4 10 45 
items 
% 29 25 17 38 22 26 27 
Fleiss' kappa = 0.78 
* PF=physical functioning, RP=role limitations due to physical health, BP=bodily pain, 
GH=general health, VT=vitality, SF=social functioning, RE=role limitations due to 
emotional problems, MH=mental health 
a Some items identified in the PGI could be classified in more than one subscale of the SF-36 
Of these 165 items, 27% (45 items) were not categorised into any of the SF-36 
subscales. Fleiss' kappa amongst the four researchers was calculated to be 0.78, indicating 
substantial agreement (Landis & Kock, 1997). Figure 4 presents the items from the PGI 
which were not captured by the SF-36. The most commonly identified areas not captured by 
the SF-36 included, problems with sleep, problems with concentration, fear of having a flare, 
fear of becoming deformed, not being able to plan for the future, and remaining independent. 
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Figure 2. Items identified in the PGI and not captured in SF-36. 
Problems with sleep (7). 
Problems with concentration (4). 
Fear of deformity (3). 
Being independent or losing independence 
(3). 
Love life - being able to love my wife 
more. 
Having to keep a medicine regime to keep 
me in reasonable health. 
Being able to think more creatively when 
designing jewellery. 
Being able to help others and feel needed. 
Rambling and walking for pleasure. 
Putting on weight because I can't exercise 
as much. 
Helping my wife with her illness. 
Being able to dance more gracefully. 
Being able to use the small parts of the 
camera. 
Fear of a flare up (5). 
Planning for the future (3). 
Being able to travel more comfortably. 
Keeping up my hobbies and using my hands 
more. 
Having a better sex life with my wife, 
problems with medication. 
Manual dexterity, especially sewing and 
mending things. 
Hobbies - photography, walking to places of 
interest, sports. 
Not feeling caged in all the time. 
Doing my needlework. 
Keeping up my hobbies, getting involved in 
all the [archaeological] digs. 
Stiffness, stops me from living. 
Can't travel as much as I would like to. 
Craft making - difficulties with my hands. 
At baseline, correlation analyses between scores on the SF-36 subscales and the PGI 
indicate significant correlations between five of the SF-36 subscales and the physical 
summary scales, with scores on the PGI. However, at post-intervention, the number of 
significant correlations decreased, with only four of the subscales and the physical summary 
scale having significant correlations with scores on the PGI. At follow-up only two of the 
subscales and the physical summary scale remained significantly correlated with scores on 
the PGI (see Table 7 for a summary of the results). 
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Results from repeated measures ANOVA reveal no significant effect for time, for the 
physical or mental summary scales of the SF-36, indicating that HRQOL as measured by the 
SF-36, for the combined intervention groups, did not change significantly over the time of the 
intervention period. However, repeated measures ANOVA for the PGI reveal a significant 
main effect for time and a very large effect size (Wilks' Lambda = 0.452, F(2,26)=15.786, 
p<. 0005, r2 =0.584). This result indicates that HRQOL as measured by the PGI did change 
significantly, for the combined intervention group, over the time of the intervention period. 
In summary, at baseline there were several significant correlations between the SF-36 
subscales and summary scales, and the PGI, but the number of significant correlations 
decreased at post-intervention, and again at follow-up. This suggests poor convergent validity 
between these two HRQOL measures. Furthermore, as the repeated measures ANOVAs 
revealed no change in HRQOL when measured by the SF-36, yet significant changes when 
measured with the PGI, we can conclude that these two measures are not measuring the same 
construct. 
HRQOL: Following an Imagery or Hypnotherapy Intervention 
HRQOL measured using a PROM the SF-36. A one-way ANOVA revealed 
significant differences in the SF-36 physical function scale (p=0.01) and SF-36 physical 
summary scale (p=0.04) between the groups at baseline. Two two-way analysis of covariance 
were conducted using group (imagery, hypnotherapy or control) and time (post-intervention, 
and follow-up) as the independent variables and pre-intervention SF-36 physical function 
scale and physical summary scale scores as covariates. The assumptions of linearity and 
homogeneity of regression slopes were not violated. The assumption of homogeneity of 
variance was violated, however Stevens (1996) identified that when group sizes are equal the 
test is still robust. 
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The results of the ANCOVA revealed that the covariate was not significant (physical 
function, p>0.05; physical summary scale, p>0.05). Consequently, two-way repeated 
measures ANOVA were conducted using group (imagery, hypnotherapy or control) and time 
(pre-, post-intervention, and follow-up) as the independent variables. No main effects or 
significant interactions for either the physical function or the physical summary scales of the 
SF-36 were found. 
A one-way ANOVA revealed no significant differences between the groups and the 
other SF-36 scale scores at baseline. Two-way repeated measure ANOVA's revealed no 
significant main effects or interactions for any of the other SF-36 subscales. In summary, 
none of the three groups reported any change in HRQOL from baseline to follow-up, when 
measured with the SF-36 (summary of results presented in tables 8 to 10). 
Table 8. HRQOL using the SF-36: Imagery group (means and standard deviation) 
SF-36 subscale scores 
PF RP BP GH VT SF RE MH PS MS 
Pre Mean 30.6 35.5 39.2 39.0 45.0 42.8 44.0 51.8 31.2 52.6 
(6.7) (9.5) (7.4) (9.8) (9.2) (10.6) (10.2) (8.2) (7.0) (8.8) 
Post Mean 32.2 36.6 40.4 41.4 47.5 47.6 43.3 53.1 33.9 54.2 
(9.2) (9.9) (8.2) (11.6) (10.3) (11.1) (13.4) (8.5) (10.2) (11.2) 
F. U Mean 34.0 38.7 40.4 41.2 45.2 47.0 48.4 54.2 34.5 55.7 
(9.3) (9.7) (8.6) (9.4) (13.2) (9.8) (7.7) (9.1) (10.8) (8.7) 
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Table 9. HRQOL using the SF-36: Hypnotherapy group (means and standard deviations) 
SF-36 subscale scores 
PF RP BP GH VT SF RE MH PS MS 
Pre Mean 40.0 37.5 39.5 34.6 41.7 42.3 44.1 44.8 36.6 45.9 
(11.9) (11.3) (9.7) (9.7) (14.0) (15.4) (13.1) (15.1) (10.1) (18.1) 
Post Mean 35.1 34.6 36.6 37.1 40.5 39.7 38.8 42.2 36.3 44.7 
(13.6) (8.6) (7.2) (10.1) (9.4) (11.5) (13.4) (12.5) (11.2) (9.7) 
F. U Mean 32.4 34.7 38.9 39.8 42.1 43.4 39.0 45.6 34.8 48.3 
(11.6) (9.8) (6.4) (8.7) (8.4) (10.0) (14.4) (10.1) (9.6) (10.0) 
Table 10. HRQOL using the SF-36: Control group (means and standard deviations) 
SF-36 subscale scores 
PF RP BP GH VT SF RE MH PS MS 
Pre Mean 39.5 39.9 44.4 41.2 49.8 44.8 46.2 50.2 39.2 52.0 
(6.5) (7.1) (4.5) (6.0) (7.5) (5.4) (5.9) (7.2) (7.4) (9.1) 
Post Mean 40.4 42.3 45.4 42.8 51.4 48.6 47.4 51.8 40.2 54.4 
(9.8) (9.2) (6.8) (6.8) (8.6) (7.1) (7.6) (6.6) (8.7) (5.7) 
F. U Mean 41.4 44.2 46.9 44.3 50.7 49.6 48.3 51.8 41.6 54.6 
(10.2) (8.4) (6.6) (6.4) (7.9) (5.8) (6.5) (5.6) (8.6) (5.7) 
HRQOL measured using a PGOM the PGI. A one-way ANOVA revealed no 
significant differences in PGI scores at baseline. A two-way analysis of variance was 
conducted using group (imagery, hypnotherapy or control) and time (baseline, post- 
intervention, and follow-up) as the independent variables and PGI scores as the dependent 
variable. A significant main effect for time, F(2,78)=9.998, p<0.001 (q 2=0.368) and group 
F(2,39)=3.375, p<0.05 (r12=0.148) were revealed. Of more central interest was a significant 
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group by time interaction, F(4,78)=4.575, p=0.002 (rye =0.195). Follow-up Tukeys test 
revealed both the imagery (58.8, sch=16.8) and hypnotherapy (55.3, sd=15.4) groups had 
significantly higher mean scores on the PGI (p=0.005 and p=0.00 18 respectively) than the 
control group (38.9, sd=13.0), with no significant differences between the imagery and 
hypnotherapy groups, at post-intervention. At follow-up the hypnotherapy group (55.3, 
sd=15.7) had significantly higher mean scores on the PGI (p=0.029) than the control group 
(39.7, sd=14.5), there was no significant difference between the imagery (46.3, sd=16.2) and 
hypnotherapy group, and no significant difference on PGI mean scores between the imagery 
and control group. In summary, the imagery group report increased HRQOL at post- 
intervention, however at follow-up this decreased to baseline levels. The hypnotherapy group 
also report increased HRQOL at post-intervention, and this was maintained at follow-up. The 
control group report no change in HRQOL from pre-intervention to follow-up. Figure 3 
illustrates the changes over time in the mean PGI scores for the three groups. 
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Figure 3. HRQOL measured by the PGI. 
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Post Experimental Questionnaire and Manipulation Check 
There were no significant differences between the three groups in what participants 
expected would happen to their condition by participating in this study. However, the control 
group scored significantly lower than the hypnotherapy group (p=0.04) on what they hoped 
would happen to their condition as a result of taking part in this study. Additionally, the 
control group scored significantly lower than both intervention groups on their reaction to the 
randomisation process (p<0.001; see table 11 for a summary of the results). 
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Table 11. Mean and standard deviation for post experimental data by group. 
Imagery Hypnotherapy Control 
What did you 4.6 (1.44) 5.6(l. 6) 5.3 (1.44) 
expect to happen? a 
What did you hope 6.4 (1.68) 7.5 (1.65) 6.2 (1.25)* 
would happen? a 
Initial reaction to 6.9 (1.68) 8.0 (1.68) 3.9 (1.35)* 
randomisation' 
How often practice 6.4 (1.94) 5.6 (2.06) - 
baseline to post- 
intervention? b 
I low often practice 4.1 (2.10) 3.7 (2.01) 
post-intervention to 
follow-up ?b 
How easy to fit into 6.0 (1.71) 5.6 (1.69) 
your daily 
schedule? ` _ ascores between 0 and 10, where higher scores indicate greater expectation for change, hope 
for change, or satisfaction with randomisation. bscores between 0 and 10, where higher scores indicate a greater frequency of practicing the 
intervention. 
`scores between 0 and 10, where higher scores indicate greater ease fitting the intervention 
into daily schedule. 
* control group significantly lower (p<0.05) 
Despite these differences, follow-up Pearson correlation analyses revealed that there 
was no significant relationship with changes in HRQOL scores and what participants hoped 
would happen by taking part in this study, and their reaction to the groups they were 
randomised to. No significant differences were found between the two intervention groups 
and the frequency in which they practiced the intervention during the six weeks post- 
intervention and six month follow-up. In summary, the results of the post-experimental 
questionnaire indicate that expectation, hope, reaction to randomisation, frequency of using 
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the CD, or the ease of scheduling the intervention into daily life routines were not 
significantly related to changes in HRQOL. 
Perceived social support received from the experimenter (2.7, sd=0.5) was 
significantly lower than social support received from either family (15.6, sd=0.5) or friends 
(15.3, sct--0.4; J=58.908, p<0.005). There were no significant differences between perceived 
social support received from the experimenter in the imagery and hypnotherapy group. 
Perceived social support received from the experimenter was significantly higher (Z=-3.204, 
p<0.001 and Z=-3.54, p<0.001) in the imagery (3.5, sd=1.04) and hypnotherapy (4.2, sd 0.9) 
group when compared to the control group (0.2, sd=0.3). However, there were no significant 
correlations between changes in PGI scores, or changes in SF-36 subscale scores and 
perceived social support received from the experimenter in the imagery or hypnotherapy 
groups. Therefore we can conclude that although perceived social support from the 
experimenter was higher in both intervention groups, as would be expected, correlational 
analyses suggest that changes in HRQOL scores and level of perceived social support 
from 
the experimenter were not significantly related. 
Discussion 
The measurement of HRQOL has become an important outcome within research and 
clinical practice, especially in patients with chronic conditions such as rheumatoid arthritis. 
With the growth of HRQOL PROMs and PGOMs it is crucial that the appropriate measure is 
chosen (Arnold et al., 2004; Garratt et al., 2002; Joyce et al., 1999). In determining which 
measures are appropriate the definition of HRQOL must be considered. Because the 
definition of HRQOL includes an individual's perception of what is important to them 
(Kushida et al., 2007), it seems logical that to include patient perceptions in HRQOL 
measures. The objective of this study was to compare a HRQOL PROM and PGOM, to 
identify whether the most common used HRQOL PROM in RA trials, the SF-36, was capable 
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of capturing patient perceptions of what is important as recorded on a PGOM, the PGI. 
Additionally, this study sought to identify whether the outcome of these two HRQOL 
measures would change similarly following a patient-centred imagery or hypnotherapy 
intervention. Finally, to explore the efficacy of these two psychosocial interventions in 
relation to improved HRQOL. 
The results of this study confirm our first hypothesis, in that the SF-36 was unable to 
capture all the items identified as important by patients with RA. On average, one out of 
every five items (20%) identified in the PGI by each participant was not captured in the SF- 
36. The important identified items in this study are similar to those identified from qualitative 
studies of patient group discussions (Kirwan, Heiberg, & Hewlett, 2003; Kirwan et al., 
2005) 
including sleep, fatigue, a return to normality, and independence. 
McHorney (2002) has stated that PROMs enable the identification of patient 
preferences, and Haywood (2006a) suggests that the clinical decision making process 
is not 
fully informed when measures do not take into account the patient's perspective. 
The SF-36 
did not fully elicit patient preferences in our sample of RA patients. 
Given that the SF-36 is 
the most common used HRQOL PROM in RA trials (Kalyoncu et at., 
2008), the results of 
this study indicate significant implications for future RA trials investigating HRQOL. 
Specifically, using fixed-item generic measures such as the SF-36 will result in the omission 
of important outcomes, and may not reflect beneficial change in outcome. Furthermore, the 
clinical implications of this are important. For example, problems with sleep and anxiety 
in 
relation to fear of deformity and flare-up were identified by several of the participants in the 
PGI, but not captured by the SF-36 in this study. Both sleep problems and increased anxiety 
have shown to be predictive of increased disease activity in RA patients (Abad, Sarinias, & 
Guilleminault, 2007; Isik, Koca, Ozturk, & Mermi, 2007). Given that HRQOL measures are 
increasingly utilised to helped clinicians make informed choices and evaluate patient 
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satisfaction with treatment, using the SF-36 in this role may provide misleading information. 
When trying to identify patient preferences, clinicians should be wary about using PROMs of 
HRQOL such as the SF-36, as these do not capture important aspects of an individuals' 
FIRQOL. Indeed, the results from the present study indicate there is a difference between 
PROMs of HRQOL, such as the SF-36, and PGOMs of HRQOL, such as the PGI. 
When considering the measurement of HRQOL, there is much debate as to which 
type of measure should be employed (Arnold et al., 2004). Some authors regard the SF-36 as 
the `gold standard' in HRQOL (Jordon-March, 2002). However the results of our study 
support Bradley et al. (1999) who state that the SF-36 is not an adequate measure of HRQOL 
of patients with chronic conditions. Furthermore, Joyce et al. (1999) have suggested when 
measuring HRQOL it is crucial to gain an understanding of what the individual perceives as 
important. The PGI specifically sets out to perform this task, whereas the fixed-item construct 
of the SF-36 does not. 
If these two measures were measuring the same construct, then high intercorrelations 
between their scores and similar trends in the outcomes of these measures would be observed. 
However, the number of significant intercorrelations decreased over time and there is a 
difference in the outcome of HRQOL between the PROM and the PGOM. This result 
confirms the second hypothesis that there would be a difference in HRQOL between these 
two measures. This difference between the PROM and the PGOM used in this study reflects 
the general concern amongst researchers about what HRQOL measures are actually 
measuring (Kind, 2003). A conclusion which can be identified from the results of this study 
is that generic HRQOL is not the same as individualised HRQOL in RA patients. 
Interestingly, this result is not exclusive to RA patients. Morris et al. (2006) identified in a 
study of patients undergoing major surgery that seven commonly used HRQOL PROMs, 
including the SF-36, would have failed to capture what these patients would have regarded as 
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being important themes in their HRQOL. This adds further evidence to the inclusion of 
PGOMs of HRQOL in research and clinical practice. 
It may be argued that the difference in the results between these two measures was 
due to the uniqueness of this study. Items identified by participants in the PGI were the 
targets of intervention, and therefore the PGI would be more sensitive to change than the SF- 
36. Indeed, the effect size for the PGI was greater than those for the SF-36 subscales. As the 
effect sizes reflect of the relationship between the two measures of HRQOL and the 
individualised nature of the intervention we can conclude that the PGI was more sensitive to 
change than the SF-36. This result suggests that the approach of tailoring interventions may 
be a promising way to optimise perceived treatment effectiveness for the individual and 
further enhance a patient-centred approach to care. Indeed, several studies support a tailored 
approach to interventions, for example Sohl and Moyer (2007) report that women who 
received a tailored psychosocial intervention were more likely to get a mammogram than 
those who did not. Webb, Simmons, and Brandon (2005) demonstrated that tailoring 
interventions for smoking cessation results in greater success. 
More specific to RA, Evers, Kraaimaat, van Riel, and de Jong (2002) conducted a trial 
of tailored cognitive behavioural therapy in early RA patients at risk of anxiety and clinical 
depression. Participant in this trial were able to chose from four different `treatment modules' 
in pain and disability, fatigue, mood disorders, and social functioning problems. The modules 
available were based on what individual patients regarded as a priority. Following the tailored 
intervention the authors identified significant decreases in fatigue and depression at post- 
intervention which were maintained at six months follow-up. These studies combined with 
the results in the present study provide evidence for tailoring interventions. Utilising the PGI 
allows identification of areas which can be targeted for tailored interventions. 
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Finally, the study sought to explore any differences in the effectiveness of two 
psychosocial interventions, namely imagery and hypnotherapy. It was hypothesised that there 
would be a significant increase in HRQOL, measured by the PGI, in both the imagery and 
hypnotherapy groups and that because of the induction procedure involved in hypnotherapy 
and not imagery, the increase in HRQOL would be greater in the hypnotherapy group than 
the imagery group. The results of the present study support this hypothesis. Furthermore, the 
increase in HRQOL was maintained at six months follow-up. The inclusion of an induction 
procedure, which is similar to relaxation, in the hypnotherapy group may have contributed to 
the increased levels of HRQOL. Keefe et al. (1997) reported that RA patients who engaged 
in coping strategies involving relaxation reported better coping and less pain than those that 
did not. In order to identify whether the induction procedure in hypnotherapy contributed to 
the improved outcome future studies of hypnotherapy and imagery should consider using a 
relaxation control group in their design. 
The post experimental questionnaire revealed no significant correlations between 
what participants hoped for, or expected, as a result of taking part in the study. This is 
surprising as expectation is believed to involve hope for improvement (Spiro, 1998) and is an 
influencing factor in the placebo effect (Mitchell, Laurent, & de Wit, 1986). Nevertheless, the 
results indicate that changes in HRQOL scores was not significantly related to variables in 
the post-experimental questionnaire. However, the post-experimental questionnaire was not 
administered until the end of the study at six months follow-up. It may be that participant's 
hopes and expectations changed from the start of the study, and perhaps if they were asked at 
the beginning there may have been significant correlations with changes in HRQOL. 
Despite these promising results, the present study has several limitations. Within the 
design of this study the control group was a `care-as-usual control group. Therefore, this 
group had significantly less contact with the experimenter than the intervention groups. This 
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raises concerns of experimenter effects confounding the results. However, because of time 
constraints, rather than add an additional control group with the same number of contact 
hours as the intervention groups, all participants were asked about perceived social support 
from the experimenter. Perceived social support is an important factor when living with a 
chronic condition (King, Willoughby, Specht, & Brown, 2006). Studies have shown that 
social support is associated with HRQOL (King, Cathers, Miller Polgar, MacKinnon, & 
I Iavens, 2000) and is a significant predictor of changes in HRQOL (Bennett et al., 2001). 
Indeed, perceived social support from the experimenter was significantly higher in both the 
intervention groups when compared to the control group. This was expected as each 
participant in the intervention groups spent on average nine hours more contact time with the 
experimenter than the control group. However, the perceived social support from the 
experimenter was significantly lower than perceived social support from either family or 
friends in all three groups. Furthermore, this increased perceived social support from the 
experimenter, in the intervention groups, was not correlated to changes in HRQOL scores 
measured by either the PGI or the SF-36. Therefore we can conclude that perceived social 
support from the experimenter was not significantly related to changes in HRQOL. 
Another limitation of the present study was the low sample size. Unfortunately due to 
difficulties recruiting patients onto this study, the required calculated sample size was not 
achieved. However, the primary outcome measure was the PGI and the observed power was 
0.987, this is indicative of sufficient sample size. The observed power of the SF-36 was low 
(mean observed power 0.45). Stevens (1996) suggests that when small sample sizes are 
involved the alpha value should be set to compensate for insufficient power values. If the 
significance alpha values were set from 0.05 to 0.1 there would have been a main effect 
for 
time in the social function and general health subscales of the SF-36. However post-hoc 
follow-up tests revealed these to be non-signifi cant. A replication study with a larger sample 
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size may be able to test whether the low responsiveness of the SF-36 was because of 
insufficient power due to a small sample size. 
In conclusion, the results of this study demonstrate that HRQOL PGOMs, such as the 
PGI, are important both in relation to research and clinical practice. The PGI is an effective 
tool for enhancing a patient-centred approach to treatment through identification of patient 
preferences. Furthermore, both imagery and hypnotherapy were effective psychosocial 
interventions for increasing HRQOL post-intervention, with hypnotherapy having longer 
term effects. The use of the PGI in the delivery of tailored psychosocial interventions such as 
imagery and hypnotherapy warrants further research. It may be that this patient-centred 
approach and use of psychosocial interventions will have HRQOL benefits for other chronic 
conditions. Given the results of this study, the limitations of fixed-item PROMs 
questionnaires, and the current debate as to whether generic or disease-specific measures 
should be used (Arnold et al., 2004) it is concluded that HRQOL PGOMs should also be 
considered in this debate. 
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CHAPTER FOUR 
IMAGERY AND HYPNOTHERAPY 
AS COMPLEMENTARY THERAPIES IN STABLE RHEUMATOID ARTHRITIS: 
A RANDOMISED CONTROLLED STUDY2 
2 This research was presented as an oral presentation at the British Psychological Society Division of Health 
Psychology and European Health Psychology Society Annual Conference in September 2008, the abstract was 
accepted for publication: Bennett, B. M., Callow, N. & Jones, J. (2008). The use of imagery and hypnotherapy as 
complementary and alternative therapies in rheumatoid arthritis patients. Psychology & Health, 23 (suppl 1), 64-65. 
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Abstract 
Objective. The objective of this study was to examine the efficacy of imagery and hypnotherapy 
as complementary therapies in patients with stable rheumatoid arthritis. 
Method Forty two participants with stable RA were randomised to an imagery intervention, 
hypnotherapy intervention, or `care-as-usual' control group. Self-reported measures of pain, 
physical and mental fatigue, pain anxiety, arthritis self-efficacy, and functional disability, were 
collected at pre-intervention, six weeks post-intervention, and six months follow up. Participants 
in the imagery or hypnotherapy groups received six sessions over a six week period, followed by 
another three sessions over a six-month period. 
Results. At six-week post-intervention both imagery and hypnotherapy groups reported 
significant decreases in pain. Additionally, the hypnotherapy group reported a significant 
decrease in physical fatigue, a significant increase in self-efficacy for controlling pain, and a 
significant decrease in functional disability. At six-month follow-up the hypnotherapy group 
maintained significantly increased self-efficacy for controlling pain, and significantly decreased 
functional disability. Clinically significant reductions were also achieved in physical and mental 
fatigue, and functional disability, for both groups at post-intervention and six months follow-up. 
Conclusions. Given that imagery and hypnotherapy achieved clinically significant reductions in 
fatigue and functional disability these complementary therapies should be offered to patients 
with stable RA experiencing increased pain, fatigue, and functional disability. 
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Complementary therapies (CTs) are defined as health care practices which are not considered 
part of conventional medicine but complement it (Manheimer & Berman, 2008) by satisfying the 
needs of individuals which are not being met by conventional medicine (Ernst, 2004). 
Practitioners of CTs adopt the view that health and disease should be conceptualised within a 
framework where the total person, including body, mind, and spirit, is the focus of an 
intervention, as opposed to the pathology of the illness or disease (Ben-Arye, Frenkel, Klein, & 
Scharf, 2008). Many CTs are now integrated within mainstream medicine (Zollman & Vickers, 
1999), indeed in the UK, Thomas, Nicholl, and Fall (2001) report that at least 40% of General 
Practitioners referred patients to CT practitioners. The most commonly utilised CTs included 
osteopathy, chiropractic, acupuncture, homeopathy, and hypnotherapy (Harris & Rees, 2000; 
White, 1998). 
The reasons individuals use CT include seeking a cure for illness and disease (Bell & 
Sikora, 1996), dissatisfaction with conventional medicine (Vincent & Furnham, 1996), perceived 
lack of efficacy, and concerns about side effects of orthodox medicine (Sharples, van Haselen, 
and Fisher, 2003). However, Thorne, Paterson, Russell, and Schultz (2002), report that 
individuals use CT as a way of assuming personal responsibility and self-management, rather 
than rejecting conventional medicine. Importantly, increased perceptions of personal 
responsibility can enhance perceived control over illness and disease, and increase general 
quality of life (Zandi, Abid-Hajbagheri, Memarian, Nejhad, & Alavian, 2005), which in turn has 
been associated with decreased pain and disability in patients where chronic pain is associated 
with their disease (Turner, Ersek, & Kemp, 2005). 
Not surprisingly, CTs are frequently utillised by people with chronic disease (Scott, 
Kearney, Hummerston, & Molassiotis, 2005). Therefore, in the present study patients with long- 
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standing rheumatoid arthritis (RA) were invited to participate in a randomised trial investigating 
the effects of two CT's on psychosocial function. RA is a chronic inflammatory disease, 
primarily involving progressive inflammation of the synovium and destruction of articular 
cartilage where disease progression fluctuates and is unpredictable in both intensity and duration 
(Dixon & Symmons, 2005). Symptoms associated with the disease are joint pain, symmetric 
joint swelling, tenderness, morning stiffness, and generalised fatigue (Lee & Weinblatt, 2001) 
which results in varying degrees of functional disability (Griffiths, 2006). 
Currently there is no cure for RA (Newman & Mulligan, 2004) and as a consequence 
medical treatment objectives are to manage and control the disease to reduce its disabling effects 
through the use of pharmacological treatments and physical rehabilitation (Combe, 2007). 
Although medication can often control the inflammation and slow the progression of disease, 
they are aggressive and can produce serious physical and psychological side effects (Gordon, 
Smith & Dhillon, 2007). In-addition many patients continue to experience varied levels of pain, 
fatigue, and decreased levels of functional disability (Flato, Vinje, & Forre, 1998). Indeed, pain 
and fatigue are amongst the most commonly reported problems identified by patients with RA 
(Repping-Wuts, Uitterhoeveb, van Riela, & van Achterberg, 2008). 
As a result of the chronic nature of the symptoms associated with RA and the negative 
side-effects of anti-rheumatic drugs, patients often turn to CT's to complement conventional 
treatments (Herman, Allen, Hunt, Prasad, & Brady, 2004). Indeed it is estimated that the 
prevalence of CT use in RA may be as high as 90% (Taibi & Bourguignon, 2003). Although 
there is a high prevalence of CT use, there is little research exploring their therapeutic 
effectiveness in this chronic disease. Consequently, the objective of this study was to examine 
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the effects of imagery and hypnotherapy, two CT's, on pain, fatigue, self-efficacy, pain anxiety, 
and functional disability in RA patients. 
Imagery and hypnotherapy are considered CT's as they are not the conventional 
treatment from RA (Galantino, Boothroyd & Lucci, 2003). However, within the literature there 
is a degree of confusion between these two interventions. The terms hypnosis, hypnotherapy, 
guided imagery, and imagery are often used interchangeably and applied to both imagery and 
hypnotherapy (Zelter et al., 2002). With regard to the evidence base of these CT interventions, 
the confusion in terminology can cause complications as these two modalities might differ in 
therapeutic effectiveness. Consequently, a further objective of this study was to examine possible 
differences between imagery and hypnotherapy as a CT in stable RA patients. 
Although imagery and hypnotherapy are similar cognitive therapeutic tools (Luskin et al., 
2000) there is a procedural difference between them. During a hypnotic state it is assumed that 
the conscious mind is guided to become dormant while the unconscious mind becomes more 
ready and open to suggestion and imagery (Spiegel, Greenleaf, & Spiegel, 2000). This is 
achieved through an induction procedure involving relaxation and focussed attention (British 
Psychological Society, 2001), which is not involved in imagery. For the purposes of the present 
study, imagery is defined as the generation of images from at least one sensory modality for the 
purpose of evoking a psycho-physiological state (Astin, Shapiro, Eisenberg, & Forys, 2003) and 
hypnotherapy is defined as `a state of inwardly focussed attention in which the mind is focussed 
on ideas of therapeutic value that can potentiate psychophysiologic change' (Anbar, 2006, 
p. 438). 
In particular imagery combined with at least one other therapeutic modality (e. g. CBT, 
relaxation, music, and music) has shown to be an effective pain management technique in other 
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chronic disease, for example cancer (Roffe, Schmidt, & Ernst, 2005), and fibromyalgia 
(I ladhazy, Ezzo, Creamer, & Berman, 2000). Imagery interventions have also shown to be 
effective for reducing stress, anxiety, and depression in patients with breast cancer undergoing 
radiotherapy (Nunes et al., 2007), improving health related quality of life in patients with chronic 
tension headache (Mannix, Chandurkar, Rybicki, Tuesk, & Solomon, 1998), and reducing pain 
and mobility difficulties in patients with osteoarthritis (Baird & Sands, 2004). 
Specifically in relation to RA, Astin, Beckner, Soeken, Hochberg, and Berman (2002) 
identified six studies which contained an element of imagery. The results identified that the 
combined imagery interventions were effective for reducing pain (Lavigne, Ross, Berry, 
Hayford, & Packman, 1992; O'Leary, Shoor, Korig, & Holman, 1988), and improving self- 
efficacy (O'Leary et al., 1988; Radojevic, Nicassio, & Weisman, 1992; Taal, Riemsma, Brus, & 
Seydel, 1993). However, as these interventions were multimodal, it is not possible to conclude 
the effectiveness of imagery as a single therapeutic modality in RA. Consequently, in order to 
investigate the effects of imagery as a singular modality, no other treatment modality was 
combined with imagery in the present study. 
The other CT employed in this study, hypnotherapy has received renewed attention 
within the medical literature (Stewart, 2005) where there is evidence to indicate that this CT is 
useful for decreasing chronic pain (Jensen & Patterson, 2006; Abrahamsen, Baad-Hansen, & 
Svensson, 2008), improving post-operative wound healing time (Ginandes, Brooks, Sando, 
Jones, & Aker, 2003), and improving psychosocial functioning in cancer patients (Walker, 
2004). 
Despite the evidence for hypnotherapy as an effective adjunct treatment for many chronic 
conditions and disease, there is little research examining its effectiveness in RA. One notable 
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exception by l-Lorton-hausknecht, Mitzdorf, and Melchart (2000) reported that patients using 
hypnotherapy achieved clinically significant decreases in disease activity and self-reported pain. 
However methodological flaws in this study require the results to be interpreted with caution. 
For example, participants chose which arm of the study they wanted to participate in, and the 
intervention was conducted in small groups. The results of this study may therefore be 
contaminated by cofounding variables such as expectancy and social support. Furthermore, 
although the design of this study included a control group there was no between-group analysis. 
Therefore the results of this study, although promising, are inconclusive. 
It is unclear how these CT's reduce pain, increase self-efficacy, and decrease functional 
disability (Baird & Sands, 2004; Christakou & Zervas, 2007). However, there are a number of 
theories which provide some insight into these mechanisms. Firstly, gate control theory 
(Melzack, 2001) may help to explain the reductions of pain associated with the use of imagery 
and hypnotherapy. Specifically, pain is modulated through the sensory discriminative and 
motivational affective systems in the brain. Imagery and hypnotherapy may reduce the extent to 
which pain is processed and perceived by refocusing attention to the content of the imagery 
rather than the pain. Indeed, in support of this Fors, Sexton and Götestam (2002) identified that 
distraction type imagery, where the individual imagines something pleasant, reduces pain more 
than when imagery related to the pain is used. Since pain is known to predict functional 
disability (Strating, van Schuur, & Suurmeijer, 2007) it can be hypothesised that a reduction in 
pain will result in decreased functional disability. 
Secondly, the benefits of these CT's may also be explained through self-efficacy theory. 
Imagery and hypnotherapy have the potential to provide mastery and vicarious experiences, two 
sources of information which Bandura (1977) stated had the ability to increase self-efficacy. 
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Repeated use of imagery may provide a platform for mental rehearsal of movements with a 
reduction in mobility-related symptoms (Pfurtscheller, Neuper, Ramoser, & Muller-Gerking, 
1999). For example, if an individual uses imagery, with or without hypnosis, to visualise a task, 
such as walking 100m with no problems, then their belief that they can accomplish that task 
successfully should increase. As a result of increased self-efficacy there is an expectation that the 
desired outcome will be achieved (Pfeifer & Beard, 1997), thus reducing perceived functional 
disability. 
Finally, a theory which may explain behavioural change following an imagery or 
hypnotherapy intervention comes from Cautela and Kearney (1990). They propose that there are 
three types of behaviour. Overt behaviour is that which is observable, covert behaviour which is 
internal and related to thoughts, and physiological behaviour which relates to physical processes, 
such as breathing and heart rate. Imagery and hypnotherapy can be considered as covert 
behaviours. The assumptions related to this theory include functional equivalence, interaction, 
and universal influence. Functional equivalence, as proposed by Cautela et al. (1990), refers to 
behaviour modification through operant conditioning. The interaction assumption suggests that 
as one type of behaviour is changed the other types of behaviour are also changed. Finally, 
universal influence refers to when one behaviour type is reinforced then the other types of 
behaviour are also reinforced in the same direction. Therefore, when a task is performed through 
covert behaviour, using imagery or hypnotherapy, the assumption is that overt behaviour will 
also be reinforced. 
Previous research using imagery and hypnotherapy, and the assumptions of the theories 
above identify potential areas which should be considered as targets for CT intervention, and 
include pain, self-efficacy, and functional disability. In RA, research has also identified that pain 
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is related to pain anxiety (Zautra, Burleson, Matt, Roth, & Burrows, 1994), therefore if these 
interventions have the ability to decrease pain they may well decrease pain anxiety. Furthermore, 
Pollard, Choy, Gonzalez, Khoshaba, & Scott (2006) have demonstrated that pain and functional 
disability are determinants of fatigue. Therefore, if pain and functional disability are reduced we 
should also expect a decrease in fatigue. 
In summary, the objective of this study was to examine the effectiveness of imagery and 
hypnotherapy in RA patients, specifically focussing on the areas of pain, fatigue, pain anxiety, 
self-efficacy and functional disability as dependent variables. A further objective was to examine 
any possible differences between these two CT's. It was hypothesised that there would be 
significant psychosocial improvement in all of the dependent variables, and due to the additional 
induction procedure in hypnotherapy, it was further hypothesised that hypnotherapy would 
produce greater improvement than imagery. 
Method 
The methods of this study, including sample size calculation and randomisation, are 
described in detail in chapter three of this thesis. Briefly, 42 patients with stable RA participated 
in this randomised controlled intervention trial. Participants were randomised to an imagery 
intervention, a hypnotherapy intervention, or `care-as-usual' control group. Dependent variables 
were measured at pre-intervention, six-week post-intervention and six-month follow-up. 
Participants in the imagery and hypnotherapy group received six intervention sessions over a six- 
week period, followed by a further three intervention sessions over the next six months. During 
the intervention sessions the imagery group were not given any instructions to relax. Participants 
in these groups also received a CD in which they could practice on a daily basis. Participants in 
the control group received usual routine care with no additional intervention during the first six 
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weeks or the following six-months, however they were invited to have the intervention of their 
choice at the end of the control period. 
Measurements 
The dependent variables measured in this study were pain, physical and mental fatigue, 
pain anxiety, self-efficacy, and functional disability. Health-related quality of life (HRQOL) was 
also measured using a generic fixed-item measure, the Short Form 36 Health Survey 
Questionnaire (SF-36; Ware & Sherbourne, 1992) and an individualised measure, the Patient 
Generated Index (PGI; Ruta, Garratt, Leng, Russell, & MacDonald, 1994). The results of the 
HRQOL measures are presented in chapter three of this thesis. 
Pain. A visual analogue scale (VAS) was used to measure perceived pain levels. The 
VAS was 100mm with endpoints labelled, `no pain' and `pain as bad as it can be'. Higher 
scores represent greater levels of perceived pain. The VAS is widely used in pain research and 
has found to have good validity and reliability (Huskisson, 1983). Changes greater than 20mm 
are considered clinically significant in RA (Wolfe, Hawley, & Wilson, 1996). 
Fatigue. Physical and mental fatigue were both measured separately using a 100mm VAS 
with the endpoints were labelled `no fatigue' or `fatigue as bad as it can be'. Wolfe (2004) has 
shown the VAS to be a reliable measure for fatigue in RA. Decreases greater than 8.2mm are 
considered clinically significant improvement, whereas increases greater than 11.3mm are 
considered clinically significant deterioration in RA (Khanna et al., 2008). 
Pain anxiety. Pain anxiety was assessed using the short form pain anxiety symptoms 
scale (PASS-20; McCracken, & Dhingra, 2002). The PASS-20 contains 4 subscales including 
cognitive anxiety, physiological anxiety, fearful appraisal of pain, and escape avoidance. Items in 
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the PASS-20 are scored from 0 (never) to 5 (always). The PASS-20 has shown good reliability 
and validity with the longer 40 item version (McCracken et al., 2002). 
Self-efficacy. Self-efficacy was measured using the Arthritis Self-Efficacy Scale (ASES; 
Lorig, Chastain, Ung, Shoor, & Holman, 1989). The ASES contains three subscales relating to 
self-efficacy in relation to controlling pain, function, and an `other symptoms scale'. Each of the 
scales starts with the phrase, "How confident are you that you can... ". Participants rate their 
responses on a 10 point likert scale. In total there are 28 items. Higher scores indicate greater 
self-efficacy for each specific subscale. The ASES has demonstrated good psychometric 
properties in a RA population (Barlow, Williams, & Wright, 1997). The pain and function scales 
were the only scales used in this study. 
Functional disability. Functional disability was measured using the Health Assessment 
Questionnaire (HAQ; Fries, Spitz, Kraines, & Holman, 1980). The HAQ is a brief self- 
administered questionnaire designed specifically for use in RA patients. It contains 8 domains of 
function, each relating to activities of daily living. The results of each of the 8 subscales are 
reported on a 0-3 scale, where scores of 0 represent no functional disability and scores of 3 
represent the worst functional disability. The HAQ has been used extensively in RA studies, and 
has been shown to be effective and sensitive to deterioration in RA (Devlin et al., 1997). 
Changes of 0.25 or greater in RA patients are considered clinically significant (Wolfe & Pincus, 
1999). 
Post-experimental questionnaire. A post experimental questionnaire was administered 
after the six month follow-up to obtain information about the effects of hope, expectation, and 
reaction to randomisation. Hope and expectation were measured with a 100mm visual analogue 
scale, which was anchored with the statements `no change' and `a lot of change' at opposite 
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ends. Initial reaction to randomisation was measured using a 100mm visual analogue scale with 
the anchors 'very dissatisfied' and `very satisfied'. Participants were asked about the frequency 
of using the CD's of the intervention, and how easy it was to schedule the intervention into their 
daily life routine. Analyses of these variables would then show if there was any confounding 
effects. 
Manipulation check. As social support has been shown to have a beneficial affect on pain 
(Evers, Kraaimaat, Geenen, Jacobs, & Bijlsma, 2003), fatigue (Riemsma, Rasker, Taal, Griep, 
Wouters, & Wiegman, 1998), self-efficacy (Taal, Rasker, Seydel, & Wiegman, 1993), and 
functional disability (Evers et al., 2003) on patients with RA a modified version of the perceived 
social support scale (PSS; Procidano & Heller, 1983) to include social support from the 
experimenter was also used to examine possible experimenter effects. Scores on the perceived 
social support scale range from +20 to -20 where higher scores indicate greater perceived social 
support. 
Datei Analyses 
Patient characteristics. Univariate statistics (means and standard deviations) were used to 
examine participant characteristics. One-way ANOVA were conducted to examine any 
differences in patient characteristics between the groups. The assumptions of normality and 
homogeneity of variance were not violated. 
Analyses of dependent variables. A series of one-way analysis of variance were 
conducted on all dependent variables to investigate differences between the groups at pre- 
intervention. As there were no significant differences between the groups, a series of two-way 
analysis of variance were then conducted to investigate possible differences between the groups 
at six-week post-intervention and six-month follow-up for each of the dependent variables. The 
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assumptions of normality, homogeneity of variance, and homogeneity of inter-correlations were 
not violated. Significance was accepted asp<0.05 (one-tailed tests). Tukeys test was employed 
as a post hoc procedure. Clinically significant change was also reported where published data 
was available for each of the dependant variables. Furthermore, where change was identified as 
being clinically significant the clinical effect size was calculated and reported. Felson, Anderson, 
and Meenan (1990) suggest that in order to calculate the clinical effect size the change in the 
mean, from pre- to post-intervention and pre-intervention to follow-up, is divided by the standard 
deviation of pre-intervention values. According to Cohen (1977) small clinically meaningful 
changes have an effect size between 0.2 and 0.49, moderate clinically meaningful changes have 
an effect size between 0.5 and 0.79, and large clinically meaningful changes have effect sizes 
greater than 0.8. 
Post experimental questionnaire. A series of one-way ANOVAs were conducted on 
expectation, hope, initial reaction to randomisation, and independent samples t-test on frequency 
of use of CD to assess whether there were any differences between the groups. Where any 
difference was identified, follow-up correlation analyses were conducted to assess the 
relationship between these variables and changes in scores in the dependent variables at post- 
intervention and follow-up. 
Manipulation check Perceived social support from the experimenter was used as a 
manipulation check. This was thought essential as the literature indicates that additional social 
support may confound the results of outcome measurement in intervention studies (Evers et al., 
2003; Riemsma et al., 1998; Taal et al., 1993). Mann-Whitney tests were conducted to 
investigate the differences in perceived social support received from the experimenter between 
the groups. Spearman's rho correlations were conducted to investigate the relationship between 
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the perceived social support received from the experimenter and scores on each of the dependent 
variables. 
Results 
Patient Characteristics 
A total of 136 patients with RA were invited to participate in this study. Forty two 
patients who met the criteria agreed to participate and completed all stages of the study. Thirty 
participants were female. The mean age of participants was 59 years (sct=9.1) and there were no 
significant differences in age within the three groups. The majority of participants (83%) were 
either married or living as married. Three participants were widowed, three were divorced and 
one participant was single. The mean disease duration was 160 months (sd=104) and there were 
no significant differences in disease duration between the three groups. Patient characteristics 
and pre-intervention values of all dependent variables are presented in table 12. 
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Table 12. Patient characteristics at pre-intervention (mean, standard deviation, 95% CI lower- 
upper limits) 
Imagery Hypnotherapy Control 
Age (years) 57.7 (9.6) 59.9 (8.7) 59.1 (9.5) 
52.1-63.2 54.8-64.9 53.6-64.6 
Disease duration (months) 182.7 (133.3) 106.4 (59.3) 190.4 (90.4) 
105 - 259 72-104 138 - 242 
Pain (0-100) 44.4 (25.1) 37.9 (17.2) 45.3 (20.2) 
29.8-58.8 28.0-47.8 33.6-56.9 
Physical fatigue (0-100) 57.5 (21.5) 43.8 (17.9) 47.3 (19.1) 
45.0-69.9 33.4-54.1 36.2-58.3 
Mental fatigue(O-100) 39.3 (28.1) 35.9 (24.7) 39.6 (22.0) 
23.0-55.5 21.7-50.6 268-52.3 
Pain anxiety (0-100) 35.9 (22.4) 35.7 (8.8) 30.6 (11.0) 
22.9-48.8 30.6-40.8 24.2-36.9 
Self-efficacy-pain (0-50) 23.8 (4.9) 26.5 (10.2) 26.9 (8.0) 
20.9-26.6 20.6-32.4 22.2-31.5 
Self-efficacy-function (0-90) 53.1 (17.9) 59.8 (16.6) 50.6 (17.1) 
42.7-63.4 50.3-69.4 40.7-60.4 
Functional disability (0-3) 1.73 (0.7) 1.29 (0.95) 2.03 (0.8) 
1.32-2.12 0.75-1.85 1.60-2.45 
Dependent variables. 
Table 13 provides a summary of scores on dependent variables over time. Significant 
within-group changes over time and clinically significant changes are identified. 
Pain. A two-way repeated measures ANOVA revealed a significant effect for time, F(2, 
78)=5.83, p<. 005, r72=0.13 and group F(2,39)=4.59, p<. 05, rj2=0.19. Of more central interest was 
a significant interaction, F(4,78)=2.66, p<. 05, , 72=0.12. Follow-up tests revealed a significant 
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difference between the groups at post-intervention, F(2,357) = 10.22, p<0.005, rig=. 34. Post hoc 
comparisons using Tukeys test indicated that both the imagery group and the hypnotherapy 
group were significantly lower than the control group (p<0.05 andp<0.005 respectively) with no 
significant difference between the imagery and hypnotherapy groups. However, at follow-up 
there were no significant differences between any of the groups. Additionally, neither imagery 
nor hypnotherapy achieved clinically significant reductions in pain. 
Physical fatigue. A two-way repeated measures ANOVA revealed a significant effect for 
time, F(2,78)=5.88, p<0.005, 2=0.13 with no effect for group. However, there was a significant 
interaction, F(4,78)=3.78, p<0.05, t12=0.16. Follow-up test revealed a significant difference at 
between the groups at post-intervention, F(2,4l9)=5.49, p<0.05,, 72=0.22. Post hoc comparisons 
using Tukeys test indicated that at post-intervention the hypnotherapy group scored significantly 
lower than the control group (p<0.05). The imagery group did not differ significantly from the 
control group. Follow-up tests further revealed no significant differences between the groups at 
follow-up. Although there were no significant differences between the groups at follow-up, both 
intervention groups achieved a clinically significant reduction in physical fatigue and the control 
group did not. The clinical effect sizes for imagery and physical fatigue were 0.84 at post- 
intervention and 0.66 at follow-up. Clinical effect sizes for hypnotherapy and reduction in 
physical fatigue were 0.83 at post-intervention and 0.62 at follow-up. The clinical effect sizes for 
imagery and hypnotherapy on reducing physical fatigue at post-intervention were large, however 
these become moderate at follow-up. 
Mental fatigue. A two-way repeated measures ANOVA revealed a significant effect for 
time, F(2,78)=5.59, p=0.005, r72=0.12 with no effect for group and no significant interaction. 
Although there was a significant decrease in mental fatigue scores from pre- to post-intervention 
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and from pre-intervention to follow-up, there were no significant differences between the groups. 
Despite there being no significant differences between the groups at post-intervention and 
follow-up, both intervention groups achieved clinically significant reductions in mental fatigue, 
and the control group did not. Clinical effect sizes for imagery and mental fatigue were 0.30 at 
post-intervention and 0.34 at follow-up. The effect sizes indicate small clinically meaningful 
reductions in mental fatigue for imagery. Clinical effect sizes for hypnotherapy and mental 
fatigue were 0.63 at post-intervention and 0.38 at follow-up. Hypnotherapy had a moderate 
clinically meaningful reduction in mental fatigue at post-intervention which became small at 
follow-up. 
Pain anxiety. A two-way repeated measures ANOVA revealed a significant effect for 
time, F(2,78)=20.38, p<0.001, r 2=0.34 with no effect for group. However, there was a 
significant interaction, F(4,78)=5.35, p=0.001, r72=0.21. Follow-up tests revealed that scores on 
pain anxiety decreased significantly from pre- to post-intervention and from pre-intervention to 
follow-up, however there were no differences between the groups. As there is no published data 
on clinically significant change in pain anxiety clinical effect sizes were not calculated. 
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Self-efficacy pain. A two-way repeated measures ANOVA revealed a significant effect 
for time F(2,78)=10.82, p<0.00I,  =0.22 with an effect for group approaching significance, 
F(2,39)=3.01, p=0.06, il' 0.13. Of more central interest was a significant interaction F(4, 
78)=3.28, p<0.05, 2=0.14. As the effect for group was approaching significance and there was a 
significant interaction follow-up tests were performed for group and time. Follow-up tests 
revealed a significant difference between the groups at post-intervention, F(2,112)=4.22, p<0.05, 
q'=0.18 and follow-up, F(2,103)=3.44, p<0.05, ry1=0.15. Post hoc comparison using Tukeys test 
indicated that hypnotherapy group scored significantly higher than the control group (p<0.05). 
The imagery group did not differ significantly from the control group at post-intervention. At 
follow-up, post hoc Tukeys test revealed the hypnotherapy group scored significantly higher than 
the imagery group (p<0.05). The control group did not differ significantly from the imagery 
group. As there is no published data on clinically significant change in self-efficacy for 
controlling pain, clinical effect sizes were not calculated. 
Self-efficacy function. A two-way repeated measures ANOVA revealed a significant 
effect for time, F(2,78)=3.67, p<0.05, 2=0.09, no effect for group, and no significant 
interaction. Although scores on self-efficacy for functioning increased significantly from pre- to 
post-intervention and from pre-intervention to follow-up, there were no significant differences 
between the groups. As there is no published data on clinically significant change in self-efficacy 
for function, clinical effect sizes were not calculated. 
Functional disability. A two-way repeated measures ANOVA revealed a significant 
effect for time, F(2,78)=7.56, p<0.005, 2=0.16 and group, F(2,39)=6.11, p=0.005, rig=0.24, 
however there was no significant interaction. Follow-up tests revealed a significant difference 
between the groups at post-intervention, F(2,0.62)=8.18, p=0.001, rig=0.30 and follow-up, 
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F(2,0.73)=5.92, p<0.01, h2=0.23. Post hoc comparison using Tukeys test indicated that 
hypnotherapy group scored significantly lower than the control group (p<0.001). The imagery 
group did not differ significantly from the control group at post-intervention. At follow-up, post 
hoc Tukeys test revealed the hypnotherapy group scored significantly lower than the control 
group (p<0.005). The imagery group did not differ significantly from the control group at follow- 
up. Although only the hypnotherapy group achieved statistically significant reductions in 
functional disability, both intervention groups achieved clinically significant decreases in 
functional disability at post-intervention which was maintained at follow-up. The clinical effect 
sizes observed were 0.36 at post-intervention and 0.40 at follow-up for the imagery group, and 
0.40 at post-intervention and 0.48 at follow-up for the hypnotherapy group. The effect sizes 
indicate a small clinically meaningful reduction in functional disability. 
Post experimental questionnaire. There were no significant differences between the three 
groups in what participants expected would happen to their disease by taking part in this study. 
However, the control group scored significantly lower than the hypnotherapy group on what they 
hoped would happen (p=0.04). Follow-up correlation analyses revealed there was a significant 
positive relationship between what participants hoped would happen as a result of taking part in 
the study and scores in functional disability (p<0.05). This result indicates that the greater hope a 
person had that their condition would improve by taking part in this study then they were more 
likely to report higher decreases in functional disability. 
The control group also scored significantly lower than both intervention groups on their 
reaction to the randomisation process (p<0.001). Follow-up correlation analyses revealed 
significant positive relationships between participants reaction to randomisation and scores of 
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physical fatigue (p<0.05), and scores in functional disability (p<0.05). This result indicates that 
the more satisfied an individual was with the group they were randomised to, they were more 
likely to report greater improvement in physical fatigue and functional disability. No significant 
differences were found between the two intervention groups and the frequency in which they 
practiced the intervention during the six weeks post-intervention and six month follow-up. 
Manipulation check Perceived social support received from the experimenter was 
significantly lower than social support received from either family or friends V=58.908, 
p<0.005). Perceived social support received from the experimenter was significantly higher (Z=- 
3.204, p<0.001 and Z=-3.54, p<0.001) in the imagery and hypnotherapy group when compared 
to the control group and there were no significant differences between imagery and 
hypnotherapy group. Follow-up correlation analyses revealed significant positive relationships 
between changes in pain scores (pre-intervention to follow-up; p<0.05), changes in functional 
disability scores (pre-intervention to post-intervention; p<0.05) and perceived social support 
from the experimenter. This result suggests that there was a significant relationship between pain 
and social support from the experimenter, and functional disability and social support from the 
experimenter. 
Discussion 
Although the use of CT's by people with RA is high (Taibi et at., 2003), little is known of 
the effectiveness of imagery and hypnotherapy. The present study set out to explore whether 
these two CTs were beneficial in stable RA patients, and if there were any differences between 
the two interventions. It was hypothesised that both interventions would have beneficial effects 
on pain, fatigue, pain anxiety, self-efficacy, and functional disability. Additionally, due to its 
Imagery & Hypnotherapy as Complementary Therapies in RA 113 
induction procedure it was hypothesised that the hypnotherapy intervention would have greater 
beneficial effect than imagery which has no induction. 
While both interventions had some effect on psychosocial function in stable RA patients, 
hypnotherapy was statistically more effective than an imagery intervention and care-as-usual. 
Hypnotherapy significantly reduced pain, physical fatigue, increased self-efficacy for controlling 
pain, and decreased functional disability at six-week post-intervention when compared to an 
imagery intervention and care-as-usual control group. Furthermore, significant improvement in 
self-efficacy for controlling pain and decreased functional disability was maintained at follow-up 
when compared to an imagery intervention and care-as-usual control group. The only statistically 
significant result for the imagery intervention was reduced pain post-intervention when 
compared to a care-as-usual control group. These key findings partially support the hypotheses. 
Additionally both imagery and hypnotherapy achieved clinically significant reductions in 
mental and physical fatigue and decreased functional disability. Both statistical and clinical 
significance should be regarded together in clinical trials. First, statistical significance informs us 
whether there was a significant difference in numerical values obtained from dependant 
measures between or within groups. This is important as researchers and clinicians need to know 
whether there was any difference between two or more groups outcome. Clinical significance is 
defined as "the noticeable difference an intervention makes in the everyday life of patients or to 
others with whom the patients interact" (Kazdin, 1999, p. 323). Furthermore, not only do we 
need to know if any statistical difference exists, but whether these difference have a noticeable 
impact on the functioning of the patient. This is where clinical significance is important. 
The results of this study indicate that in some cases, for example mental fatigue, there 
was no statistical difference between the interventions and the control group, yet there was a 
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clinically significant difference. This poses a dilemma for researchers and clinicians. From a 
research perspective the use of imagery and hypnotherapy to decrease mental fatigue in RA 
patients is statistically no better than no intervention, however from a clinical perspective both 
these interventions make a noticeable difference in mental fatigue in patients with RA. 
The results for the imagery group in the present study are similar to those reported in the 
literature. For example, Leibling, Pfingsten, Bartmann, Rueger, and Schuessler (1999) report that 
an imagery intervention combined with pain management and active coping skills resulted in 
decreased pain, disability, and increased self-efficacy post-intervention, however at follow-up 
there were no significant differences between their intervention and control group. Additionally 
Astin et al. (2002) reported that interventions employing imagery with another modality resulted 
in significant psychosocial improvement at post-intervention, however at follow-up the 
improvement became non-significant. 
With regard to the difference in results between the two CT's employed in this study, 
firstly the procedural difference between imagery and hypnotherapy should be taken into 
consideration. The induction procedure in hypnotherapy involves instructions for deep relaxation 
and focussed attention (British Psychological Society, 2001). As hypnotherapy includes imagery 
and this induction procedure, then a possible reason why this group achieved better outcomes 
may be because of the induction procedure. However, as no published research has examined the 
use of imagery with and without deep relaxation specifically in RA patients then future trials 
may want to consider investigating this and compare it to hypnotherapy. 
Secondly, the differences between imagery and hypnotherapy may be due to the 
influence of the placebo effect. Gandhi and Oakley (2005) investigated the use of the word 
`hypnosis' and `relaxation' in a hypnotic induction procedure. They found that when participants 
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were told the procedure was `hypnosis', measures of behavioural and subjective responsiveness 
to suggestibility increased significantly more than when participants were told the same 
procedure was `relaxation'. They concluded that the word `hypnosis' had a powerful effect on 
outcome. Within the present study participants in the hypnotherapy group were told that they 
would receive hypnotherapy. Based on the finding of Gandhi et at. (2005), the results in the 
hypnotherapy group may be due to the placebo effect. 
Thirdly, there is evidence that individuals who have a greater imagery ability and 
hypnotic susceptibility achieve better outcome (Ogston et al., 1997; Appel & Bleiberg, 2005). In 
the present study imagery ability and hypnotic susceptibility were not measured. It may be 
possible that participants in the imagery group had low imagery ability and those in the 
hypnotherapy group has high hypnotic susceptibility. This would help to explain the differences 
between these two interventions. 
Although the results from this study are promising, and indicate hypnotherapy is a 
beneficially therapeutic complement to conventional treatment of RA, there are several 
limitations of the present study. The results demonstrate statistically significant reductions 
in 
pain at post-intervention these results were obtained from a subjective measure. However, 
anecdotal evidence from some participants suggests that they did decrease the amount of pain 
medication they took. Future studies should examine the amount of pain medication taken 
throughout the duration of the study as this would provided more concrete evidence for the 
analgesic effect of these two interventions. 
A primary concern within the methodology of the present study was the possibility that 
perceived social support from the experimenter may have contaminated the results. King, 
Willoughby, Specht, and Brown (2006) have suggested social support is an important factor in 
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adapting to adversity, including living with a chronic condition. Indeed, studies have shown that 
social support can affect long-term functional disability and pain in early RA (Evers et al., 2003). 
In the present study perceived social support from the experimenter was higher in both the 
intervention groups when compared to the control group. This was expected to be the case as 
each participant in these groups spent on average nine hours more contact time with the 
experimenter than the control group. Although, perceived social support was higher in both 
intervention groups it was significantly lower than perceived social support from either family or 
friends in all three groups. However, significant correlations between social support from the 
experimenter, pain reduction, and decreased functional disability were identified. This indicates 
that social support from the experimenter may have contributed to decreased pain and functional 
disability, and not the CT's. Future research should include a control group where participants 
have the same amount of contact time as the intervention groups. 
The post-experiment questionnaire revealed significant correlations between reaction to 
randomisation and decreased physical fatigue, and decreased functional disability. Participants in 
the control group were less satisfied than participants in the intervention groups about the group 
they were randomised to. Their initial reaction to randomisation may have had a negative impact 
on psychosocial function. Indeed, Holtzman, Newth, and Delongis (2004) reported that 
disappointment is associated with maladaptive coping in RA. However, in the present study 
when participants in the control group were informed of randomisation, they were also told that 
they could receive either sessions in imagery or hypnotherapy after the control period. No 
participant in the control group declined this offer. More importantly, no participants in the 
control group dropped out of the study. This suggests that participants in the control group were 
not too dissatisfied. 
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Another limitation of the present study is the sample of RA patients who participated in 
the study. These participants were people who had lived with RA for a long time, on average 
over thirteen years, and their disease was considered to be stable with their medication. 
Throughout the literature there is evidence to suggest that interventions are not as effective in 
chronic progressive disease as they are in early disease (Kraaimaat, Brons, Geenen, & Biljsma, 
1995). Specifically, it is suggested that within two years of diagnosis provides the optimum 
opportunity to treat the disease (Emery, 1995; Devlin et at., 1997). Sharpe, Sensky, Timberlake, 
Ryan, and Allard (2003) have shown that a multimodal cognitive behaviour therapy with 
standard clinical care in recently diagnosed RA patients result in improvement for both physical 
and psychological outcomes, which were maintained 18 months follow-up. Future studies may 
want to investigate possible therapeutic differences using imagery and hypnotherapy between 
early and late stage RA. 
In conclusion, the results of this study present evidence both interventions providing 
some psychosocial improvement in the short-term, specifically in statistically reduced pain and 
clinically significant reduced fatigue. Additionally, hypnotherapy demonstrated longer-term 
beneficial effects. There are clinical implications of this research. Imagery and hypnotherapy 
should be considered as routine adjunct treatments for pain relief in RA patients. Specifically, 
RA patients often experience a flare in their arthritis, which can cause a high level of pain. By 
offering patients the option of including imagery or hypnotherapy in their routine clinical care, 
they will be given the opportunity to take personal responsibility in the self-management of their 
disease. Furthermore, given the maintained clinically significant improvements in the present 
study, hypnotherapy should be considered in the long-term routine care of RA patients. 
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CHAPTER FIVE 
ACTIVE RHEUMATOID ARTHRITIS: A SERIES OF CASE STUDIES 
INVESTIGATING HYPNOTHERAPY AND IMAGERY WITHIN A 
BIOPSYCHOSOCIAL FRAMEWORK? 
3 This research was accepted as a poster presentation at the British Society of Rheumatology and British Health 
Professionals in Rheumatology joint Annual Conference in April 2009, and the abstract was accepted for 
publication: Bennett, B. M., Callow, N. & Jones, J. G. (2009). Active rheumatoid arthritis: A case study approach 
investigating hypnotherapy and imagery within a biopsychosocial framework. Rheumatology, 48 (suppl 1), i63-i64. 
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Abstract 
Objective. Within a biopsychosocial framework it is assumed that psychological, social, and 
biological factors interact with each other. An objective of this study was to test this theoretical 
assumption in patients with active RA. Previously, imagery and hypnotherapy demonstrated 
psychosocial improvement in stable RA patients. Given positive changes in the psychological 
system of this model it was hypothesised that there would be beneficial changes in disease 
activity. 
Method Ten patients with active RA received a two week intervention of either hypnotherapy or 
imagery. All participants received six intervention sessions based on what they identified as 
being important aspects of their life affected by the disease. The biological outcome measures 
were ESR, CRP and DAS28. Psychosocial measures included pain, fatigue, pain anxiety, self- 
efficacy, and functional disability. Measures were obtained pre- and post-intervention. The 
EULAR DAS28 response criteria were used to decide whether biological improvement had 
occurred. 
Results. There were several areas of improvement in clinical assessment, with the DAS28 of six 
patients showing a moderate response to the intervention in accordance with EULAR response 
criteria. Additionally, participants reported improvement in psychosocial function with clinically 
significant reductions in pain and fatigue in some cases, and reductions in HAQ in all ten 
participants. 
Conclusions. Psychosocial improvement coincided with a moderate improvement in clinical 
outcomes of disease activity in six out of ten patients. However, the small numbers and the 
natural tendency of a flare in RA to improve mean these results should be interpreted with 
caution. However there is a suggestion that as well as improving psychosocial function, these 
psychosocial interventions may have influenced biological outcome measures and possibly the 
disease process. 
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Rheumatoid arthritis (RA) is a chronic disease which has a physical, social, and psychological 
impact on the patient (Uhlig, Loge, Kristiansen, & Kvien, 2007). It is a disease primarily 
involving progressive inflammation of the synovial tissue lining the joints and destruction of 
articular cartilage (Dixon & Symmons, 2005). Symptoms associated with the disease are joint 
pain, swelling, tenderness, and generalised fatigue (Lee & Weinblatt, 2001) which results in 
varying degrees of functional disability (Griffiths, 2006). RA is also associated with 
unpredictable acute painful flare-ups (Strahl, Kleinknecht, & Dinnel, 2000), which have been 
shown to cause further progressive joint damage with increased disability and associated pain 
anxiety (Zautra, Burleson, Matt, Roth, & Burrows, 1994). With no known cure (Newman & 
Milligan, 2004) current medical objectives are to control the disease and minimise disability 
using pharmacological interventions such as disease-modifying antirheumatic drug (DMARD) 
therapy (Combe, 2007). 
Patients with RA may present with very similar clinical measures of disease activity, 
severity, and swollen and tender joints, yet have very different degrees of disability (Barlow, 
Cullen, & Rowe, 2002). The discrepancy between disease activity and the resultant disability 
indicates the limitations of applying the biomedical model of disease in RA. Indeed, the 
biomedical model ignores non-disease factors such as demographic characteristics and 
psychosocial variables which can contribute to overall outcome of disease (Foster et al., 2003). 
In order to account for this discrepancy researchers have explored a biopsychosocial 
model of disease for RA. In support of this theoretical transition, Walker, Littlejohn, Jackson, 
and Dudgeon (2005) reported that the biopsychosocial model accounted for more variance in 
disability in RA than the traditional biomedical model. Specifically, the biomedical model could 
only account for 39% of the variance in basic activities of daily living, compared to 51% 
predicted by the biopsychosocial model. 
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The biopsychosocial model also provides a systems perspective of RA, in that, changes 
in one part of the system can produce changes in the other parts of that system (Keefe et al, 
2002). For example, increases in the number of swollen joints and elevated inflammatory 
markers (the biology subsystem) can lead to increased pain, anxiety, and decreased self-efficacy 
(the psychology subsystem), which may result in a decrease in the amount of time spent in 
leisure activities (the social subsystem). Applying a biopsychosocial model in context of the 
disease-disability pathway of RA, Escalante and del Rincon (1999) identified several variables, 
including the main disease pathway, which contributed to overall disability. External modifiers, 
including pain, anxiety, fatigue, and self-efficacy, are biopsychosocial variables which may have 
a reciprocal relationship to pathology, impairment, functional limitations, and eventual 
disability. 
In relation to these external modifiers, Schoenfeld-Smith et al. (1996) demonstrated that 
pain had a greater mediating influence on the development of disability in RA patients, than the 
direct effects of the disease activity. Additionally, they found pain had a direct influence on both 
psychological and physical disability, as well as being related to pain anxiety. Unpredictable 
painful flare-ups associated with RA make these patients more susceptible to pain anxiety 
(Zautra et al., 1994). Furthermore, Strahl et al. (2000) demonstrated that pain anxiety is 
independently associated with function and increased disability. 
Pain has also been related to self-efficacy. Lefebvre et al. (1999) reported that scores on 
the arthritis self-efficacy scale (ASES; Lorig, Chastain, Ung, Shoor, & Holman, 1989) could 
explain an additional 28% of the variance in daily joint pain of RA patients. Additionally, 
Brekke, Hjortdahl, & Kvein (2001) concluded that baseline scores of self-efficacy influenced 
changes in health status over a two year period. More recently, `personal mastery' which is 
synonymous with self-efficacy has been shown to predict levels of stress, pain, and fatigue in 
RA (Younger, Finan, Zautra, Davis, & Reich, 2008). Fatigue is reported by RA patients as being 
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one of the most bothersome symptoms associated with the disease (Pollard, Choy, Gonzalez, 
Khoshaba, & Scott, 2006). It has also been noted that levels of fatigue increase during painful 
flare-ups and decrease during remission (Pinals, Masi, & Larsen, 1981). Studies have shown 
fatigue to be affected by demographic, psychosocial, and clinical characteristics of disease in 
RA patients (Mancuso, Rincon, Sayles, & Paget, 2006). 
Within the context of a biopsychosocial model the above literature posits that pain, pain 
anxiety, self-efficacy, and fatigue should be critical targets for psychosocial intervention and 
that targeting these areas may reduce disability and disease activity. Indeed there is evidence 
that psychosocial interventions are beneficial in RA by improving psychosocial functioning 
(Astin, Beckner, Soeken, Hockberg, & Berman, 2002). In their meta-analysis of psychosocial 
interventions employed as adjunctive treatments in RA, Astin et al. (2002) reported significant 
pooled effect sizes post-intervention for pain, psychological status, and self-efficacy. More 
recently in a clinical review of `mind-body' psychosocial therapies (for example relaxation 
techniques, meditation, imagery, hypnotherapy, biofeedback, and cognitive behavioural 
therapy), Astin, Shapiro, Eisenberg, & Forys (2003) concluded that there was moderate 
evidence of efficacy, and consideration should be given to using them as "potentially effective 
adjunctive treatments for RA" (p. 140). 
However, there are inconsistencies within the literature regarding the effectiveness of 
psychosocial interventions. Newman, Steed, and Mulligan (2004) in their review of randomised 
trials involving psychosocial interventions, highlight that the outcome for many participants 
did 
not differ significantly when compared to controls. In another review, Savelkoul, 
de Witt, and 
Post (2003) concluded that not all studies employing psychosocial interventions report 
beneficial outcomes. Specifically, psycho-educational interventions had very little, if any, 
beneficial therapeutic effect (Riemsma, Taal, Kirwan, & Rasker, 2003), although one could 
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argue that the purpose of such an intervention was to provide the individual with facts rather 
than act as a therapy (Jones, 2002). 
A further limitation of many psychosocial intervention studies is the absence of outcome 
measures of disease activity (Keefe et al., 2002). Pisetsky (2007) argues that to fully assess the 
impact of psychosocial interventions within a biopsychosocial framework, measures of disease 
activity should be employed in the methodology. The reciprocal relationship between the three 
systems of a biopsychosocial model implies that changes in the psychological or social systems 
would have an impact on the biological system. However, from the studies that do report some 
form of clinical assessment (commonly tender and swollen joint counts) there is little evidence 
that psychosocial interventions have a significant impact on the biology of the disease 
(Hammond & Freeman, 2001; Hill, 2001; Evers, Kraaimaat, van Riel, & de Jong, 2002). 
It was the assumed relationship within a biopsychosocial model that stimulated the 
present study. Consequently, an objective of the present study was to examine the theoretically 
based assumption of the biopsychosocial model. Specifically, that a psychosocial intervention 
would directly affect the psychology system of the model and this would be reflected in 
beneficial changes in the biological system. 
Studies in psychoneuroimmunology provide useful evidence for a possible mechanism 
through which a psychosocial intervention may impact on immune and neuroendocrine 
processes. The hypothalamic-pituitary-adrenocortical (HPA) and sympathetic adrenomedullary 
(SAM) axes have been identified as possible pathways (Lutgendorf & Costanzo, 2003) which 
are involved with both psychological and inflammatory processes (Straub, Dhabhar, Bijlsma, & 
Cutolo, 2005). Briefly, psychosocial processes such as increased perceived stress activate 
certain brain regions, including the paraventricular nucleus of the hypothalamus. This causes 
secretion of corticotrophin-releasing hormone (CRH), which leads to production of 
adrenocorticotropic hormone (ACTH) via the pituitary gland. This increase in ACTH then 
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activates the adrenal medulla producing cortisol and norepincphrine, which have been shown to 
have an impact on both cellular and humoral immunity resulting in an inflammatory response 
(Tausk, Elenkov, & Moynihan, 2008). Specifically, during inflammation white blood cells 
secrete cytokines, such as interleukin-6 (IL-6). These cytokines then stimulate hepatic cells, 
macrophages, and lymphocytes to produce increased amounts of C-reactive protein (CRP) (Jabs 
et al.. 2003). CRP is an acute phase reactant and a non-specific inflammatory marker which has 
been reported as the most useful biochemical marker of disease activity in RA patients (Yildirim 
et al., 2004). The erythrocyte sedimentation rate (ESR) is a more non-specific index of 
inflammation which has been used to assess disease activity in RA patients for many years 
(Pelson et al., 1995). 
Lutgendorf and Costanzo (2003) propose that psychosocial interventions alter the 
psychosocial processes, for example perceived stress, anxiety, and self-efficacy, or improve 
health behaviours, to provide a positive influence on neuroendocrine and immune factors. It has 
also been suggested that psychosocial interventions may reduce the perception of stress and 
emotional strain caused by a chronic disease such as RA (Pradhan et al., 2007) and facilitate 
homeostasis of the immune system (Lutgendorf et al., 2003). The result of this influence would 
be a decrease in disease activity. 
In their meta-analysis Astin et al. (2002) concluded that while psychosocial interventions 
do not significantly influence the biological markers of disease activity in RA, they can 
influence some objective clinical indices of disease activity, namely tender joint count. 
However, in a novel study, Yoshino and Mukai (2003) investigated the effects of hearty laughter 
on the neuroendocrine and immune systems of RA patients and healthy controls. Clinical 
measures of immune function including NK cell activity, CD4 and CD8 ratios, and IL-6 
revealed significant differences between the groups at baseline. After the intervention, only IL-6 
levels remained significantly different. The results of this study provide suggestive evidence that 
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a psychosocial intervention can influence the immune system of individuals with RA. More 
recently, Bagheri-Nesami, Mohseni-Bandpei, and Shayesteh-Azar (2006) reported that a 
relaxation technique combined with meditation improved psychosocial outcomes significantly in 
people with RA when compared to controls. Additionally, there was a trend for improved 
clinical outcomes and decreased disease progression however the magnitude of this trend was 
not significant. 
The literature indicates that psychosocial interventions may have a possible role in the 
modulation of immune function in RA. The psychosocial interventions employed in the present 
study were hypnotherapy and imagery. Hypnotherapy is defined as a state of focussed attention 
and concentration causing a temporary suspension of peripheral awareness (Spiegel & Moore, 
1997). Hypnotherapy includes an induction to achieve this state before using imagery and 
suggestion for the purposes of therapeutic change. There is evidence to suggest that individuals 
who score higher in hypnotic susceptibility experience a greater degree of therapeutic change. 
For example in a study of HIV+ patients, participants who were highly hypnotisable 
experienced greater immunological response, specifically a significantly higher CD4+ t- 
lymphocyte count (Laidlaw et al., 2004) when compared to low hypnotic susceptibility 
participants. Additionally, cancer patients who score higher in hypnotic susceptibility report 
greater reductions in pain than cancer patients who score low in hypnotic susceptibility (Appel 
& Bleiberg, 2005). 
In an early clinical trial of hypnotherapy with no control group, Domangue, Margolis, 
Lieberman, and Kaji (1985) demonstrated significant decreases in pain, anxiety, and depression 
post-intervention and increased plasma levels of ß-endorphin. The authors concluded that 
hypnotherapy not only reduces self-report levels of pain, but also a biochemical correlate of pain 
intensity. Although this study indicates some evidence for hypnotherapy reducing the 
consequences of RA, including biochemical indices, there are several limitations. There was no 
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control group in the study and therefore it is possible that the changes observed were not the 
result of the intervention but the natural course of RA. Furthermore, the authors did not report 
disease activity. As the natural progression of the disease is characterised with unpredictable 
hares, participants may have been recovering from such flares. This would account for the 
changes observed in the outcomes measured. 
Horton-hausknecht, Mitzdorf, and Melchart (2000) used a hypnotherapy intervention in 
26 RA patients and reported significant improvements in acute phase reactants, ESR and CRP, 
as the biological markers of disease activity. However, the results of this study should be 
interpreted with caution. Some participants choose which arm of the study they wanted to 
participate in, and the intervention was conducted in small groups. The results of this study may 
therefore be contaminated by cofounding variables such as expectancy and social support. 
Additionally, the RA patients in this study had low levels of ESR (27mm/hr) and CRP (5mg/1) 
indicating that their disease status was not active. 
The other psychosocial intervention, imagery, which is an integral part of hypnotherapy, 
has been defined as the generation of images from at least one sensory modality for the purpose 
of evoking a psychophysiological state (Astin et al., 2003). Similarly to hypnotic susceptibility, 
there is evidence to suggest that imagery ability is related to greater therapeutic change. 
For 
example higher levels of imagery ability have been related to improved immune function 
in 
cancer patients using a psychosocial intervention involving an element of imagery (Ogston et 
al., 1997). 
Limited research exists on the use of imagery in RA. A notable exception by Jacobi and 
Eisenberg (2001-2002) reported that an intervention using both imagery and music resulted in a 
significant decrease in pain in RA patients. However, the authors did not report any measures of 
disease activity. Studies using imagery combined with other modalities, including relaxation and 
cognitive behavioural therapy have demonstrated improved psychosocial functioning (Astin, et 
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al., 2002). Although in their meta-analyses Astin et al. (2002) report effect sizes for tender joints 
they do not include any direct measures of disease activity. A further limitation of these studies 
is that imagery was combined with other therapeutic modalities which made it impossible to 
assess the impact of imagery as a singular psychosocial intervention. 
In chapter three of this thesis it was reported that hypnotherapy and imagery 
interventions in RA patients result in significantly improved health-related quality of life, and in 
chapter four, improved psychosocial functioning, specifically decreased pain, fatigue and 
functional disability. However, disease in these patients was controlled with pharmacological 
therapy and no disease outcome measures were reported. 
Using patients with active disease, indicated by elevated ESR and CRP levels, would 
provide the opportunity to demonstrate whether psychosocial interventions such as 
hypnotherapy and imagery can influence clinical markers of disease activity and have an impact 
on the underlying biological disease process. To the best of the present authors' knowledge, no 
other published studies exist on the use of hypnotherapy or imagery, specifically in relation to 
disease activity in R. A. 
Recent improvements in the drug treatment of RA have been shown to reduce long term 
joint damage as well improve symptoms in the short term, therefore, it is no longer considered 
ethical to leave patients with active RA without drugs (Haslock, 1989; Stein & Pincus, 1999). 
Thus a double blind placebo controlled trial is no longer possible in active RA. Additionally, 
because of these improvements in drug treatment there are fewer patients with active disease 
who are not having their treatment regimen modified or starting on new drugs. These 
pharmaceutical interventions are aimed at reducing the activity of the disease and will of course 
impact on measures of disease activity. This means that it is very difficult to find a model of 
active RA to attempt to demonstrate whether a psychosocial intervention does influence the 
biological activity of RA. However there are some patients with active disease who are 
Psychosocial interventions in active RA 128 
"between drugs" and others who have suffered many side effects and request a few weeks off all 
drugs. This small group of patients was targeted for the present study. 
In summary, the objectives of this experimental study were to examine the effect of 
imagery and hypnotherapy on psychosocial functioning and biological markers of disease 
activity in active RA patients. Given the results of the previous studies and the theoretical 
assumptions of the biopsychosocial model, it was hypothesised that these interventions will 
result in improved psychosocial function and a decrease in biological markers of disease activity 
in patients with active RA. Additionally, it was also hypothesised that those participants who 
score higher in hypnotic susceptibility or imagery ability will show a greater improvement in 
psychosocial functioning and disease activity than those who score lower in hypnotisability and 
imagery ability. 
Method 
Participants 
Ten patients, 8 females and 2 males, were recruited directly from the North West Wales 
NHS Trust Rheumatology department. The average age of participants was 53.4 years. Inclusion 
criteria included a diagnosis of rheumatoid arthritis according to the American Rheumatism 
Association criteria (Arnett et al., 1987), active disease as indicated by an erythrocyte 
sedimentation rate (ESR) greater than 30mm/h, or a C-reactive protein (CRP) rate greater than 
30mg/dl, and/or a disease activity score (DAS) greater than five. No new medications were to be 
taken for the duration of the study, which was no longer than two weeks. Patients with 
controlled disease were not considered for this study. There were no exclusion criterion for age 
or gender, however patients were excluded if there was a current history of substance abuse or 
serious mental health condition. Although participants were given no financial incentive to 
participate, traveling expenses were offered. The study was approved by the North West Wales 
NHS Ethics committee. Written consent was obtained from all participants. 
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Study Design 
Due to the limited number of patients who were available to participate in this study, 
experimental case studies were the most appropriate methodology. Participants were randomised 
via a computerised on-line randomisation package to either a hypnotherapy or imagery 
intervention. All participants completed a set of outcome measures at baseline pre-intervention, 
and no longer than 2 weeks post-intervention. 
Measurements 
The independent variables were hypnotic susceptibility and imagery ability. 
Hypnotic susceptibility. Hypnotic susceptibility was measured using the Stanford 
Hypnotic Susceptibility Scale, form C (SHSS: C; Weitzenhoffer & Hilgard, 1962). The SHSS: C 
was administered to each participant individually. There were 12 items which progressively 
increased in difficulty, and administration of this measure took one hour to complete. Three 
items measure participants response's to suggestions for changes in cognitive function and the 
remaining nine measure changes in perception and ideomotor functioning. Scores range from 0 
to 12 where higher scores indicate greater susceptibility to hypnosis. Scores for zero to four are 
regarded as `low hypnotisables', five to seven as `medium hypnotisables', eight to ten as `high 
hypnotisables', and 11 or 12 as `very high hypnotisables' (Hilgard, 1965). 
Imagery ability. Imagery ability was measured using the vividness of movement 
questionnaire (VMIQ; Isaac, Marks, & Russell, 1986). The VMIQ contains 24 items related to 
general movement imagery. Participants are asked to imagine these 24 items from two 
perspectives, watching someone else performing the task, and performing the task themselves. 
Each of the items on the VMIQ are scored from 1 (perfectly clear image) to 5 (no image at all). 
Overall scoring is summative, ranging from 2 to 240, with lower scores indicating greater 
imagery ability. The reliability of the VMIQ has been established using a test-retest method 
(Isaac et al., 1986). 
Psychosocial interventions in active RA 130 
The dependent variables measured in this study were clinical assessment of disease 
activity and psychosocial function, including, health related quality of life, pain, physical and 
mental fatigue, pain anxiety, self-efficacy, and functional disability. 
Measure of disease activity. Measures of disease activity were obtained from a clinical 
examination by the same consultant or rheumatology specialist nurse at both baseline and post- 
intervention. These included: (a) the number of swollen and (b) tender joints using the 28 joints 
score (Smolen et al., 1995), (c) the patients global assessment of disease severity, using a 
100mm VAS with the start and endpoint labelled `no disease activity' and `worst imaginable 
disease activity', (d) erythrocyte sedimentation rate (ESR), and (e) C-reactive protein (CRP). 
From the patient's global assessment of disease activity, swollen and tender joint score, and 
ESR, the disease activity score was calculated using the formula devised by Prevoo et al. (1995): 
0.564 (b) + 0.28 4 (a) + 0.7 In(d) + 0.014(c). A response criterion set by the European League 
Against Rheumatism (EULAR) considers changes of 1.2 on an initial score of 3.2 or less on the 
DAS28 as a good response to therapy. Moderate responders are those with an initial DAS28 of 
less than 5.1 and show an improvement between 0.6 and 1.2, or an initial score of 3.2 and 
improvement of greater than 1.2. Non-responders are patients with an improvement of less than 
0.6, or those with an initial DAS28 greater than 5.1 and improvement between 0.6 and 1.2 (van 
Gestel, Haagsma, & van Riel, 1998). This response criterion was included in the present study. 
With regard to changes in ESR and CRP, the American College of Rheumatology have defined 
changes of 20% or more as clinical improvement (Felson et al., 1995). This criterion was also 
applied to changes in these acute phase reactants. 
Health-related quality of life (HRQOL). HRQOL was measured using an individualised, 
and a generic HRQOL questionnaire. The individualised HRQOL was used to provide 
information relating to areas of the participants life which was important to them, and which 
would be used in tailoring either the imagery or hypnotherapy sessions. The Patient Generated 
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Index (PGI; Ruta et at., 1994) was employed as the individualised HRQOL measure. When 
completing the PGI, participants can identify up to five areas of their life that they perceive to be 
important (e. g., playing with grandchildren). In many studies a `prompt' card is shown to 
participants to help them identify important areas. A score between 0 (the worst you could 
imagine) and 10 (exactly as you would like it to be) is allocated by participants to reflect how 
severely each of these areas is affected by their disease. Participants then are asked to give their 
own weighting to each of these areas. This is conducted by dividing a total of 12 points on each 
of the areas identified, the more points spent on a specific area indicates greater importance. The 
resultant index score is an overall reflection of the individual's perceived HRQOL. Higher 
scores indicate higher perceived HRQOL. The PGI has good reliability, validity and 
responsiveness (Martin, Camfield, Rodham, Kleimpt, & Ruta, 2007). Furthermore, in 
musculoskeletal disorders, when compared to eight other individualised HRQOL questionnaires, 
the PGI had the highest rating for validity, reliability, and responsiveness (Jolles, Buchbinder, & 
Beaton, 2005). The Short Form 36 Health Survey Questionnaire (SF-36; Ware & Sherbourne, 
1992) was employed as a generic HRQOL measure. The SF-36 contains 36 items which are 
grouped into eight subscales, measuring physical functioning, role limitations due to physical 
health, bodily pain, general health, vitality, social functioning, role limitations due to emotional 
problems, and mental health. Scores on each subscale are expressed as values between 0 and 
100 where a high score indicate good health. The SF-36 has been shown to have good 
psychometric properties in RA (McHorney, Ware, & Raczek, 1993). 
Pain. A visual analogue scale (VAS) was used to measure perceived pain levels. The 
VAS was 100mm whose endpoints were labelled, `no pain' and `pain as had as it can be'. 
Higher scores represent greater levels of perceived pain. The VAS is widely used in pain 
research and has found to have good validity and reliability (Huskisson, 1983). Changes of 
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20mm or more in RA patients are considered as clinically important (Wolfe, Hawley, & Wilson, 
1996). 
Fatigue. Physical and mental fatigue were both measured separately using a 100mm 
VAS with the endpoints were labelled `no fatigue' or `fatigue as bad as it can be'. Wolfe (2004) 
has shown the VAS to be a reliable measure for fatigue in RA. Decreases greater than 8.2mm 
are considered clinically significant improvement for patients with RA, whereas increases 
greater than 11.3mm are considered clinically significant deterioration (Khanna et al., 2008). 
Pain anxiety. Pain anxiety was assessed using the short form pain anxiety symptoms 
scale (PASS-20; McCracken & Dhingra, 2002). The PASS-20 contains 4 subscales including 
cognitive anxiety, physiological anxiety, fearful appraisal of pain, and escape avoidance. Items 
in the PASS-20 are scored from 0 (never) to 5 (always). The PASS-20 has shown good 
reliability and validity with the longer 40 item version (McCracken et aL, 2002). 
Self-efficacy. Self-efficacy was measured using the Arthritis Self-Efficacy Scale (ASES; 
Lorig et al., 1989). The ASES contains three subscales relating to self-efficacy in relation to 
controlling pain, function, and an `other symptoms scale'. Each of the scales starts with the 
phrase, "How confident are you that you can... ". Participants rate their responses on a 10 point 
Likert scale. In total there are 28 items. Higher scores indicate greater self-efficacy for each 
specific subscale. The ASES has been shown to be valid for this group of participants (Barlow, 
Williams, & Wright, 1997). The pain and function scales were the only scales used in this study. 
Functional disability. Functional disability was measured using the Health Assessment 
Questionnaire (HAQ; Fries, Spitz, Kraines, & Holman, 1980). The HAQ is a brief self- 
administered questionnaire designed specifically for use in RA patients. It contains 8 domains of 
function, each relating to activities of daily living. The results of each of the 8 subscales are 
reported on a 0-3 scale, where scores of 0 represent no functional disability and scores of 3 
represent the worst functional disability. The HAQ has been used extensively in RA studies, and 
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has been shown to be effective and sensitive to deterioration in RA (Devlin et at., 1997), 
furthermore changes of . 25 are considered clinically significant (Wolfe & Pincus, 1999). 
Procedure 
Patients who met the inclusion criteria were given an information sheet detailing the 
objectives of the study and what would be expected of them if they chose to participate. They 
were also given a brief description of hypnotherapy and imagery, and a consent form. All 
patients were given more than 24 hours before deciding whether they wished to participant in 
the study. After taking consent, blood samples were taken by a trained phlebotomist who was 
blind to the trial. Samples were taken for acute phase reactants, ESR and CRP, and a 
rheumatology consultant or specialist rheumatology nurse, who was unaware of randomization, 
performed the clinical assessment for the disease activity score. Participants were given a 
questionnaire pack (see Appendix A) and asked to complete it. The PGI in this questionnaire 
pack did not contain any `prompt' list. This was to ensure that participants only mentioned those 
items which they felt were important. 
Randomization to either the hypnotherapy or imagery group occurred when completed 
questionnaires were returned using an on-line software package (www. randomizer. org). Each 
participant was contacted to arrange a testing session for hypnotic susceptibility or imagery 
ability and to arrange the intervention sessions. Participants received six sessions of either 
hypnotherapy or imagery over a period of no longer than two weeks. The intervention period 
was decided through discussion with rheumatology consultants and the ethics committee at 
North West Wales NHS Trust. 
Following, the six intervention sessions each participant had another two samples of 
blood taken at the same time of day as the previous samples. Participants met with the same 
consultant rheumatologist or specialist rheumatology nurse for a final clinical assessment. 
Finally, participants were asked to complete the same set of questionnaires as in the start of the 
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study. The original items that participants had identified as being important were written on 
post-intervention PGI, however participants were informed that they could amend these if they 
Zelt some items were no longer important or another item not previously mentioned was 
important. None of the participants changed any of the original items. 
Intervention 
The intervention sessions took place either at Bangor University or at the participants' 
own home. Each of the sessions lasted no more than one hour. The first sessions were 
standardized so that all participants in the hypnotherapy group received the same hypnotherapy 
session and those in the imagery group received the same imagery session. The content of the 
remaining five sessions was determined by what the participants identified as important in the 
PGI. Where any participant identified less than five areas the remaining intervention sessions 
focused on previous items identified in the PGI. Participants were also given a CD of their 
sessions to enable them to practice on a daily basis. 
Data Analyses 
Descriptive statistics of clinical assessment and disease activity are presented in tables 
14 (hypnotherapy group) and 16 (imagery group). Tables 15 (hypnotherapy group) and 17 
(imagery group) provide descriptive data from the psychosocial assessments. Two individual 
cases from each psychosocial intervention are presented as profiles under the headings of 
(a) 
demographic and social data, (b) disease history, (c) disease activity pre-intervention, (d) areas 
identified as important with scores pre-intervention, (e) intervention, (f) disease activity post- 
intervention, (g) and areas identified as important with scores post-intervention. The cases 
presented were matched as much as possible by sex, age, and disease duration. Following the 
presentation of case profiles, case summaries were produced for the five participants in each of 
the two intervention groups. These summaries were constructed to identify similarities and 
differences within this case-orientated approach (Stake, 1998). Stake (1998) argues that 
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conducting comparison of cases in this manner is "a powerful conceptual mechanism, fixing 
attention upon the few attributes being compared" (p. 97). A cross-case comparison is also 
provided exploring similarities and differences between the two interventions groups. In 
analysing the cases this way it will be possible to make limited generalisations about these two 
psychosocial interventions within a biopsychosocial framework in RA. 
Results 
Clinical outcomes of hypnotherapy group. Table 14 provides a summary of each 
participant's scores of hypnotic susceptibility and results from the clinical assessment. 
Participants in the hypnotherapy group scored between low to medium hypnotic susceptibility. 
Of interest, two out of five participants in the hypnotherapy group achieved a moderate 
response as set out in the EULAR response criteria. The remaining three are classified as `non- 
responders'. Three participants reported a decrease of between one or two swollen joints, and 
two participants reported no change in the number of swollen joints. All five participants 
reported a decrease of between one to four tender joints. All five participants reported a decrease 
in global assessment of disease severity. Two participants achieved a decrease in ESR, with one 
of these being considered clinically important. The remaining three participants reported an 
increase in ESR. All participants achieved a decrease in CRP levels, with four of these being 
considered clinically important. Four of the five participants achieved a decrease in DAS28, 
with a mean decrease of 0.82. The remaining participant showed an increase of 0.1 for the DAS. 
Psychosocial outcomes of hypnotherapy group. Table 15 reports the outcomes from 
psychosocial assessments for the hypnotherapy group. All five participants reported a decrease 
in pain, with two achieving a clinically significant reduction. Two participants reported a 
clinically significant decrease in physical fatigue. A further two participants reported an 
increase, however these were not considered clinically significant. The remaining participant 
reported no change in physical fatigue. Four participants reported a decrease in mental fatigue, 
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two being clinically significant, and one participant reported a slight increase. All five 
participants reported a decrease in pain anxiety. Self-efficacy for reducing pain increased in four 
participants, and slightly decreased in one participant. Self-efficacy for function increased in all 
five participants. All five participants reported a clinically significant decrease in functional 
disability. Health related quality of life, measured by the PG[, increased in three out of the five 
participants, and the remaining two participants reported no change. Where HRQOL was 
measured using the SF-36, all participants reported an increase in physical health, and four 
reported increased mental health while the remaining participant reported a decrease in mental 
health summary score. 
Table 14. Hypnotic Susceptibility and Clinical Assessment 
Participant Hypnotic 
Susceptibility 
(0-12) a 
Swollen 
joints 
(0-28) 
Tender 
joints 
(0-28) 
Global 
assessment 
(0-100) 
ESR 
(mm/h) 
CRP 
(mg/dl) 
DAS28 
(0-10) 
JJ pre 6 5 1 59 64 37 4.14 
post 5 0 19 75 27b 3.91 
MT pre 6 8 6 74 84 75 6.30 
post 6 3 45 28b 60b 4.62c 
AW pre 3 10 11 69 72 64 6.70 
post 9 9 52 75 60 6.22 
JCT pre 4 6 11 72 14 16 5.40 
post 6 9 70 21 10b 5.48 
CJ pre 3 8 9 68 127 86 6.81 
post 7 5 48 110 50b 5.96 
a higher scores represent greater susceptibility to hypnosis. 
b clinical improvement as defined by ARC criteria. 
Moderate response to hypnotherapy intervention as defined by EULAR criteria. 
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Case Profile 1: MT 
Demographic and social data. MT is a divorced woman aged 47. Her marriage failed 
several years ago and she described it as being a `not too pleasant break-up'. She is a full- 
time carer to her elderly mother who has been diagnosed with dementia for several years. She 
also cares for her two sons, one who is still at junior school, the other has left school and is 
unemployed. Both her sons have mild to moderate learning difficulties. 
Disease history. Although MT was recently diagnosed with RA she claims that she 
can trace the start of the disease shortly after her marriage break-up and becoming less 
tolerable after her mother's diagnosis of dementia. She had been prescribed with 100mg daily 
of diclofenac, an anti-inflammatory drug rather than a DMARD. 
Disease activity pre-intervention. Clinical assessment revealed that the present state 
of disease activity in MT at the start of the trial was very acute with elevated ESR and CRP 
levels and a DAS28 of 6.30. 
Areas identified as important with scores pre-intervention. Important aspects of MT's 
life that had been affected by her RA were identified as; (1) not being able to walk her son to 
school because of her pain in her knees and legs rated extremely poor at 0/10, (2) not being 
able to cook because of pain in her hands rated at 3/10, (3) being unable to wash her hair 
independently because of pain in her hands rated at 3/10, and (4) generally being less mobile 
than ever before rated at 3/10. 
Intervention. MT had 6 sessions of hypnotherapy over a period of two weeks. She 
scored 6 in the SHSS: C. As pain was a constant theme which she had identified in areas of 
her life that were important, MT had four sessions of hypnotherapy focussing on pain 
reduction. She also had a session on improving her immune function. 
Disease activity post-intervention. Following the six hypnotherapy sessions, clinical 
assessment revealed a decrease in disease activity. She showed a clinically important 
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reduction in both ESR and CRP and a decreased DAS28 from 6.30 to 4.62. With the changes 
in the DAS28, MT showed a moderate response to the hypnotherapy intervention. 
Areas identified as important with scores post-intervention. Following the 
intervention MT reported that `not being able to walk her son to school because of her pain in 
her knees and legs' had improved from 0/10 to 6/10. She also reported that now she was 
walking her son to school most days. `Not being able to cook because of pain in her hands' 
improved from 3/10 to 6/10, `being unable to wash her hair independently because of pain in 
her hands' also improved from 3/10 to 5/10, `generally being less mobile than ever before' 
improved slightly from 3/10 to 4/10. 
Case Profile 2: JCT 
Demographic and social data. JCT is 53 year old married woman who lives with her 
husband and four children in a small holding. Two of the children that live with her are 
fostered and have behavioural difficulties. She and her husband look after a number of 
animals including dogs, geese, several goats, and horses. She is a keen horse rider, and 
although she participated in competitions in the past she explained that it was more of a 
hobby for her now. 
Disease history. JCT was diagnosed with RA ten years ago. She has had numerous 
DMARD's, however these have failed to make any significant impact on her disease. At the 
time of the study she was taking 10mg of prednisolone, but complaining of increased aches 
and pains. 
Disease activity pre-intervention. Although JCT did not have elevated ESR or CRP 
levels, clinical assessment revealed a number of high number of swollen and tender joints, 
and the patients global assessment of disease severity was also high. Therefore, clinical 
assessment suggested active disease indicated with a DAS28 of 5.40. 
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Areas identified as important with scores pre-intervention. JCT identified several 
important areas of her life that were affected by her RA. These included; (1) interrupted sleep 
which made her feel tired all day rated low at 3/10, (2) unable to ride her horses as often as 
she would like because of pain and tiredness rated at 4/10, (3) unable to play with her foster 
children because of pain and tiredness rated at 5/10, (4) unable to walk her dogs as often as 
she would like because of pain rated at 4/10, and (5) feeling tired and fatigued most of the 
time rated very low at 2/10. 
Intervention. JCT received six sessions of hypnotherapy over a period of 8 days. She 
scored 4 in the SHSS: C. As fatigue and tiredness throughout the day were dominant themes 
raised by JCT the sessions focussed on fatigue and increasing energy levels, sleeping better 
through the night. She also received hypnotherapy session focussed on decreasing pain and 
improving immune function. 
Disease activitypost-intervention. Following the hypnotherapy sessions, clinical 
assessment revealed no change in swollen joints, a decrease in tender joints and improvement 
in the patients global assessment of disease severity. Her ESR increased slightly, but there 
was a clinically important reduction in CRP levels. Yet despite some improvement the overall 
DAS28 score increased from 5.40 to 5.48. In terms of response to this intervention, 
JCT is 
considered a non-responder. 
Areas identified as important with scores post-intervention. Originally JCT rated 
`interrupted sleep which made her feel tired all day' at 3/10, this improved to 5/10. `Unable to 
ride her horses as often as she would like because of pain and tiredness' slightly from 4/10 to 
5/10, `unable to play with her foster children because of pain and tiredness' remained the 
same at 5/10, `unable to walk her dogs as often as she would like because of pain' was rated 
worse, from 4/10 to 3/10, and `feeling tired and fatigued most of the time' improved from 
2/10 to 6/10. 
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Case Summation for Hypnotherapy Group 
The hypnotherapy group consisted of four females and one male. Hypnotic 
susceptibility of this group was low with an average of 4.4 out of 12, ranging from three to 
six. The average age of participants in this group was 53.2 years, ranging from 47 to 63 years. 
Four the participants were married and one was divorced. None of the participants in this 
group were in full-time employment. With the exceptions of JJ, all of the participants were 
carers for their children, spouse, or parents. MT was the only recently diagnosed patient in 
this group, however she was able to trace the start of her symptoms to her marriage break-up 
several years ago, and increased severity of her disease with the rapid progression of her 
mother's illness. The remainder of this group had been diagnosed for between ten and 29 
years. All participants in this group were able to identify an event in their life which they 
believed may have contributed to increase in disease activity. For example, JJ and her 
husband were in the process of trying to sell their house and AW's wife had a chronic 
condition which had deteriorated rapidly. 
Clinical assessment pre-intervention revealed that all participants had a high level of 
disease activity indicated by the DAS28 scores, however in some cases levels of acute phase 
reactants were not particularly high. Following the intervention, clinical assessment revealed 
that four of the five participants in the hypnotherapy group achieved a decrease in disease 
activity, with several demonstrating clinically important reductions in CRP. Using the 
EULAR response criteria, two participants achieved a moderate response to the hypnotherapy 
intervention. The remaining three participants were classified as non-responders. 
Of the areas identified by participants in the hypnotherapy group, pain was the most 
prominent factor. Fatigue and tiredness was also identified by most of the participants in this 
group. Other areas identified were; interrupted sleep, lack of motivation, stiffness, and 
general mobility problems. 
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Following the hypnotherapy intervention, psychosocial assessments revealed 
improved psychosocial function, specifically in relation to decreased pain, decreased mental 
fatigue, decreased pain anxiety, increased self-efficacy for function, decreased functional 
disability, and increased health-related quality of life measured by the SF-36. 
Clinical outcomes of imagery group. Table 16 provides a summary of each 
participant's imagery ability score and results of the clinical assessment. Scores on imagery 
ability in this sample ranged between 102 and 164. In terms of low, medium, high imagery 
ability, all participants can be classified as medium imagery ability. 
Importantly, four out of five participants achieved a moderate response to the imagery 
intervention, as defined by the EULAR response criteria. Two of the five participants in this 
group each reported a decrease of one in the number of swollen joints, and the remaining 
three reported no change. Three participants reported a decrease in the number of tender 
joints, and the remaining two reported no change. Four participants reported a decrease in 
global assessment of disease severity, the remaining participant reported an increase. All five 
participants in the imagery group showed a clinically important decrease in ESR levels. CRP 
was not recorded in one participant due to a laboratory error however, in the remaining four 
participants CRP levels also showed a clinically important decrease. All five participants 
achieved a decrease in DAS28. 
Psychosocial outcomes of imagery group. Table 17 reports the outcomes from 
psychosocial assessments for the imagery group. All five participants reported a decrease in 
pain, with two of these being clinically significant. All participants reported a decrease in 
physical fatigue with three being clinically significant, and decreased mental fatigue with two 
being clinically significant. Four out of the five participants reported a decrease in pain 
anxiety, and the remaining participant reported a slight increase. Self-efficacy for reducing 
pain increased in four participants, and decreased in one participant. Self-efficacy for 
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Function increased in four of the five, and remained unchanged in one participant. All five 
participants reported a clinically significant decrease in functional disability. Health related 
quality of life, as measured by the PGI, increased in all five participants. Where HRQOL was 
measured using the SF-36, all participants reported an increase in physical health, and four 
increased mental health. One participant reported no change in the mental health summary 
score. 
Table 16. Imagery ability and clinical assessment 
Participant Imagery Swollen Tender Global ESR CRP DAS28 
Ability joints joints assessment (mm/h) (mg/dl) (0-10) 
(2-240) (0-28) (0-28) (0-100) 
a 
JB pre 121 4 0 20 110 157 4.68 
post 4 0 30 70b 266 3.58 
DD pre 164 1 2 43 59 67 4.53 
post 1 1 9 30b 45b 3.35 
KT pre 156 18 20 68 48 97 7.35 
post 17 20 42 32b 63b 6.67 
SS pre 102 3 15 85 42 - 
6.46 
post 2 2 72 32b - 
4.62 
CD pre 114 4 5 62 57 68 5.51 
post 4 3 48 42b 54b 
4.82 
a lower scores represent greater imagery ability. 
b clinical improvement as defined by ARC criteria. 
Moderate response to Imagery intervention as defined by EULAR criteria. 
- CRP was not measured in this participant due to a 
lab error. 
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Case Profile 3: JB 
Demographics and social data. JB is a 55 year old divorced female who lives alone. She 
is a keen gardener and spends much of her time in her garden or greenhouse. JB has no 
immediate family as she and her husband decided not to have children. She has not worked for 
over three years, her last job being in a factory as a semi-skilled worker. JB says that she enjoys 
socialising with her friends and is a member of a local garden club. 
Disease history. JB has been diagnosed with RA for three and a half years, and has not 
been in employment since her diagnosis. She was prescribed 7.5mg of prednisolone to control the 
disease activity. She attended the rheumatology urgency clinic after experiencing increased pain 
and swollen joints. 
Disease activity pre-intervention. Clinical assessment revealed elevated levels of ESR and 
CRP, she also had several swollen joints, but no tender joints. Her disease status was active 
indicated by a DAS28 of 4.68. 
Areas identified as important with scores pre-intervention. Within the PGI, JB identified 
(1) pain stopping her living her life to the full rated at 4/10, (2) being unable to do her gardening 
due to the pain and fatigue rated at 7/10 and (3) unable to socialise with friends as often as she 
would like due to the pain rated at 4/10. 
Intervention. JB was given six sessions of imagery over a two week period. She scored 
121 on the VMIQ. The sessions focussed on reducing pain and increasing energy levels as these 
were the main areas identified. JB also received an imagery session aimed at improving her 
immune function. 
Disease activitypost-intervention. Following the imagery sessions, clinical assessment 
revealed a clinically important decrease in ESR and CRP, however there was no change in 
swollen joints. Consequently disease activity was reduced indicated by a DAS28 of 3.58. The 
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decrease in the DAS28 score indicates that JB demonstrated a moderate response to the imagery 
intervention. 
Bretts identified as important with scores post-intervention. JB originally rated `pain 
stopping her living her life' at 4/10, this improved to 8/10. `Being unable to do her gardening due 
to the pain and fatigue' improved from 7/10 to 9/10 and `unable to socialise with friends as often 
as she would like due to the pain' also improved from 4/10 to 8/10. 
Case Profile 4: KT 
Demographic and social data. KT is a 70 year old married woman, who lives with her 
husband. She is a retired school teacher and her husband is a retired engineer. Both are members 
of a local walking club and enjoy regular days away with their club on walks all over the country. 
Disease history. KT has been diagnosed with RA for ten years. At the time of the study 
she was prescribed 3g sulphasalazine daily, 7.5mg prednisolone, and gold injections to help 
control her disease activity. She attended the urgency clinic complaining of increased pain and 
swelling in both her hands and knees. 
Disease activity pre-intervention. Clinical assessment revealed a very active disease status 
in MT, indicated by elevated ESR and CRP levels, and a high number of swollen and tender 
joints. KT had a DAS28 of 7.35, the highest DAS28 in all participants. 
Areas identified as important. KT identified the following areas as being important in her 
life but were affected by her RA: (1) pain preventing her from walking with her friends at their 
local walking club rated at 5/10, (2) problems driving to places where the walking club had set up 
a walk because of pain and fatigue rated at 6/10, and (3) unable to write as much as she wanted to 
because of pain and stiffness in her hands rated at 5/10. 
Intervention. KT received six sessions of imagery over a two week period. She scored 156 
on the VMIQ. Five of the imagery sessions focussed on pain reduction so that she would be able 
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to enjoy her walking more, and be able to write longer without pain in her hands. The final 
imagery session focussed on increasing energy levels and help to alleviate stiffness. 
Disease activitypost-intervention. Following the imagery sessions, clinical assessment 
revealed clinically important decreases in ESR and CRP, although she reported one less swollen 
joint, her tender joint count remained the same. Overall there was a decrease in the DAS28 to 
6.67. Despite clinically important decreases in both acute phase reactants, the reduction is DAS28 
was not sufficient and KT was a non-responder to the imagery intervention. 
Areas identified as important with scores post-intervention. `Walking with her friends in 
their local walking club' improved from 5/10 to 6/10, `driving to places where the walking club 
had set up a walk' remained the same rated at 6/10, and `unable to write as much as she wanted to 
because of pain and stiffness in her hands' improved from 5/10 to 6/10. 
Case Summation for Imagery Group 
The imagery group consisted of four women and one man. The average age of 
participants in the imagery group was 53.6 years, ranging from 29 to 70. Three participants in this 
group were married, one of the women was divorced and another woman was single. One of the 
women, KT, had never worked, and the three other women had retired due to ill health. DD, the 
only male in this group, was the only person in this study who still remained in full-time 
employment. The duration of diagnosis for the group was very widespread. KT had been 
diagnosed with RA from childhood, and although recently diagnosed, DD reported that he had 
lived with the symptoms of RA for more than four years. The other participants had been 
diagnosed between three and a half, and ten years. DD was able to identify an event which may 
have contributed to the increase in his disease activity, which he reported was positive event. The 
other participants were unable to identify any event which they perceived as possibly contributing 
to their disease activity. 
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Clinical assessment pre-intervention revealed that all participants in the imagery group 
had a high level of disease activity indicated by the DAS28 scores. Following the intervention, 
clinical assessment revealed that all five participants achieved a decrease in disease activity. 
Using the EULAR response criteria, four participants achieved a moderate response to the 
imagery intervention. The remaining participant was classified as a `non-responder'. 
The most prominent area identified by participants in the imagery group was pain. For 
example, JB reported that pain stopped her from socialising with her friends as much as she 
would like, DD reported that pain prevented him from walking as much as he would like and 
being a dairy farmer this had an impact on his business, KT identified pain from stopping her 
writing as much as she would like to, and SS reported that pain prevented her from spending time 
with her children. Other areas identified as important were; fatigue, general mobility, sleep, and 
anxiety. 
Following the intervention intervention, psychosocial assessments revealed improved 
psychosocial function, specifically in relation to decreased pain, decreased physical and mental 
fatigue, decreased functional disability, and increased health-related quality of life measured by 
the SF-36 and the PGI. 
Hypnotherapy and Imagery Cross-Case Comparisons 
In summary, when comparing the number of participants reporting improvement in each 
of the dependant variables, the evidence from these ten case studies suggests that hypnotherapy 
was more effective than imagery at reducing the number of swollen joints, tender joints, pain 
anxiety, and increasing the patient's global assessment of disease severity, and self-efficacy for 
function. Imagery was more effective than hypnotherapy at decreasing ESR levels, reducing 
physical and mental fatigue, and increasing health related quality of life when measured by the 
PGI. Additionally, the imagery intervention produced a greater number of participants achieving 
a moderate response to the intervention, in accordance with the EULAR response criteria, than 
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the hypnotherapy group. Both interventions produced the same number of participants reporting 
clinically important decreases in CRP, decreased pain, self-efficacy for controlling pain, 
decreased functional disability and improved health related quality of life measured by the SF-36. 
Discussion 
The objective of this study was to examine the theoretical assumption of the biopsychosocial 
model of disease using active RA as the disease model, in that changes in the psychology system 
would result in changes in the biology system. More specifically, it was hypothesised that 
following a hypnotherapy or imagery intervention participants would report an increase in 
psychosocial functioning and due to the reciprocal relationship within the three systems in the 
model it was hypothesised that there would be a decrease in disease activity. The results from this 
series of case studies support the hypothesis that hypnotherapy and imagery improve 
psychosocial function and provide some evidence that these psychosocial interventions can 
positively influence disease activity in patients with active RA. 
Disease activity was high in the participants of this study; nevertheless, it was reduced in 
the majority of participants. More importantly, six out of ten participants achieved a moderate 
response, as measured in DAS28, to the intervention. There are three possible explanations for 
the decreases in disease activity. First, it is important to consider the unpredictable nature of RA 
(Strahl et al., 2000). Participants in this study were in the process of having a flare in their 
arthritis. It may be possible that during the intervention period the flare ran its natural course, 
therefore the change in disease activity was not entirely due to the interventions. Second, the 
DAS28 is a composite measure of objective and subjective scores. The number of swollen joints 
and ESR are the objective measures in the DAS28. In the sample only half participants had a 
decrease in the number of swollen joints, and of those, the number of decreased swollen joints 
was low, between 1 and 2 per participant. Seven out of the ten participants had lower levels of 
ESR following the intervention, indeed six of these were regarded as clinically important 
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reductions. However, if these decreases are not explained by the natural remission of the flare, it 
may be possible that the subjective scores, namely the number of tender joints and the patient's 
global assessment of disease inflated the reduction in disease activity. 
The final possible reason could be due to the reciprocal relationship between the 
psychology system and the biology system in the biopsychosocial model of disease. From a 
psychoneuroimmunological perspective, these two interventions may have buffered negative 
psychosocial experiences of these participants with active RA. This would have led to a decrease 
in the secretion of CRH, causing a reduction in ACTH and reduced immune activity, resulting in 
a decreased inflammatory response. Psychosocial function did improve in this group of 
participants, as did acute phase reactants, ESR and CRP, the biological markers of disease 
activity. 
The design of this study did not permit for identification of a causal relationship between 
the three systems of the biopsychosocial model. In order to examine the relationship between the 
three systems of the model to identify causality, further research would have to adopt a 
prospective longitudinal design in a larger sample of RA patients. Such a study would 
undoubtedly be expensive, not only in funding, but also in the time required by participants 
completing psychosocial measures and having samples taken for laboratory analyses to assess 
levels of disease activity. Furthermore, the design of such a study would pose a 
dilemma in 
relation to ethical consideration. 
As a measure of disease activity in RA, the DAS28 has shown to be a valid and reliable 
measure (Prevoo et al., 1995). It is the most commonly used measures of disease activity 
in 
clinical practice and clinical trials. However, there are some criticisms of this measure. 
The 
DAS28 does not take into account the number of tender or swollen joints in the feet or ankles 
(Kameda et al. 2006). This is an important consideration particularly as some of the participants 
in the present study identified mobility as a problem, which may have been caused by swelling 
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and tenderness in the feet and ankles. Furthermore, Gardiner et at. (2005) reports that the DAS28 
score has been shown to change significantly even when there is little evidence of clinical 
improvement. This is due to the formula used to calculate the DAS28. Acute phase reactant ESR 
values are log transformed so that changes in high baseline values of ESR have less contribution 
to the overall score than lower baseline ESR values of the same absolute change. In relation to the 
present study, the hypnotherapy group had a higher average ESR levels at baseline than the 
imagery group. Therefore, in order to achieve comparable changes in the DAS28 score 
participants in the hypnotherapy group were required to have greater absolute ESR changes post- 
intervention. 
In response to the criticisms of ESR, Yildirim et al. (2004) report that the acute phase 
reactant, serum CRP, is a more useful biochemical marker of disease activity in RA patients. 
Using serum CRP levels as an indicator of disease activity in participants of the present study, 
eight out of the ten achieved clinically important decreases in CRP. This provides further 
evidence for the biological effects of imagery and hypnotherapy in active RA. 
An investigation of psychosocial outcomes reveals that both hypnotherapy and imagery 
improved psychosocial function in patients with active RA. These results are consistent with 
results from other previous chapters in this thesis using patients with stable RA. Astin et al. 
(2002) reported that imagery combined with relaxation or cognitive behavioural therapy resulted 
in moderate effect sizes for pain, fatigue and self-efficacy. Specifically, chapter three of this 
thesis reports improved health related quality of life when measured with the PGI, and chapter 
four identifies that both imagery and hypnotherapy resulted in clinically significant reductions in 
pain, fatigue and functional disability in patients with stable RA. 
Pain and fatigue are the most common problems reported by patients with RA 
(Schoenfield-Smith et al., 1996; Pollard et al., 2006), and contribute to increased levels of 
functional disability (Walker et al., 2005). Pain and fatigue were reduced in these participants 
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post-intervention. Furthermore there were clinically significant reductions in functional disability 
in all participants. However, due to the sample size it is not possible to determine whether the 
psychosocial interventions employed in this study had a direct influence on disability or whether 
these clinically significant reductions were due to the decreases in pain and fatigue as suggested 
by Walker et al. (2005). 
Self-efficacy is an important construct which has been reported to influence pain and 
fatigue in RA (Younger et al., 2008). However, given that self-efficacy has been related to pain 
and fatigue it was unexpected that those participants who reported the highest increases in self- 
efficacy were not those who reported the highest decreases in pain and fatigue. This is in contrast 
to the findings of Younger et al. (2008). A possible explanation for this inconsistency could be 
the wide range of self-efficacy scores at baseline. The participant with the highest increase in 
self-efficacy had a low baseline score. Furthermore, the post-intervention score for this 
participant was lower than other participants' baseline score of self-efficacy. Therefore, although 
the increase was higher in absolute terms, the actual score was still lower than other participants. 
Pain anxiety was reduced in all participants in the hypnotherapy group and all but one 
participant, from the imagery group. As pain anxiety has been linked with functional disability 
(Strahl et al., 2000), it was expected that functional disability would be decreased in all those 
participants who reported a decrease in pain anxiety. Our results confirmed this hypothesis. 
Studies employing hypnotherapy report that participants who score higher on measures of 
hypnotic susceptibility achieve better outcomes than those who score lower (Appel et al., 2005; 
Laidlaw et al., 2004). The hypothesis that higher hypnotic susceptibility would have greater 
improvement was not supported by the results of this study. Although participants who scored 
medium hypnotisability showed greatest improvements in pain reduction and self-efficacy for 
functioning, those who scored the lowest on the SHSS: C showed the greatest improvements in 
physical fatigue and pain anxiety. Changes in mental fatigue and self-efficacy for controlling pain 
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were similar for both medium and low hypnotic susceptibility. With respect to clinical assessment 
and hypnotic susceptibility, there are also some conflicting results. For example, of the two 
participants who scored the highest on the SHSS: C, one had the greatest decrease in the number 
of swollen joints, ESR and DAS28 score, whereas the other had no change in the number of 
swollen joints, an increase in ESR and the lowest DAS28 score change. This is not consistent 
with previous research and indicates that hypnotic susceptibility in our sample was not a factor 
which influenced overall psychosocial or clinically beneficial outcome. However, given the 
sample size in the present study these interpretations should be treated with caution. 
A similar trend was also observed in the imagery group. The hypothesis that participants 
with greater imagery ability would achieve better outcomes is not supported by the results of this 
study. With respect to psychosocial assessment, the participants with the greatest decreases in 
pain, physical fatigue, mental fatigue, pain anxiety, and self-efficacy for function did not have the 
highest imagery ability score. In the clinical assessments, the participant with the greatest 
imagery ability had the largest decrease in the number of tender joints and greatest decrease in 
overall DAS28 score. However, it was reported that they also had the lowest change in ESR, and 
the same change in number of swollen joints as the participant with the lowest imagery ability. 
Indeed, the person with the lowest imagery ability had the second greatest change in overall 
DAS28 score. It is apparent that, for the participants in this study, imagery ability did not 
influence outcome. However, as no other published studies exist examining the relationship 
between imagery ability and therapeutic change in RA patients, further research is warranted in 
this area. 
Two possible explanations for the differences between the expected and actual results in 
hypnotisability and imagery ability may be due to social factors within a biopsychosocial model 
and stress in the daily lives of the participants in this study which were not taken into 
consideration. Although socio-economic status was not an independent variable in this study it 
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was apparent that both intervention groups contained a heterogeneous sample of participants. For 
example some participants lived in council properties and received state benefits, whereas others 
lived in private accommodation with added income from private pensions. Jacobi et al. (2003) 
has shown that in patients with a low socio-economic status the impact of RA is more severe. 
Within a biopsychosocial model it would be reasonable to assume that the beneficial impact of 
these psychosocial interventions may have been reduced by the negative impact from the social 
system, for example poorer socioeconomic status. Gender has also been identified as a variable 
which influences disability in RA. Harrison and Symmons (2000) noted that disability scores tend 
to be higher in women than in men. Indeed this was evident in the present sample of participants. 
Both men who participated in this study reported less functional disability than the women, even 
when biological markers of disease activity were higher in these men than most of the women. A 
possible explanation for this comes from a cultural-phenomena perspective, which suggests that 
men do not necessarily have less functional disabilities than women, but that men with RA 
actually over-estimate their functional abilities (van den Ende, Hazes, Le Cessie, Breedveld, & 
Dijkmans, 1995). 
Of specific interest is the role of care-giver with the majority of participants in this study. 
Such individuals are at an increased risk of higher disease activity due to the additional perceived 
stress from care-giver strain (van Zanten, Ring, Carroll, & Kitas, 2005). Specifically, caregiver 
strain has shown to be associated with increased levels of the acute phase reactant 
CRP (Wright 
et al., 2004). In the present study the smallest changes in CRP were found in participants who 
were full-time carers for either chronically ill spouse, children with behavioural difficulties, or 
chronically ill parent. Within a biopsychosocial framework it is possible to hypothesise that the 
beneficial effects of hypnotherapy and imagery in these participants may have been 
buffered and 
reduced by the negative influence of their care-giver role. 
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A possible mechanism through which hypnotherapy and imagery make beneficial 
changes to psychosocial function and disease activity might be through the use of more active 
coping strategies employed by these participants. Treharne, Lyons, Booth and Kitas (2007) have 
investigated the effects of different coping strategies employed by RA patients and report that 
patients under greater perceived stress who do not use active coping strategies are at risk of 
psychological comorbidity. Dekkers et al. (2001) also identified that problem focussed coping 
buffers the effects of stress. It is already know that stress can have a negative impact on the 
immune system of individuals (Lutgendorf et al., 2003), and more specifically on disease activity 
of RA patients (Zautra, Smith, & Yocum, 2002). Given the situations that the majority of the 
participants in this study were under it is probable that they had increased perceived stress from 
either their role as care-giver or from the unpredictable nature of RA. Therefore it may be the use 
of imagery or hypnotherapy facilitated a change in coping style which could buffer the effects of 
stress and have a positive impact on disease activity. 
There are a number of limitations with the present study. The sample size is low, however 
as indicated earlier it is not possible to conduct a randomised controlled trial in active RA patients 
due to the ethical considerations. Related to this was the short time allowed for the intervention. 
It 
may be that with prolonged use of these interventions the results would be more encouraging. 
In 
the study of stable RA patients reported in chapter four there was no correlation between amount 
of time practising imagery or hypnotherapy, and beneficial psychosocial outcomes. However, 
it 
should be noted that participants in that study had six weeks of the intervention whereas 
participants in the present study had a maximum of two weeks. Additionally, there are a number 
of variables within the biopsychosocial framework which were not considered in this study, 
particularly the role of care-giver, perceived stress, and coping style. Future research could 
focus 
on the use of hypnotherapy and imagery as adjunct psychosocial interventions with active RA 
patients taking prescribed medication and take into account the role of care-giver, perceived 
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stress and different types of coping styles. This would help to establish any beneficial clinical 
outcomes over and above that of medication alone, and identify whether these psychosocial 
interventions influence perceived stress, and facilitate a change in coping style. Since such a 
study would inevitably involve a larger sample size, it would be possible to examine the effects 
of hypnotisability and imagery ability more thoroughly. 
In conclusion, the results of these case studies indicate that hypnotherapy and imagery 
have a beneficial impact on psychosocial functioning and provide some evidence for these two 
interventions impacting disease activity in active RA patients. Furthermore, the results support 
future research on a larger scale using these interventions with active RA patients taking 
medication. Combined with the results of previous studies exploring the therapeutic effects of 
hypnotherapy and imagery in stable RA patients, we concur with the conclusions of Astin et al. 
(2003) that psychosocial interventions, specifically hypnotherapy and imagery should be 
considered as adjunct therapies in the clinical care of patients with RA. 
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CHAPTER SIX 
GENERAL DISCUSSION 
Summary 
The objective of this research programme was to explore the use of imagery and 
hypnotherapy as psychosocial interventions using a patient-centred approach in patients 
with rheumatoid arthritis (RA). Patient-centredness was enhanced throughout the 
research programme by allowing participants to identify their own specific areas for 
therapeutic change through the use of the Patient Generated Index (PGI; Ruta, Garratt, 
Leng, Russell, & MacDonald, 1994), a patient generated outcome measure (PGOM). 
Additionally, measurement of dependent variables utilised patient reported outcome 
measures (PROMs). 
The first chapter of this thesis provided an overview of rheumatoid arthritis and a 
biopsychosocial perspective of the disease, indicating some of the symptoms which may 
be targeted for psychosocial intervention. Chapter two included a review of the literature 
of psychosocial interventions in RA and providing a platform for the use of imagery and 
hypnotherapy as psychosocial interventions in the present research programme. 
Specifically, within this review and in the literature it is identified that there was a need 
to utilise imagery as a stand-alone intervention. Furthermore, given the usefulness of 
hypnotherapy in other chronic disease yet a lack of this intervention being investigated in 
RA patients, these two psychosocial interventions were utilised in the research 
programme. 
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A patient-centred approach specific to health related quality of life (HRQOL) was 
examined in chapter three of this thesis. Specifically, the measurement of HRQOL has 
become an important outcome in chronic diseases where there is no cure, and measuring 
HRQOL should help to direct how the disease is managed (Fayers & Machin, 2000). In 
chapter three a PGOM, the PGI (Ruta, Garratt, Leng, Russell, & MacDonald, 1994) was 
compared to a PROM, the Short Form 36 Health Survey Questionnaire (SF-36; Ware & 
Sherbourne, 1992). Forty two participants with stable RA completed the PGI, identifying 
important areas of their life which were affected by their disease. The results indicated 
that the SF-36 did not capture all of the areas that individuals identified. The evidence of 
a discrepancy between these two measures has clinical and research implications which 
are discussed later in this chapter. 
Furthermore, it was also identified that following psychosocial intervention using 
imagery or hypnotherapy, the SF-36 was less sensitive to detect changes in HRQOL than 
the PGI, which showed increases in HRQOL. The SF-36 is the most widely used 
HRQOL measure in RA trials and clinical practice (Kalyoncu, Dougados, Daures, & 
Gossec, 2008), however the results presented in chapter three demonstrate that HRQOL, 
as measured by the SF-36, following a psychosocial intervention did not change. The 
clinical implications of this are discussed further in this chapter. 
Using the same group of stable RA patients, the forth chapter of this thesis 
examined the efficacy of imagery and hypnotherapy with a particular focus on the 
symptoms associated with this disease (e. g. pain, fatigue, pain anxiety, self-efficacy, and 
functional disability). Using a randomised controlled trial design it was identified that 
both these psychosocial interventions significantly improved some areas of psychosocial 
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functioning, and in many cases this improvement was clinically significant. Specifically, 
both imagery and hypnotherapy significantly reduced pain at post-intervention. Only 
hypnotherapy demonstrated significant long-term beneficial effects, specifically in 
increased self-efficacy for controlling pain and decreased functional disability. However, 
both interventions achieved clinically significant results in physical and mental fatigue, 
and functional disability, which were maintained at six months follow-up. 
Given that imagery and hypnotherapy have a clinically significant impact on 
some of the symptoms associated with RA, chapter five explored the effect of these 
psychosocial interventions on disease activity in active RA patients, where these patients 
often experience more severe symptoms than stable RA patients. Specifically in a 
biopsychosocial model of disease, the assumption that changes in one system (in this case 
the psychology system) can lead to changes in the other systems (the biology system), 
was tested using ten patients in a case study approach. 
The results presented in chapter five identified several areas of improvement in 
clinical assessment, indicating a reduction in disease activity with two participants in the 
hypnotherapy group and four participants in the imagery group achieving a moderate 
response to the intervention in accordance with EULAR response criteria. Additionally, 
all participants reported some improvement in psychosocial function, for example all ten 
participants reported decreased pain and functional disability, four participants in the 
hypnotherapy group and all five in the imagery group reported decreased mental fatigue, 
and all five participants in the hypnotherapy group and four participants in the imagery 
group reported decreased pain anxiety. Furthermore, clinically significant reductions in 
pain were achieved in two participants in the hypnotherapy group and two from the 
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imagery group. Two participants in the hypnotherapy group and three from the imagery 
group also achieved clinically significant reductions in physical fatigue and clinically 
significant reductions in functional disability was achieved in all ten participants. 
The implications to research and clinical practice have been discussed in the 
relevant chapters of this thesis. The objective of this final chapter is to synthesise the 
research and clinical implications from the preceding chapters in an attempt to provide 
meaningful conclusions from this research programme. Specifically, several areas are 
discussed including imagery and hypnotherapy as psychosocial interventions, 
methodological issues, the strengths and weaknesses of the research programme are 
identified, future research and applied clinical directions are suggested. Finally, this 
thesis is concluded using the mnemonic FINER suggested by Hartrick (2008) for aiding 
systematic reflection of the research process. 
Imagery and Hypnotherapy as Psychosocial Interventions 
Imagery and hypnotherapy were the psychosocial interventions employed in the 
present research programme. Within a large body of the wider research literature the 
terms hypnosis, hypnotherapy, guided imagery, and imagery are used interchangeably 
and applied to both imagery and hypnotherapy (cf. Zelter et al., 2002). However, in this 
research programme the concepts were defined and operationalised separately. The 
present research programme further identified differential effects of these two 
psychosocial interventions. While these psychosocial interventions are similar therapeutic 
tools (Luskin et al., 2000) and imagery is an integral part of hypnotherapy (Spiegel, 
Greenleaf, & Spiegel, 2000), there is an induction procedure involved in hypnotherapy 
and not imagery. This induction procedure has been likened to a state of deep relaxation 
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(Gay, Philippot, & Luminet, 2002). Participants in the imagery group were given no 
instructions to relax therefore the difference between these two interventions may be due 
to relaxation. As there was no relaxation control group in this research programme this is 
identified as a weakness and discussed later in this chapter. 
Within the results of this thesis it was demonstrated that both these psychosocial 
interventions significantly improved many of the symptoms associated with RA and 
achieved significantly increased HRQOL. Furthermore, in chapter five it is reported that 
imagery and hypnotherapy significantly improved psychosocial functioning in RA and in 
some cases had clinically meaningful impact on the biology of the disease. However, 
there were some differences in the results between imagery and hypnotherapy. In chapter 
three it was reported that at post-intervention both imagery and hypnotherapy 
significantly improved HRQOL when measured by the PGI, with only the hypnotherapy 
group maintaining this increase at six months follow-up. In chapter four it was also 
reported that hypnotherapy was more effective than imagery in relation to decreasing 
physical fatigue, increasing self-efficacy for controlling pain, and decreasing functional 
disability. Given the results presented in these two chapters it was concluded that 
hypnotherapy was overall more effective than imagery for patients with stable RA. 
Although the explanation that the induction procedure in hypnotherapy makes this 
psychosocial intervention more effective than imagery, the results presented in chapter 
five are not consistent with this. Specifically, both imagery and hypnotherapy were 
equally effective at improving psychosocial functioning in active RA patients. 
Importantly, in terms of changes in disease activity, more participants in the imagery 
group achieved a moderate response, defined by EULAR, to the intervention than those 
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who had hypnotherapy. Furthermore, all five participants in the imagery group achieved 
clinical improvement in ESR values, as defined by ARC criteria, and only one in the 
hypnotherapy group achieved this. Therefore, it could be argued that imagery was more 
effective than hypnotherapy in patients with active RA. 
It is difficult to compare the results from the studies in this thesis to draw 
meaningful conclusions about the effectiveness of imagery and hypnotherapy for three 
reasons. First, there was a difference in the disease status of participants who participated 
in this research programme. Specifically, chapters three and four involve patients with 
stable RA (i. e. their current anti-rheumatic medication is controlling the biology of their 
disease), whereas participants in the study reported in chapter five had active disease (i. e. 
their anti-rheumatic medication was not controlling the biology of their disease). Indeed, 
no published evidence exists comparing the efficacy of these psychosocial interventions 
in active and stable RA patients. However, Kessler (2001) suggests that psychosocial 
intervention at the early stages of disease may be more effective and have lasting effects 
than later intervention. 
Indeed, Sharpe et al. (2001) raise the question that similarly to early 
pharmacological intervention, psychosocial interventions in early RA may be more 
beneficial. Using cognitive behavioural therapy as a psychosocial intervention they 
reported significant reductions in depression and improvement in joint function when 
compared to a `care-as-usual' control group (Sharpe, Sensky, Timerlake, Ryan, & Allard, 
2003). Although the results of their study suggest that CBT was an effective adjunct 
therapy in early RA with the outcomes remaining significant at 18 months follow-up, the 
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question as to whether early psychosocial intervention is better remains unanswered, as 
they did not compare with long-standing RA patients. 
If, similarly to early pharmacological intervention, early psychosocial intervention 
has longer term better outcome, then this might explain the non-significant results at 
follow-up reported in this research thesis. Participants who took part in this research 
programme had long disease duration, specifically in the study reported in chapter three 
and four, the mean disease duration was more than 13 years. This is discussed further 
later in this chapter. 
The second notable difference between the studies presented in this thesis was 
that hypnotic susceptibility and imagery ability were not measured in the study reported 
in chapters three and four. Therefore, it is possible that participants in the imagery group 
had lower imagery ability and participants in the hypnotherapy group had high hypnotic 
susceptibility. This might explain the differences between the effectiveness of these two 
interventions. However, the results in chapter five indicate that hypnotic susceptibility 
and imagery ability were not related to better overall improvement. Participants with 
greater hypnotic susceptibility or imagery ability did not report the greatest improvement, 
nor did participants with the lowest hypnotic susceptibility or imagery ability report the 
least improvement. 
Finally, the methodologies were different. Chapters three and four used a 
randomised controlled trial design, whereas the study reported in chapter five used a case 
study approach. An objective of the study reported in chapter five was to investigate the 
biopsychosocial model of active disease following a psychosocial intervention. Although 
randomised controlled trials are regarded as the gold standard (Barton, 2000), this was 
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not possible. To investigate the effects of imagery and hypnotherapy in active RA would 
require withholding anti-rheumatic drugs, as these would affect the biology of the 
disease. This is not considered ethical (Haslock, 1989; Stein & Pincus, 1999). Therefore 
a case study approach was utilised. Consequently, the analyses performed on the data in 
chapters three and four included inferential statistical analyses and clinical significance 
whereas no inferential statistical analyses were performed in chapter five. 
Methodological Issues 
Statistical versus clinical significance. Within this thesis both statistical and 
clinical significant changes in dependent variables were reported. Specifically, the 
reporting of statistically and clinically significant change reported in chapter four raises 
some important issues for researchers and clinicians. Traditionally, treatment effects have 
been examined using statistical significance where the mean changes between groups are 
compared. Statistical significance informs us that the associations between the tested 
variables (e. g. changes in a dependent variable between two intervention groups) did not 
occur by chance. More specifically, with an alpha level of 0.05 we can reject the null 
hypothesis in the knowledge that probability of the association occurring by chance was 
less than 5% (Kramer, 1988). However, this approach to examining the clinically efficacy 
of interventions has been criticised as it neglects the impact of a treatment, which is 
considered more important from a clinical perspective (Jacobson & Traux, 1991). 
Throughout the literature clinical significance is further confused as the definition 
of this construct varies from different perspectives, for example the patient, the clinician, 
and policy makers (Greenstein, 2003). Indeed, there is a lack of consensus in the 
definition of `clinically significant' (cf. Sloan, Cella, & Hays, 2005). However despite 
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this lack of consensus, clinical significance is generally regarded as "the noticeable 
difference an intervention makes in the everyday life of patients or to others with whom 
the patients interact" (Kazdin, 1999, p. 332). Where statistical significance and clinical 
significance differ the greatest is in their perspective of change. With regard to treatment 
efficacy, statistical significance focuses on the numerical differences between and within 
groups (Greenstein, 2003), whereas clinical significance focuses on the impact to the 
patient of this numerical change (Kadzin, 1999). For example, in the current thesis it was 
reported that there were no statistically significant difference in pain post-intervention 
between the imagery and hypnotherapy group, however these were statistically 
significantly lower than the control group. From a statistical perspective this result seems 
promising, and may indicate that both imagery and hypnotherapy are beneficial for 
relieving pain in RA patients in the short term. However, neither group achieved a 
clinically significant result, meaning that the decreases in pain observed in these two 
intervention groups did not have a significant impact in these patients. Similarly, it was 
reported in chapter four that the hypnotherapy group had significantly less physical 
fatigue than both the imagery and control group, however both intervention groups 
achieved a clinically significant change in physical fatigue. Notably though, the clinical 
effect size was greater for the hypnotherapy group. 
Crosby, Koltkin, and Williams (2003) have stated that statistical significance is 
not the same as clinical significance. For example, in studies with large sample sizes 
significant differences may be found with small numerical differences, however this does 
not necessarily mean there is a clinically significant difference between or within groups. 
Similarly, in studies with small sample sizes there may be no statistically significant 
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differences between or within groups with large numerical differences which may be 
clinically significant. Indeed, this is apparent in the results reported in chapter four of this 
thesis. Clearly, in clinical research and specifically in clinical practice, both statistical and 
clinical significance should be considered as equal and not in opposition. 
Strengths of the Research Programme 
Patient-centred approach within the research programme. A particular strength 
of the present research programme was the patient-centred approach used throughout. A 
patient-centred approach encompasses a biopsychosocial perspective of disease, where 
the individual is central to treatment, rather than the disease (Del Piccolo, Mazzi, 
Scardoni, Gobbi, & Zimmermann, 2008). This patient-centred approach was achieved by 
three specific techniques. First, the use of PROMs, second, the use of a PGOMs, and 
finally, tailoring the psychosocial intervention to the items identified as important by 
participants in the PGOM. 
The use of patient reported outcome measures in research and clinical practice is 
not a novel technique (Fairclough, 2004). Indeed such measures have been used for 
decades allowing patients to report, for example levels of pain, depression and anxiety 
(Bowling, 1995). The use of PROMs in research and clinical practice encourages patient 
and physician communication, and a greater understanding of the patient's perspective of 
illness and disease (Higginson & Carr, 2001). However, as demonstrated in chapter three 
of this thesis, the use of fixed-item HRQOL PROMs, specifically the SF-36, may not 
facilitate greater patient-centredness as it does not fully capture what is important from a 
patient's perspective. 
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The use of the PGI as a PGOM enhanced the patient-centred approach throughout 
this research programme. The main difference between PROMs and PGOMs is that 
PGOMs allow patients to identify areas which they consider important, rather than 
completing items on a pre-defined domain, traditionally selected by researchers and 
clinicians, in PROMs (Patel, Veenstra, & Patrick, 2003). Perhaps the greatest strength of 
this research programme which distinguishes it from the current literature was the use of 
a PGOM to identify areas for psychosocial intervention. To the best of the present 
author's knowledge this is the first intervention study to use this approach in RA. This 
approach exemplifies a patient-centred approach in that the patient takes shared 
responsibility for the identification of areas for therapeutic change and the goals of 
treatment. 
Imagery as a stand-alone therapeutic modality. Throughout the RA literature, 
when imagery has been employed as a psychosocial intervention it has never been used 
independently from other therapeutic modalities. Indeed, in chapter two of this thesis, the 
review identified seven studies which combined imagery with another modality. As a 
consequence the efficacy of imagery in RA is unknown. Indeed, several authors have 
recognised this limitation and recommended the use of imagery as a stand alone therapy 
in future studies (Astin, Beckner, Soeken, Hochberg, & Berman, 2002; Luskin, Newell, 
Griffith et al., 2000; Morone & Greco, 2007). The present research programme addressed 
this limitation and used imagery as a psychosocial intervention without combining it with 
any other psychosocial modality. 
Focus on dependant variables important to RA patients. Throughout this research 
programme the dependant variables measured were selected because of their relevance to 
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RA patients. This was achieved in two ways. First, through the use of the PGI 
participants are able to identify specific items and areas of their life. The use of the PGI 
has been discussed in detail in this chapter and within this research thesis. Second, 
dependant variables in this research programme were taken from the OMERACT 
(Outcome Measures in Rheumatology Clinical Trials) core set of outcome measures (e. g. 
pain, fatigue, functional disability). Specifically, at the OMERACT 6 meeting in 2002, 
provision was made for patient participation (Kirwan et al., 2005). The result of involving 
patients in the OMERACT group means that outcomes measured in clinical studies will 
be of more relevance to RA patients, and increase the generalisability of the results of 
such studies. 
Interdisciplinary research team. Although this thesis is the work of the present 
author, it is acknowledged that a particular strength of the research programme was the 
interdisciplinary approach in the research team. Specifically, the research programme was 
supervised by Dr Nichola Callow with expertise in psychology and research, and Dr 
Jeremy Jones, an expert in the clinical area of rheumatology. The interdisciplinary 
approach to this research programme meant that both clinical and academic areas were 
synthesised to produce designs of studies which met the demands of academia whist 
incorporating the needs of `real life' clinical aspects of rheumatology. Furthermore, it is 
the opinion of the present author that this approach increased the applied value of the 
research programme and this completed thesis. 
Post-experimental questionnaire. Including a post-experimental questionnaire in 
the design of the research programme made it possible to examine variables other than 
the intervention which may have had an influence on the outcome, for example hope, 
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expectation, and reaction to randomisation. In chapter four it was identified that the 
participant's reaction to randomisation was significantly related to decreases in physical 
fatigue and functional disability. As a result of utilising the post-experimental 
questionnaire in the present research programme we now know that the results should be 
interpreted with some caution. Throughout the health research literature very few 
intervention studies report the use of post-experimental questionnaires. Given the 
findings reported, specifically that reaction to randomisation may influence outcome, this 
raises questions regarding the results of other randomised studies which have not 
incorporated such a measure in their design. 
Measurement of imagery ability and hypnotic susceptibility. A potential weakness 
of many studies, involving imagery and hypnotherapy as psychosocial interventions, is 
the omission of imagery ability and hypnotic susceptibility. Specifically, in the review of 
psychosocial interventions presented in chapter two of this thesis, none of the studies 
which utilised imagery as part of their therapeutic modality measured imagery ability. 
In 
relation to hypnotic susceptibility, the two studies identified in the review 
did not 
measure hypnotic susceptibility. Research from other domains, for example sports 
psychology have identified that imagery ability has an impact on outcome (cf. Gregg, 
Hall, & Butler, 2007). There is also evidence from the health literature that hypnotic 
susceptibility can influence outcome (cf. Appel & Bleiberg, 2005; Laidlaw et al., 
2004). 
Although imagery ability and hypnotic susceptibility were not measured in chapter three 
and four, and this was discussed as a potential weakness of this study, they were 
measured in the study reported in chapter five of this thesis. 
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Ethical considerations. Particularly, for the study reported in chapter five of this 
thesis careful attention was given to the ethical considerations of such a study involving 
patients with active RA not taking any pharmacological intervention. After consulting 
with rheumatology specialists a case study design was considered the best research 
methodology, with active RA patients who were in-between anti-rheumatic drugs chosen 
as the target population. Furthermore, it was agreed that the psychosocial intervention 
duration should be no longer than two weeks. Following these consultations with 
rheumatology specialists the design of the study was presented to the NHS ethics 
committee and was given a favourable ethical opinion. Another ethical issue which is 
presented as a strength of the research programme was that all participants in the control 
group of the study reported in chapter three and four were offered a choice of imagery or 
hypnotherapy intervention following the control period. Incidentally, no participant 
declined the offer. 
Mixed methodologies. An objective of the research programme was to provide 
training in the research process. By using mixed methodologies, specifically a 
randomised controlled trial approach and a case study approach, the present author 
gained an understanding of these different types of research methodologies. Furthermore, 
using different methodologies within this research programme also gave the present 
author the opportunity of valuable experience of working collaboratively with patients 
and health service providers in designing the studies presented in this thesis. 
Applied focus. A particular strength of the present research programme was its 
applied focus. Participants of this research programme were patients with a chronic 
disease. Associated with the advantages of conducting applied research, there are some 
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disadvantages in terms of time. For example studies involving patients from the NHS 
requires additional ethical permission, which can be a lengthy procedure. Furthermore, 
recruiting patients to participate in such studies can also involve additional time, for 
example going to clinics and identifying possible participants. 
Informing RA group at local hospital. Part of this research programme, which can 
be considered a strength, involved attending the local hospital rheumatology 
multidisciplinary team meeting. It was during those meetings that the present author was 
able to demonstrate how imagery and hypnotherapy might be used for patients with RA 
and present interim findings to the rheumatology group. This undoubtedly helped with 
recruitment and offered the rheumatology MDT the opportunity to ask questions and find 
out more about the studies presented in this thesis. Furthermore, it helped to foster a good 
working relationship between two institutions, namely the university and the hospital. 
Weaknesses of the Research Programme 
Applied versus theoretical focus. The objectives of this research programme were 
not to explicitly examine the theory related to imagery and hypnotherapy, but to utilise 
these two psychosocial interventions in a clinical population, specifically RA patients, 
with an applied focus. Notwithstanding the objectives of the research programme, the use 
of psychosocial interventions in clinical populations should be informed by theory 
(Salkovskis, 2002). However, throughout the health research literature, studies employing 
these two psychosocial interventions often fail to provide theoretical rational for their 
use, or to explain the possible mechanisms of change. The present author acknowledges 
that in order to understand the mechanisms that underpin the clinical effects following an 
imagery or hypnotherapy it is essential to gain some insight from theories related to these 
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two psychosocial interventions. Although there was not a theoretical focus to the present 
thesis, several theoretical mechanisms were discussed, for example Cautela and Kearney 
(1990) behaviour theory, Bandura's (1977) self-efficacy theory, and Melzack's (2001) 
gate control theory, with respect to changes in dependent variables, throughout this 
thesis. 
Attention control groups. A potential weakness in the research programme is the 
lack of an attentional control group. The objective of attentional control groups is 
different from a `care-as-usual' control group in that the former takes into account 
participant expectations and attention received by taking part in the research and thus 
tests the null hypothesis more stringently (Bootzin, 1985). Therefore the beneficial 
changes observed in the dependent variables of this research programme may not be due 
to the interventions, but may be the result of non-specific therapeutic effects (e. g., effects 
of attention, positive regard, and therapeutic alliance). 
The decision not to include an attention control group was based on interpreting 
the available literature. For example in a recent meta analyses Jensen, Weersing, 
Hoagwood, and Goldman (2005) identified 14 out of 29 studies reported significant 
differences between the active intervention group and the attention control group, 
indicating that the effects of the psychosocial intervention were not dependent on non- 
specific therapeutic factors. Furthermore, two studies, specifically involving the 
psychosocial interventions utilised in the present thesis were identified which included an 
attention control group. Huth, Broome, & Good (2004) investigated the effects of an 
imagery intervention following surgery and Saadat et al., (2006) investigated the effects 
of hypnotherapy for post-operative anxiety. Both these studies reported significant 
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differences between the active intervention group and the attention control group, with no 
significant differences between the attention control group and the `care as usual' control 
group. The fact that there was no significant differences between the attention and `care 
as usual' control groups provides some evidence for not including an attention control 
group specifically for imagery and hypnotherapy interventions. Therefore, within the 
present research programme there was no attention control group in any of the studies. 
However, in order to identify possible non-specific therapeutic effects, 
participants completed a post-experimental questionnaire which examined expectancy, 
hope, and reaction to randomisation, and a modified perceived social support 
questionnaire which included perceived social support from the experimenter. Although 
in chapter three it was reported that there were no significant correlations between 
variables in the post-experimental questionnaire, or the modified perceived social support 
questionnaire, and changes in HRQOL, there were some significant correlations reported 
in chapter four. Specifically there was a significant correlation between pain reduction, 
decreased functional disability, and perceived social support from the experimenter. 
Furthermore, there was also a significant correlation between reaction to randomisation 
and decreased physical fatigue and decreased functional disability. Consequently, the 
results presented in chapter four should be interpreted with caution because of these 
significant relationships. Furthermore, future studies involving psychosocial interventions 
should include an attention control group. 
Volunteer bias. A common limitation of many studies involving psychosocial 
interventions for chronic disease is volunteer or self-selection bias (Malani, 2008). In 
cases where the objective of the study is to examine the effect of a particular intervention 
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in a specific group of patients, such as the present thesis, randomisation does not 
eliminate the problem of volunteer bias (Heckman & Smith, 1995). Volunteer bias was 
particularly evident in the first study reported in chapters three and four. Specifically, 
only 22 out of the 102 patients who were invited to take part in this study at the 
rheumatology clinic, accepted the invitation. Unfortunately the number of patients invited 
to participate in the study reported in chapter five was not recorded. However, the 
rheumatology nurses involved in recruitment commented that many people were less 
enthusiastic to participate in this study for two reasons. First, the amount of time required 
in participating and second, preconceived ideas of what hypnotherapy was (even though 
definitions of imagery and hypnotherapy were on the patient information sheet). 
Volunteer bias may compromise external validity and therefore generalisability of results. 
However, in keeping with a patient-centred focus, if these psychosocial interventions 
were made available, then the likelihood of patients with no interest using them would 
probably be very low. Indeed, irrespective of volunteer bias in the research, patient 
preference and choice still exist outside the realms of a research study. 
Future Research Directions 
Although this thesis adds value to the literature on psychosocial interventions in 
RA, it also raises important questions which require future research attention. The use of 
PROMs in HRQOL is increasing (Emery, Perrier, & Acquadro, 2005) reflecting a 
growing awareness of the importance of a patient-centred approach to the treatment of 
chronic disease (Kushida et at., 2007). With the growth of HRQOL PROMs it is crucial 
that the appropriate measure is chosen (Joyce et al., 1999; Garratt et al., 2002; Arnold et 
al., 2004). In chapter three it was identified that the SF-36 did not fully capture what 
General Discussion 175 
patients reported as their HRQOL. However, other HRQOL widely used include the 
EuroQOL EQ-5D (Brooks, 1996) and the Nottingham Health Profile (NHP; Hunt, 
McEwan, & McKenna, 1986). Given the importance of HRQOL in chronic diseases 
future research should investigate whether the items in these HRQOL measures are able 
to capture what an individual perceives as being important. 
On reflection, the decision not to include an attentional control group, based on 
the present author's interpretation of evidence from the literature, was incorrect. The 
results in chapter four indicated that there was a significant relationship between 
reductions in pain and functional disability, and perceived social support from the 
experimenter. Contrary to Gross (2005) and following the results above, attentional 
control groups enhance scientific rigour, and as such future studies using psychosocial 
interventions should employ a suitable attention control group. 
It was suggested that a possible explanation for the differences between the two 
psychosocial interventions was the induction procedure, which is similar to relaxation 
(Gay et al., 2002) in hypnotherapy and not in the imagery intervention. However, as there 
was no relaxation group in any of the studies, this explanation is speculative. Imagery is 
an integral component of hypnotherapy, a replication study involving a combined 
relaxation and imagery intervention might confirm whether the induction procedure in 
hypnotherapy was responsible for the added benefit reported in chapters three and four. 
In chapter five it was reported that both imagery and hypnotherapy interventions 
improved psychosocial function and in some cases biological markers of disease activity 
in active RA patients. The results from this study provide some evidence that imagery 
and hypnotherapy influencing the biology of the disease. However, it is not possible to 
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conduct a randomised controlled trial to investigate the effects of imagery and 
hypnotherapy in active RA as it is no longer considered ethical to leave patients with 
active RA without drugs (Haslock, 1989; Stein & Pincus, 1999). Nevertheless, it would 
be possible to conduct a randomised trial using imagery and hypnotherapy in recently 
diagnosed RA patients all receiving the same anti-rheumatic medication. Such a study 
would identify whether the inclusion of imagery or hypnotherapy with anti-rheumatic 
medication improves psychosocial function and disease activity more than ant-rheumatic 
medication alone. 
Applied Clinical Directions 
The PGI was used throughout the research programme to enhance a patient- 
centred approach to the research. In the UK the National Health Service (NHS) has 
adopted a strategy in creating a patient-led NHS, giving patients greater choice and 
control of treatment (Department of Health, 2005). This strategy reflects the growing 
awareness of the changing roles of patients as service users and physicians as service 
providers, the need for increased satisfaction in service provision, and a change in focus 
from disease to understanding the patient's perspective (Epstein et al., 2005). It has been 
acknowledged that the focus from the disease to the person integrates a patient-centred 
focus, rather than a physician-centred, or disease-centred focus (Silverman, 1987; 
Stewart, 2001). Therefore using the PGI in clinical practice will increase patient- 
centredness and contribute to the aims of the strategy adopted by the NHS in creating a 
patient-led NHS. 
Specifically in clinical practice, the use of measures such as the PGI should 
facilitate greater patient-centredness through improved patient-clinician communication 
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(Gilbody, Whitty, Grimshaw, & Thomas, 2003), and identification of patient preferences 
enabling shared power and responsibility for goals of treatment (Lindblad, Ring, 
Glimelius, & Hansson, 2002). Indeed, in chronic diseases such as RA this is important as 
patient-centredness is associated with greater patient satisfaction, adherence to 
medication and rehabilitation programmes, and better overall health outcome (Stewart, 
1995) 
Another applied clinical direction which comes out of this research programme 
could be educational programmes instructing RA health care providers how to use 
imagery and hypnotherapy in everyday practice. Both these interventions are simple to 
use and can easily be adopted as a self-management programme. Additionally, adverse 
side effects are minimal and infrequent (Astin et al., 2003) which may increase their 
appeal as self-management techniques. 
Conclusion 
Reflecting on the research process which culminated in the production of this 
thesis, the mnemonic FINER suggested by Hartrick (2008) for aiding systematic 
reflection of the research process is employed. Specifically, Hartrick (2008) argues that 
high quality studies should be feasible, interesting, novel, ethical, and relevant. 
The present research programme may lack some feasibility in that sample size of 
the study reported in chapter three and four were low. With small sample sizes Stevens 
(1996) suggests that the alpha levels should be adjusted to compensate for lower power. 
However, the power of the primary outcome measure used in this study indicated a 
sufficient sample size. Investigation of psychosocial interventions in patients with active 
RA raised ethical concerns which meant a large randomised control trial could not be 
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conducted. Therefore a case study approach was employed in chapter five. Ten 
participants were included in this study. In terms of sample sizes for case studies this is a 
large sample size. 
The use of imagery and hypnotherapy as psychosocial interventions in patients 
with RA was interesting due to the direct interface with patients required for this research 
programme together with the breadth of research required to understand the specialist 
areas of patient-centredness and psychosocial approached to chronic disease. 
Furthermore, the results of this research were the subject of considerable interest by both 
local and national press. The results from this research programme also demonstrate that 
these psychosocial interventions significantly improved several areas of psychosocial 
function and in some patients decreased disease activity. These results strengthen the 
evidence for the use of these interventions in clinical practice, and should engender 
further research in these areas. 
The research programme was novel in several ways. Many of the strengths of this 
research programme reflect this. First, throughout the research programme the PGI was 
used to enhance a patient-centred approach, not only in the design, but also the 
administration of the intervention. Although several studies have employed a `tailored' 
intervention approach where participants could chose from a number of pre-selected 
modules, for example Zauta et al. (2008), to the best of the present author's knowledge, 
no published studies exist where the intervention was based exclusively on what 
participants had identified as being important. 
Throughout the research programme a number of steps were taken to avoid 
unethical study design. First, a consultant rheumatologist was involved in the design of 
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each study. Second, study protocols were presented to a local NHS research ethics 
committee before the commencement of any research. Furthermore, presentations were 
made to a local NHS rheumatology department at interim stages of the research 
programme for feedback. These steps ensured that ethical guidelines were strictly 
adhered to throughout the research programme. 
Finally, Hartrick (2008) suggests that research in clinical practice must be 
relevant. He suggests asking the question, "Who will care? " (Hartrick, 2008, p. 435). 
Considering that RA has a physical, social, and economic impact not only on the patient, 
but also their families and society, the answer to this question involves many parties. 
First, the patient who has improved health related quality of life and improved 
psychosocial functioning will care. Second, the families and carers of those patients will 
also care. Third, the health care providers of RA patients, for example, GP's, 
rheumatology specialist nurses and consultants will also care. Finally, if these 
psychosocial interventions significantly improve both the psychosocial and physical 
health of the patient then it may reduce the burden on health care resources, therefore 
policy makers may also care. 
In conclusion, the primary objective of this research thesis was to investigate the 
use of imagery and hypnotherapy as psychosocial interventions in RA patients. A 
secondary objective was to provide training in research. In the present author's opinion 
these objectives were successfully achieved in the thesis. Specifically, using a patient 
centred approach these two psychosocial interventions were utilised to examine their 
effects on the symptoms associated with this disease. Allowing participants to direct the 
areas for therapeutic change, and using patient reported outcome measures ensured that a 
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patient centred approach was enhanced throughout the research programme. The results 
from the studies indicate a therapeutic benefit following the use of imagery or 
hypnotherapy, although determining which provides the better outcome is difficult to 
ascertain from the results. Specifically, hypnotherapy proved significantly better than 
imagery for stable RA patients, however imagery provided more clinically significant 
changes for active RA patients. 
This research contributes to the knowledge base of psychosocial interventions in 
RA, specifically the use of imagery as a single therapeutic mode, and has also provided 
several areas for additionally research, and has implications for clinical practice. The 
secondary objective of this research programme was to provide training in research, from 
inception of the research question to dissemination of research findings. The training 
provided by this research programme has provided me with the research skills necessary 
to conduct further research and to be able to pass these skills to other future researchers. 
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YOUR PAIN AND FATIGUE 
Your Pain 
Please take a moment and put a cross on the line below that you think represents your pain in the 
last week. 
For example if you had experienced little or no pain during the past week your cross would be 
near the left hand side of the line. 
None As bad as it could 
be 
None 
be 
As bad as it could 
Your Physical Fatigue 
Please take a moment and put a cross on the line below that you think represents your pain in the 
last week. 
None As bad as it could 
be 
Your Mental Fatigue 
Please take a moment and put a cross on the line below that you think represents your pain in the 
last week. 
None As bad as it could 
be 
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PAIN ANMETY SYMPTOM SCALE 
Individuals who experience pain develop different ways to respond to that pain. We would like to 
know what you do and what you think about when in pain. Please use the rating scale below to 
indicate how often you engage in each of the following thoughts or activities. Circle any number 
from 0 (NEVER) to 5 (ALWAYS) for each item. 
Never Always 
I think that if my pain gets too severe, it will never decrease 0 1 2 3 4 5 
When I feel pain I am afraid that something terrible will happen 0 1 12 3 4 5 
I go immediately to bed when I feel severe pain 0 1 12 3 4 5 
I begin trebling when engaged in an activity that increases pain 0 1 2 13 4 5 
I can't think straight when I am in pain 0 1 2 3 4 5 
I will stop any activity as soon as I sense pain coming on 0 1 2 3 4 5 
Pain seems to cause my heart to pound or race 0 1 2 3 4 5 
As soon as pain comes on I take medication 0 1 2 3 4 5 
When I feel pain I think that I may be seriously ill 0 1 2 3 4 5 
During painful episodes it is difficult for me to think of anything else 
besides the pain 
0 1 2 3 4 5 
I avoid important activities when I hurt 0 11 21 3 4 5 
When I sense pain I feel dizzy or faint 0 1 2 3 4 5 
Pain sensations are terrifying 0 1 2 3 4 5 
When I hurt I think about the pain constantly 0 1 2 3 4 5 
Pain makes me nauseous (feel sick) 0 11 21 3 4 5 
When pain comes on strong I think I might become paralyzed or more 
disabled 
0 1 2 3 4 5 
I find it hard to concentrate when I hurt 0 1 2 3 4 5 
I find it hard to calm my body down after periods of pain 0 1 2 3 4 5 
I worry when I am in pain 0 11 2 3 4 5 
I try to avoid activities that cause pain 0 1 2 3 4 
5 
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ARTHRITIS SELF EFFICACY 
For each of the following questions, please circle the number that corresponds to how certain you 
are that you can do the following tasks regularly at the present time. 
Self-Efficacy Pain Scale 
1 How certain are you that you can decrease your pain quite 
a bit? 
2 How certain are you that you can keep arthritis pain from 
interfering with daily activities? 
3 How certain are you that you can keep arthritis pain from 
interfering with your sleep? 
4 How certain are you that you can make a small-to- 
moderate reduction in your arthritis pain by using other 
methods other that extra medication? 
123456789 10 
very 
certain 
very 
certain 
very 
certain 
123456789 10 
very 
certain 
very 
certain 
123456789 10 
very 
certain 
123456789 10 
very 
certain 
very 
certain 
5 How certain are you that you can make a large reduction in 123456789 
10 
your arthritis pain by using methods other than taking 
extra medication? 
very 
certain 
Self-Efficacy Function Scale 
1 How certain are you that you can walk 100ft on flat 
ground in 20 seconds? 
very 
certain 
123456789 10 
very 
certain 
very 
certain 
2 How certain are you that you can walk 10 steps downstairs 123456789 
10 
in 7 seconds? 
very very 
certain certain 
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3 How certain are you that you can get out of an armchair 
quickly, without using your hands for support? 
4 How certain are you that you can button and unbutton 3 
medium-sized buttons in a row in 12 seconds? 
5 How certain are you that you can cut 2 bite-size pieces of 
meat with a knife and fork in 8 seconds? 
123456789 10 
very 
certain 
very 
certain 
123456789 10 
very 
certain 
very 
certain 
123456789 10 
very 
certain 
very 
certain 
6 How certain are you that you can turn an outdoor faucet all 123456789 10 
the way off? 
very 
certain 
7 How certain are you that you can scratch your upper back 
with both your right and left hands? 
8 How certain are you that you can get in and out of the 
passenger side of a car without assistance from another 
person without physical aids? 
9 How certain are you that you can put on a long-sleeve 
front opening shirt or blouse (without buttoning) in 8 
seconds? 
very 
certain 
123456789 10 
very 
certain 
very 
certain 
very 
certain 
123456789 10 
very 
certain 
123456789 10 
very 
certain 
very 
certain 
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HEATH ASSESSMENT QUESTIONNAIRE 
In this section we are interested in leaning how your illness affects your ability to function in daily 
life. Please feel free to add any comments on the back of this page, 
Please CIRCLE the number which describes your usual abilities OVER THE PAST WEEK. 
without ANY with SOME with MUCH UNABLE to do 
difficulty difficulty difficulty 
Dressing & Grooming 
Are you able to: 
Dress yourself including tying shoelaces 0123 
and undoing buttons? 
Shampoo your hair? 0123 
Arising 
Are you able to: 
Stand up from a straight chair? 0123 
Get in and out of bed? 0123 
Eating 
Are you able: 
Cut your meat? 0123 
Lift a full cup or glass to your mouth? 0123 
Open a new milk carton? 0123 
Walking 
Are you able to: 
Walk outdoors on flat ground? 0123 
Climb up five stairs? 0123 
Please tick the boxes that you usually use for any of the activities: 
E Cane E Devices used in dressing 
Fj Walker Built up or special utensils 
E Crutches Li Special or built up chair 
[-ý Wheelchair ) [l Other (Specify: .......................................... 
Please tick the boxes for which you usually need HELP FROM ANOTHER PERSON 
E] Dressing and Grooming 
E Eating 
ersing Walking 
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Please CIRCLE the number which best describes your usual abilities OVER THE PAST 
WEEK. 
without ANY with SOME with MUCH UNABLE to do 
difficulty difficulty difficulty 
Hygiene 
Are you able to: 
Wash and dry your body? 0123 
Take a bath 0123 
Get on and off the toilet? 0123 
Reach 
Are you able to: 
Reach and get down a 51b object from just 0123 
above your head? 
Bend down and pick up clothing from the 0123 
ground? 
Grip 
Are you able to: 
Open car doors? 0123 
Open jars? 0123 
Turn taps on and off? 0123 
Activities 
Are you able to: 
123 Run errands and shop? 0 
Get in and out of a car? 0123 
Do chores such as vacuuming or yard work? 0123 
Please tick the boxes that you usually use for any of the activities: 
Raised toilet seat fl Bathtub bar 
Bathtub seat 
fl Long-handed appliances for reach 
Jar opener Long-handed appliances for reach 
) F-I Other (Specify: .......................................... 
Please tick the boxes for which you usually need HELP FROM ANOTHER PERSON 
Hygiene J Gripping and opening things 
LI Reach LI Errands and chores 
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Your Health and Well-being 
'T'his survey asks for your views about your health. This information will help keep track of how 
you feel and how well you are able to do your usual activities. 
For each of the following question, please tick the one box that best describes your answer. 
1. In general, would you say your health is: 
Excellent Very good Good Fair Poor 
Q Q Q Q Q 
2. Compared to one year ago, how would you rate your health in general now? 
Much better now 
than one year ago 
El 
Somewhat better 
now than one year 
ago 
El 
About the same as 
one year ago 
1-: 1 
Somewhat worse 
now than one year 
ago 
ED 
Much worse now 
than one year ago 
E-1 
3. The following questions are about you might do during a typical day. Does your health 
now limit you in these activities? If so, how much? 
Yes Yes, No, not 
limited a limited a limited at all 
lot little 
participating 
Vigorous 
in 
activities, such 
strenuous 
as 
sports 
running, lifting heavy objects, 
a El 
Moderate activities, such as moving a table, pushing a vacuum 
cleaner, bowling, or playing golf 
Q 
Lifting or carrying groceries 
a Q 
Climbing several flights of stairs 
Q Q 
Climbing one flight of stairs 
Q Q Q 
Bending, kneeling, or stooping 
Q Q Q 
Walking more than a mile Q 
Q Q 
Walking several hundred yards 
Q Q 
Walking one hundred yards 
Q Q Q 
Bathing or dressing yourself F-I 
Q 171 
SF-36v2TM Health Survey C 1992-2002 by Health Assessment Lab, Medical Outcomes Trust and Quality Metric Incorporated. 
All rights reserved SF-361D is a registered trademark of Medical Outcomes Trust. (IQOLA SF-36v2 Standard, English (United 
Kingdom) 08/02) 
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4. During the past 4 weeks, how much of the time have you had any of the following 
problems with your work or other regular daily activities as a result of your physical 
health? 
All of 
the 
Most of 
the 
Some 
of the 
A little 
of the 
None of 
the 
time time time time time 
Cut down on the amount time you 
s ent on work or other activities 
F] F-I 
El 17 1: 1 
p 
Accomplished less than you would 
like 
F7 Q Q Q Q 
Were limited in the kind of work or 
other activitie 
F1 F] Q 1: 1 
s 
I lad difficulty performing the work F71 F-I 
a El El 
or other activities 
5. During the past 4 weeks, how much of the time have you had any of the following 
problems with your work or other regular daily activities as a result of any emotional 
problems (such as feeling depressed or anxious)? 
All of Most of Some A little None of 
the the of the of the the 
time time time time time 
Q Cut down on the amount of time you QQQ 
1-1 
spent on work or other activities 
Accomplished less than you would 
QQQ 
like 
Did work or other activities less 
QQQQ 
carefully than usual F7 
6. During the past 4 weeks, to what extent has your physical health or emotional problems 
interfered with your normal social activities with family, friends, neighbours, or groups? 
Not at all Slightly Moderately Quite a bit Extremely 
0 H 0 H 
7. How much bodily pain have you had during the past 4 weeks? 
None Very Mild Moderate Severe Very 
mild severe 
77 1-1 F-I 0 11 
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8. During the past 4 weeks, how much did pain interfere with your normal work (including 
both work outside the home and housework)? 
Not at all A little Moderately Quite a bit Extremely 
bit 
1-1 171 F-I Fý 
9. These questions are about how you feel and how things have been with you during the 
past 4 weeks. For each question, please give the one answer that comes closest to the way 
you have been feeling. How much of the time during the past 4 weeks. 
AU of 
the 
Most of 
the 
Some 
of the 
A little 
of the 
None of 
the 
time time time time time 
Did you feel full of life? Q 7 1-1 
F1 Q 
Have you been very nervous? Q 7 II 
Q Q 
Eiave you felt so down in the dumps 
that nothing could cheer you up? 
ý ý Q Q 
Have you felt calm and peaceful? Q 
Q Q I II 
Did you have a lot of energy? Q 
Q Q Q 171 
Have you felt downhearted and low? JI 
Q Q Q Ii 
Did you feel won out? Q Q 
Q F-I Q 
Have you been happy? Q 
Q Q Q ru 
Did you feel tired? Q Q 
Q II Q 
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10. During the past 4 weeks, how much of the time has your physical health or emotional 
problems interfere with your social activities (like visiting with friends, relative, etc. )? 
All of the Most of Some of A little of None of 
time the the time the time the time 
time 
Q a Q a F-I 
11. How TRUE or FALSE is each of the following statement for you? 
Definitely 
true 
Mostly 
true 
Don't 
Know 
Mostly 
false 
Definitely 
false 
other 
I seem to 
people 
get ill more easily than 17 
F] 1-1 Q 17 
I am as healthy as anybody I know Q F7 JJ 
Q Q 
I expect my health to get worse Q 
Q Q F71 
Q 
My health is excellent Q 
El QQQ 
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APPENDIX B 
Post Experimental Questionnaire 
Please read over the following questions carefully. In questions 1 to 6, please circle 
the number you feel is your answer. For the other questions please write your answer. 
Q1. Thinking back to when you first decided to take part in this study, what did you 
EXPECT would be the change in your condition? 
No Very Little A little Some A Lot of 
change change change change change 
0123456789 10 
Q2. Thinking back to when you first decided to take part in this study, what did you 
HOPE would be the change in your condition? 
No Very Little A little Some A Lot of 
change change change change change 
0123456789 10 
Q3. You were randomised to the imagery group. What was your initial reaction to this? 
Very Quite Neither satisfied Quite Very 
dissatisfied dissatisfied nor dissatisfied satisf ied satisfied 
0123456789 10 
Q4. How often did you use the CD's during the first 6 weeks? (the first six weeks when 
you met with the experimenter). 
Never Less than More than Every other Every Twice a day 
twice a week twice a week day day or more 
0123456789 10 
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Q5. How often did you use the CD's, after the first 6 weeks, during the next 6 months? 
Never Less than More than Every other Every Twice a day 
twice a week twice a week day day or more 
0123456789 10 
Q6. How easy did you find it to fit listening to the CD's into your schedule? 
Very Quite Neither easy Quite Very 
difficult difficult nor difficult easily easily 
0123456789 10 
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APPENDIX C 
The statements below refer to your feelings and experiences which occur to most people at one time 
or another in their relationships with friends. For each statement there are three possible answers: 
Yes, No, Don't know. 
1. My friends give me the moral support I need. Yes No Don't Know 
2. Most other people are closer to their friends than I am. Yes No Don't Know 
3. My friends enjoy hearing about what I think. Yes No Don't Know 
4. Certain friends come to me when I have problems or need advice. Yes No Don't Know 
5. I rely on my friends for emotional support. Yes No Don't Know 
6. If I felt that one or more of my friends were upset with me, 
I'd just keep it to myself. Yes No Don't Know 
7. 1 feel that I am on the fringe with my circle of friends. Yes No Don't Know 
8. There is a friend that I could go to if I were feeling down, 
without feeling funny about it later. Yes No Don't Know 
9. My friends and I are very open about what we think about things. Yes No Don't Know 
10. My friends are sensitive to my personal needs. Yes No Don't Know 
11. My friends come to me for emotional support. Yes No Don't Know 
12. My friends are good at helping me solve problems. Yes No Don't Know 
13. I have a deep sharing relationship with a number of friends. Yes No Don't 
Know 
14. My friends get good ideas about how to do things or make ' things from me. t Know Yes No Don 
15. When I confide in friends it makes me feel uncomfortable. Yes No Don't Know 
16. My friends seek me out for companionship. Yes No Don't Know 
17. I think that my friends feel that I'm good at helping them ' 
solve problems. t 
Know Yes No Don 
18. I don't have a relationship with a friend that is as intimate 
as other people's relationships with friends. Yes No Don't Know 
19. I've recently gotten a good idea about how to do something ' from a friend. t 
Know Yes No Don 
20.1 wish my friends were much different. Yes No 
Don't Know 
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The statements which follow now refer to feelings and experiences which occur to most people at 
some point or another in their relationships with their families. Again, for each statement there is 
three possible answers: Yes, No, and Don't know. Please write your answer next to each statement. 
I I. My family gives me the moral support I need. 
2. I get good ideas about how to do things or make things 
from my family. 
3. Most people are closer to their family than I am. 
4. When I confide in the members of my family who are closest 
to me, I get the idea that it makes them feel uncomfortable. 
5. My family enjoys hearing about what I think. 
6. Members of my family share many of my interests. 
7. Certain members of my family come to me when they 
have problems or need advice. 
8.1 rely on my family for emotional support. 
9. There is a member of my family I could go to if I was feeling 
down, without feeling funny about it later. 
10. My family and I are open about what we think about things. 
11. My family are sensitive to my personal needs. 
Yes No Don't Know 
Yes No Don't Know 
Yes No Don't Know 
Yes No Don't Know 
Yes No Don't Know 
Yes No Don't Know 
Yes No Don't Know 
Yes No Don't Know 
Yes No Don't Know 
Yes No Don't Know 
Yes No Don't Know 
12. Members of my family come to me for emotional support. Yes 
13. Members of my family are good at helping me to solve problems. Yes 
14.1 have a deep sharing relationship with a number 
of members of my family. Yes 
15. Members of my family get good ideas about how to do things 
or make things from me. Yes 
16. When I confide in my family it makes me feel uncomfortable. Yes 
17. Members of my family seek me out for companionship. Yes 
18. I think my family feels that I'm good at helping them solve 
problems. Yes 
19. I don't have a relationship with a member of my family that is 
as close as other people's relationships with family members. 
20.1 wish my family were much different. 
No Don't Know 
No Don't Know 
No Don't Know 
No Don't Know 
No Don't Know 
No Don't Know 
No Don't Know 
Yes No Don't Know 
Yes No Don't Know 
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These sets of statements refer to feelings and experiences which occurred to you when you were 
taking part in the research study with the experimenter. For each statement there are three possible 
answers: Yes, No and Don't know. Please write your answer beside each statement. 
1. The experimenter gave me the emotional support I needed. Yes No Don't Know 
2. I got good ideas about how to do things or make things from 
the experimenter. Yes No Don't Know 
3. Most other participants were closer to the experimenter 
than I was. Yes No Don't Know 
4. When I confided the experimenter I got the idea it made 
them uncomfortable. Yes No Don't Know 
5. The experimenter enjoyed hearing about what I think. Yes No Don't Know 
6. The experimenter shared many of my interests. Yes No Don't Know 
7. The experimenter could come to me when they had a problem ' or needed advice. t Know Yes No Don 
8. I relied on the experimenter for emotional support. Yes No Don't Know 
9. The experimenter was someone I could go to when I felt down ' without feeling funny about it later. t Know Yes No Don 
10. The experimenter and I were open about what we think ' 
about things. t 
Know Yes No Don 
11. The experimenter was sensitive to my personal needs. Yes No Don't Know 
12. The experimenter came to me for emotional support. Yes No 
Don't Know 
13. The experimenter was good at helping me solve my problems. Yes No 
Don't Know 
14. I have a deep sharing relationship with the experimenter. Yes 
No Don't Know 
15. The experimenter got good ideas about how to do things or ' 
make things from me. t 
Know Yes No Don 
16. When I confide in the experimenter it makes me feel ' 
uncomfortable. t 
Know Yes No Don 
17. I think the experimenter thought I was good at helping ' them solve problems. t 
Know Yes No Don 
18. I didn't have a relationship with the experimenter as close 
as other participants relationship with the experimenter. Yes 
No Don't Know 
19. 1 wish the experimenter was much different. Yes No 
Don't Know 
Thank you for answering these questions. 
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APPENDIX D 
EXAMPLE OF AN IMAGERY INTERVENTION 
Participant AB randomised to the imagery intervention group. 
Session I- Same session given to all participants in the imagery group. This was a general introduction 
to imagery. The principle aim of this session was to help participant AB to use as many sensory 
modalities as possible, for example, sight, smell, taste, hearing, and touch. 
Within this introductory session participant AB was asked to imagine picking up an orange from 
a fruit bowl, peeling the orange with her fingers and eating a segment of the orange. During the session 
she was invited to describe as many things as possible. For example participant AB said that the fruit 
bowl was made of glass and had flowers etched around the sides. She was encouraged to describe how 
her hands felt as she picked up the orange from the glass fruit bowl, the texture of the orange in her hand 
and to imagine the smell of the orange. Participant AB was then asked to imagine starting to peel the 
orange, and to imagine hearing the skin of the orange tear away from the fruit. She was also asked to 
imagine that she could see the zest of the orange splashing over her fingers as she tore at the skin. Finally, 
participant AB was asked to imagine taking one segment of the orange and eating it. She was encouraged 
to talk about how this felt and any physiological reactions she had to this imagery session. 
Session 2- This session was based on the individual item identified in the PGI: `Spending time with the 
grandchildren without, feeling tired 
Before the imagery session commenced participant AB identified that she enjoys playing 
football with her two grandsons in the garden. However, as she tires so quickly she cannot play as long as 
she and her grandsons would like to. At the beginning of the imagery session participant AB was 
encouraged to imagine herself in the garden with her grandchildren playing football. She was asked to 
describe the surroundings and provide as much information as possible about the environment, including 
visual, auditory, kinaesthetic, and emotional information. Throughout the session she was encouraged to 
imagine how her muscles and joints were working as she kicked the ball gently to her grandson and his 
reaction when he managed to save the ball going into the net. Participant AB was also encouraged to 
imagine her energy levels increasing as she played and enjoyed the game. Participant AB reported that 
she would visualise a thermometer like object to represent her energy levels and how she would increase 
this by turning a valve on at the bottom of the thermometer to increase her energy level and prevent 
tiredness. A primary focus would be on the pleasurable aspect of being able to spend time in this activity 
with her grandsons without being tired. 
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APPENDIX E 
EXAMPLE OF A HYPNOTHERAPY IN'T'ERVENTION 
Participant CD was randomised to the hypnotherapy group. 
Session I- Same session given to all participants in the hypnotherapy group. This was a general 
introduction to hypnotherapy. The principle aim of this session was to help participant CD become familiar 
with the use of hypnotherapy. 
Within this introductory session participant CD was asked to focus her eyes on a spot on her hand. 
She was given verbal suggestions that her eyelids were becoming heavier and heavier, until she felt that she 
wanted to close her eyelids. It was then suggested to her that she would go into a deeper hypnotic trance as 
the experimenter counted down from six to zero. After this deepening procedure participant CD was asked 
to imagine taking an orange from a fruit bowl, similarly to participant AB in the imagery group. She was 
asked to imagine picking up an orange from a fruit bowl, peeling the orange with her fingers and eating a 
segment of the orange. During the session she was invited to describe as many things as possible. She was 
encouraged to describe how her hands felt as she picked up the orange from the glass fruit bowl, the texture 
of the orange in her hand and to imagine the smell of the orange. Next participant CD was asked to imagine 
starting to peel the orange, and to imagine hearing the skin of the orange tear away from the fruit. She was 
also asked to imagine that she could see the zest of the orange splashing over her fingers as she tore at the 
skin. Finally, participant CD was asked to imagine taking one segment of the orange and eating it. After this 
it was suggested to participant CD that she would gradually start to reorient herself as the experimenter 
counted up from zero to six. 
Session 2- This session was based on the individual item identified in the PGI: `Spending too much time in 
bed in the morning because ofpain in her knees' 
Before the hypnotherapy session commenced CD identified that she felt as though she spent too 
much time in bed in the morning because of pain in her knees. She said that the pain often stopped her from 
doing things she had to get done, for example housework and shopping. Using the same procedure as in the 
introductory session, participant CD focussed her eyes on a spot on her hands and continued with the 
deepening procedure, counting down from six to zero. It was then suggested to participant CD that she was 
inside a control room that represented her brain, and that this room was full of dials and digital read-outs. 
Whilst in this room she was instructed to find the dial that represented the pain sensation in her knees. After 
identifying the correct dial, participant CD was instructed to breath in as she reached up for that dial, and to 
breath out as she turned the dial down. This was repeated several times before she was then asked to 
imagine herself getting out of bed in the morning with no pain in her knees. Towards the end of the session 
participant CD was then asked reorient herself and open her eyes by the time the experimenter counted up 
from zero to six. 
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PERSONAL STATEMENT 
Before starting this research programme I had often heard many other PhD students and 
graduates say how their life was on hold until they finished their thesis. Naively, I thought 
that life was too short to put on hold, and with several years of research and clinical 
experience behind me I would not have to put my life on hold. 
For me this research programme was more than `doing' research. It was a particularly 
steep learning curve. At the start I really enjoyed what I was `doing'. Designing the studies, 
recruiting patients, administering the interventions, and collecting data. This is the part I 
enjoyed the most. However, conducting a research programme is a whole lot more than this. 
Within submitting the first draft of the first study it became apparent that my greatest 
weakness (apart from taking instruction! ) was academic writing. I was (and perhaps still am! ) 
hopeless at it. Finding and collecting information related to the research area - not a problem. 
However, structuring it into a critical piece of work .... hmmm, I had lots to learn. 
During the last year of this research programme I have never worked so hard, never 
tried so hard, and put my life on `hold'. And it was tiring - not only for me, but also my 
supervisors. Without their help and tuition I have no doubts that I would not be submitting 
this thesis today - or anytime in the near future. Finishing the task and writing the thesis was 
a lengthy process of writing then taking irrelevant parts out, and adding more relevant parts 
in, which culminated in this written piece of work. Although it was a struggle for me to 
produce this thesis, I believe that it has not taken away the exciting findings that have come 
out of the research. This thesis identifies that areas such as health related quality of life, 
specifically how this construct is operationalised and measured, needs further attention, it 
also identifies that imagery and hypnotherapy, these simple and easily applied psychosocial 
interventions helped many participants, and may even had influenced the biology of their 
disease. For me this has been exciting. 
Therefore, asking myself if I would do it all again, I have to be honest and say that I 
would. The past four years of this research programme has enriched my life. I have learnt so 
much more than I thought I would at the start. I have met many wonderful people who have 
taught me valuable skills and life lessons. I would do it all again if I had to. Would I change 
anything if I had to do it all over again? I probably would. I would focus more on academic 
writing at the very start. 
